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Summary 
Due to increased urbanisation, frequent droughts and poor water sources in rural communities, 
the scarcity of water has become a major concern. Water is an essential part of life – in order to 
meet the ever growing demand for water, it is imperative to search for alternative water 
sources. Domestic rainwater harvesting (DRWH) is considered a potential source of water and is 
commonly used in most parts of the world. However, the microbial quality of harvested 
rainwater poses a serious health risk to the consumer. Pathogenic bacteria such as 
Staphylococcus spp., Salmonella spp., Pseudomonas aeruginosa and Klebsiella spp., amongst 
others, have been associated with rainwater harvesting systems and the poor quality of the 
water is mainly attributed to faecal contamination caused by mammals, birds and reptiles.  
Generally, these pathogenic strains are highly virulent and are often resistant to common 
antimicrobials utilised for the treatment of diseases caused by these pathogens. An increase in 
drug-resistant infectious diseases presents a significant challenge to antimicrobial therapies. 
Urgent developments of novel antimicrobial agents are required to treat a wide spectrum of 
targets which include bacteria, fungi, viruses and parasites.  
Actinomycetes are a group of soil microorganisms known for the production of bio-active 
compounds. Streptomyces pharetrae CZA14T is one such actinomycete which was first 
described in 2005. Preliminary tests revealed that the strain has the ability to produce bio-
active compounds. Subsequently, the genome of CZA14T was sequenced and submitted to an 
online secondary metabolite prediction software, antiSMASH, to predict secondary metabolite 
biosynthetic gene clusters (smBGCs) which then govern the expression of the compounds of 
interest. Fifty-five smBGCs encoding for secondary metabolites of interest were predicted by 
antiSMASH, of which, 23 were non-ribosomal peptide synthetases (NRPSs), seven were 
lantipeptide/lassopeptides/bacteriocins, eight were polyketide synthases (PKSs) and the 
remaining 17 biosynthetic gene clusters include genes for siderophores, terpenes, 
butyrolactones, ectoines, melanin and genes labelled as “other”.  
In the current study, previously identified optimal production media and fermentation 
conditions for maximum antimicrobial production by CZA14T were scaled-up from 0.5 L, 1 L and 
2 L baffled flasks, to fermentation in a 3 L airlift reactor (ALR) and a 5 L continuous stirred tank 
reactor (CSTR). Solvent extractions were performed on both the supernatant and mycelia to 
test for extra- and intra-cellular production of bio-active compounds. Fermentation samples 
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were also collected from the ALR at days 3, 6, 9 and 12, and used for molecular studies for 
which RNA extraction was performed and cDNA was synthesised and sequenced. Using 
molecular techniques, it was determined that CZA14T possess the genes for the expression of a 
Type-II PKS – curamycin A. Sequence information indicated that the Type II PKS involved in the 
production of curamycin A was expressed under the fermentation conditions used in the ALR. 
This Type-II PKS corresponded to the predicted Type-II PKS from contig 196, cluster 24 of the 
CZA14T genome. 
Solvent extracts were analysed using Thin Layer Chromatography (TLC) and the inhibitory 
efficacy of the crude and partially purified extracts were determined using filter disk diffusion 
and bioautography assays against a range of ATCC clinical test strains and environmental DRWH 
system isolates. Compounds separated by TLC showed bands with similar Rf values when 
visualised under UV light throughout all fermentation processes, but the focus of the study was 
mostly on the extracts prepared from the fermentation in the ALR. Compounds produced by 
CZA14T exhibited a broad spectrum of bio-activity against all the test strains used in this study, 
displaying both anti-bacterial and anti-fungal activity. Compounds produced by CZA14T in the 
ALR displayed various chemical and physicochemical characteristics as determined by different 
staining methods of the developed TLC plates and UV/Vis spectroscopy of the biologically active 
compounds. 
The crude compounds were partially purified using silica column chromatography and the 
fractions collected were analysed by liquid chromatography-mass spectrometry (LC-MS). 
Furthermore, the ALR fermentation broth was subjected to ammonium sulphate precipitation, 
dialysis and organic solvent extraction. This yielded a set of bio-active compounds with activity 
against various ATCC strains and DRWH system isolates. This sample was also subjected to LC-
MS analyses and results showed the presence of a mass (1374.8 m/z) that corresponds to that 
of curamycin A, which serves as additional confirmation that the smBGC that encodes for 
curamycin A, is expressed under the fermentation conditions used in the ALR. Future studies 
will focus on the purification and structural elucidation of the bio-active compounds produced 
by CZA14T, including curamycin A.  
Key words: antimicrobial, polyketide synthases (PKSs), curamycin, broad-spectrum bio-activity 
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Opsomming 
Toenemende verstedeliking, gereelde droogtes, swak gehalte water en skaars waterbronne, 
veral in landelike gebiede, is ‘n bron van kommer wat voorsiening van vars water aanbetref. 
Water is noodsaaklik vir lewe en om die groeiende vraag na water te voorsien, is dit 
noodsaaklik om alternatiewe waterbronne te ondersoek. Die opvang van reënwater word as 'n 
potensiële alternatiewe bron van water beskou en word algemeen in baie dele van die wêreld 
as ‘n water bron gebruik. Daar is egter ‘n ernstige gesondheidsrisiko verbonde aan die gebruik 
van versamelde reënwater, veral as dit as drink-water bron gebruik word. Die rede hiervoor is 
dat patogene soos Staphylococcus spp., Salmonella spp., Pseudomonas aeruginosa en Klebsiella 
spp. bewys is om teenwoordig te wees in reënwater tenks, en die kontaminasie van die tenks 
met hierdie patogene word dan algemeen toegeskryf aan fekale besmetting van die opvang 
area van die tenks deur klein soogdiere, voëls en reptiele. Hierdie patogene is oor die algemeen 
hoogs virulent en weerstandig teen antimikrobiese middels wat huidiglik gebruik word om 
siektes te behandel wat deur hierdie organismes veroorsaak word. 'n Toename in 
antimikrobiese weerstandige infeksies en siektes plaas druk op antimikrobiese terapie vir die 
suksesvolle behandeling van hierdie infeksies en siektes. Daarom is dit noodsaaklik om nuwe 
antimikrobiese middels te ondersoek wat effektief sal wees teen ‘n wye spektrum van 
bakterieë, fungi, virusse en parasiete.  
 
Aktinomisete is 'n groep grond mikro-organismes wat bekend is vir die produksie van bio-
aktiewe verbindings. Streptomyces pharetrae CZA14T is een so aktinomiseet wat vir die eerste 
keer in 2005 beskryf is. Voorlopige toetse het getoon dat CZA14T die vermoë het om bio-
aktiewe verbindings te produseer. Die genoom volgorde van CZA14T is daarom bepaal. Die 
genoom is toe gebruik om die teenwoordigheid van sekondêre metaboliet biosintetiese geen 
klusters (smBGKs) te voorspel, wat beheer uitoefen oor die uitdrukking van bio-aktiewe 
verbindings. Dit is gedoen deur gebruik te maak van die sagteware AntiSMASH. Vyf-en-vyftig 
smBGCs is geïdentifiseer deur AntiSMASH, waarvan 23 kodeer vir nie-ribosomale peptied 
sintetases (NRPSs), sewe kodeer vir lantipeptiede / lassopeptiede / bakteriosiene, agt kodeer 
vir poliketide sintases (PKSs) en die oorblywende 17 biosintetiese geen klusters kodeer vir 
siderofore, terpene, butyrolaktone, ektoines, melanien en gene wat as "ander" beskryf is. 
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In die huidige studie is ‘n medium en fermentasie kondisies gebruik wat voorheen bewys is om 
optimaal te wees vir die produksie van antimikrobiese verbindings deur CZA14T. Die 
eksperimente is opgegradeer van 0.5 L, 1 L en 2 L gekeepte fles fermentasies na fermentasie in 
‘n 3 L “airlift reactor (ALR)” en 5 L aanhoudend gemengde tenk reaktor (CSTR). Ekstraksies is 
uitgevoer op beide die miselium en supernatant om te toets vir intra- en ekstrasellulêre 
produksie van bio-aktiewe verbindings. Fermentasie monsters is ook geneem uit die ALR op dag 
3, 6, 9 en 12, en daarna gebruik vir molekulêre analises naamlik: RNA ekstraksies, cDNA sintese 
en cDNA volgorde bepaling. Deur die gebruik van molekulêre tegnieke, is vasgestel dat CZA14T 
gene besit vir die uitdrukking van 'n Tipe-II PKS kuramisin A. Volgorde inligting het aangedui dat 
die Tipe-II PKS, onder die gespesifiseerde fermentasie kondisies in die ALR, uitgedruk is. Hierdie 
Tipe-II PKS het ooreengestem met die voorspelde Tipe-II PKS van kontik 196, kluster 24 van die 
genoom van CZA14T. 
 
Oplosmiddel ekstraksies is ontleed met behulp van dunlaagchromatografie (DLC) en die 
inhiberende doeltreffendheid van die kru- en gedeeltelike gesuiwerde ekstraksies is bepaal 
deur gebruik te maak van diffusie filter skyfies en bioautografiese toetse. Die ekstraksies is 
getoets teen 'n reeks ATCC kliniese isolate en omgewings-isolate wat vanuit reënwater tenks 
geïsoleer is. Die verbindings wat met behulp van DLC geskei is, het deurentyd dieselfde bande 
getoon (onder UV-lig gevisualiseer) met ooreenstemmende Rf-waardes vir die fermentasie-
tydperk. Die fokus van die studie was egter op die ekstraksies wat vanuit die fermentasie-
produk van die ARL voorberei is. Die verbindings wat deur CZA14T geproduseer is, was aktief 
teen al die toets organismes wat in hierdie studie gebruik is en het dus beide anti-bakteriële en 
anti-fungi aktiwiteit getoon. Verbindings wat deur CZA14T geproduseer is in die ALR, het 
verskeie chemiese en fisiese-chemiese eienskappe vertoon, soos bepaal deur verskillende 
kleuringsmetodes van die ontwikkelde DLC plate en UV / Vis spektroskopie van die biologiese 
aktiewe verbindings. 
 
Die kru-verbindings is gedeeltelik gesuiwer met behulp van silika kolomchromatografie en die 
versamelde breukdele is ontleed deur vloeistofchromatografie-massaspektrometrie (LC-MS). 
Daarbenewens is die ALR fermentasie mengsel onderwerp aan ammoniumsulfaat presipitasie, 
dialise en organise oplosmiddel ekstraksie. ‘n Stel bio-aktiewe verbindings, wat aktiwiteit teen 
‘n verskeidenheid ATCC – en reënwater isolate getoon het, is op hierdie manier geïdentifiseer. 
Hierdie monster is ook blootgestel aan LC-MS analise en resultate het die teenwoordigheid van 
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'n massa (1374,8 m/z), wat ooreenstem met dié van kuramisin A, getoon. Hierdie resultate dien 
as addisionele bevestiging dat die smBGC wat kodeer vir kuramisin A uitgedruk word tydens die 
ALR fermentasie kondisies. Toekomstige studies sal fokus op die suiwering en strukturele 
ontleding van die bio-aktiewe verbindings wat deur CZA14T geproduseer word, insluitende 
kuramisin A. 
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Clarification of basic terms and concepts 
Actinomycete:  Filamentous, Gram positive bacterium, typically with a high GC content in its 
DNA 
Antimicrobial: A natural or synthetic substance capable of inhibiting the growth of a 
microorganism  
Antimicrobial Resistance: Ability of an organism to resist the effects of a pharmacological 
compound/drug 
Bio-active Compound:  A compound that has an effect on a living cell, tissue or organism 
Bactericidal Activity:  An agent/compound capable of killing a bacterium 
Bacteriostatic Activity:  An agent/compound which prevents the growth of a bacterium 
Gene: A section/region of DNA that encodes a protein product or functional RNA 
Genome: A particular organism’s complete genetic material/make-up 
Nosocomial infection:  An infection acquired in hospitals 
Secondary Metabolite: Compounds which are not directly involved in the normal development, growth 
or reproduction of an organism 
Zone of Inhibition:  Area of clearing around an actinomycete colony or filter disk impregnated with 
a bio-active compound when exposed to test strains 
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CHAPTER 1: INTRODUCTION 
1.1. Background Introduction 
Water is imperative to the survival of all living organisms. The provision of adequate, accessible 
and safe water sources to the entire global population is thus essential. Currently a number of 
the world’s population, particularly in sub-Saharan Africa, struggle to obtain access to a safe 
drinking-water source and often results in zoonotic disease outbreaks.  Rainwater harvesting 
(RWH) has been earmarked as an alternative and sustainable water source and has been 
adopted in many countries worldwide. However, numerous pathogenic microorganisms have 
been isolated from RWH tanks, which could negatively affect the health of the consumer.  This 
problem is exacerbated as microorganisms isolated from the environment often build up or 
acquire resistance to various classes of antibiotics. 
1.2. Motivation for study 
The growing prevalence of infections associated with poor drinking water quality and the 
emergence of new pathogenic organisms that are resistant to current antimicrobial therapies, 
together with a decrease in the number of compounds entering the market for treatment of 
these diseases, presents a challenge. It is therefore imperative to search for new, efficient and 
safe antimicrobials with novel mechanisms of action that are active against a broad range of 
pathogens.  
Streptomyces pharetrae CZA14T used in this study has the potential to produce a number of 
biologically active compounds when conditions for production are optimised. In a previous 
study, the genome of strain CZA14T was sequenced and annotated. The genome of CZA14T was 
analysed during a study that was conducted in fulfilment of the academic requirements for an 
Honours degree (Kim Durrell, UWC, 2013). The bioinformatics online tool, antiSMASH, detected 
55 biosynthetic gene clusters indicating the potential of this strain for antimicrobial production. 
The optimised parameters for the production of the maximum number of compounds was also 
determined during this study and served as the basis for the scale-up production of 
antimicrobials that was the focus of the current study. 
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1.3. Aims and Objectives 
The aim of this study was to scale-up the production of the bio-active compounds produced by 
strain CZA14T and to test their bio-activity against a range of American Type Culture Collection 
(ATCC) strains and domestic rainwater harvesting (DRWH) system isolates. The specific 
objectives of the study were therefore the following: 
a) The optimisation of medium-scale (3 L and 5 L) production of secondary metabolites 
produced by S. pharetrae CZA14T; 
b) To test the inhibitory efficacy of crude antimicrobial extracts against a number of known 
pathogenic bacteria (ATCC test strains); 
c) To test the inhibitory efficacy of crude antimicrobial extracts against the pathogenic 
bacteria isolated from the DRWH systems; and 
d) The partial purification of selected compounds and the determination of their 
antimicrobial profiles. 
1.4. Methodology 
Phase 1: A pre-determined production medium for optimal antimicrobial production were 
scaled-up to medium- and larger-scale production in baffled flasks (2 L size) and/or 
fermentation vessels (3 L and 5 L capacity). 
Phase 2: Inhibitory efficacy of antimicrobials produced by strain CZA14T during fermentation 
processes in phase 1 were tested against a wide range of known pathogenic microorganisms 
(e.g. bacteria and microfungi/yeasts) to determine bio-activity potential. 
Phase 3:  Purification techniques suitable for the separation of compounds produced by strain 
CZA14T were determined and applied in this study. Furthermore, LC/MS analysis was 
performed to determine the exact mass of compounds produced by strain CZA14T. 
1.5. Structure of Thesis 
This thesis consists of an introduction and literature review (Chapter 1 and 2), four 
experimental chapters (Chapters 3, 4, 5 and 6), and one chapter concluding the thesis. Chapter 
3 focused on the production of secondary metabolites produced by S. pharetrae CZA14T used in 
this study in varying fermentation vessels. Chapter 4 focused on the antimicrobial potential of 
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strain CZA14T against a range of ATCC test strains and DRWH isolates, as well as, the partial 
identification of DRWH system isolates using 16S rRNA gene sequencing. Chapter 5 focused on 
the partial purification of selected compounds produced by strain CZA14T. Lastly, Chapter 6 
focused on the biosynthetic potential of strain CZA14T; molecular and bioinformatics based 
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CHAPTER 2: LITERATURE REVIEW 
2.1. Chapter Summary 
The literature review covers aspects of domestic rainwater harvesting (DRWH), the microbial 
quality of water found in DRWH tank systems, the diseases associated with the consumption of 
rainwater collected in these systems, and ways to curb the spread of diseases caused by 
pathogens found in DRWH systems. The chapter concludes with information on antimicrobials, 
and actinomycetes as a source of these compounds. 
2.2. Introduction 
Over the past few decades an increased incidence of infectious diseases caused by 
microorganisms resistant to conventional treatment has been observed with one of the leading 
causes attributed to waterborne outbreaks (WHO: Antimicrobial Resistance, 2012). These 
infections may result in prolonged disease and even untreatable diseases, which eventually 
result in death. Poor sanitation along with inadequate drinking-water quality is of global 
concern as it is amongst the world’s major causes of preventable morbidity and in turn, 
mortality (OECD and WHO, 2003).  
In order to alleviate this problem, the Millennium Development Goals (MDGs) were established 
by the United Nations (UN) in the year 2000. One-hundred and three UN member states and at 
least 23 international organisations adopted this strategy with South Africa being one of its 
signatories. The target of the MDGs was to halve the proportion of people who are without 
sustainable water sources and basic sanitation by the year 2015 (Millennium Project, 2006). 
According to the 2012 projected results in the WHO and the UN International Children’s 
Emergency Fund (UNICEF) 2014 update report, more than two billion people worldwide have 
received an improved drinking-water source since 1990. One-hundred and sixteen countries 
have reached the water target set out by the MDGs, while 77 countries have met the MDGs 
target for sanitation; furthermore, 56 countries have already met the MDGs target for both 
water and sanitation (WHO and UNICEF, 2014).  
However, according to the 2014 WHO/UNICEF update report, at least 11% of the world’s 
population remain without access to an improved source of drinking-water with sub-Saharan 
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Africa having the lowest drinking-water coverage as depicted in Figure 2.1 (WHO and UNICEF, 
2014). 
Figure 2.1: Proportion of the world's population that are using an improved drinking-water source in 
2012 (WHO and UNICEF, 2014). 
Currently, more than 663 million people world-wide still lack access to an improved drinking-
water source (United Nations, 2015), with more than 300 million people in sub-Sahara Africa 
still utilising inadequate water supplies. In addition, almost 173 million people rely on 
untreated groundwater with well over 90% of these people living in rural areas.  
A post-2015 development agenda was devised, the Water, Sanitation and Hygiene (WASH) 
report, with targets to obtain universal access to basic drinking water, sanitation and hygiene 
for schools, households and health facilities; and to halve the proportion of the world’s 
population without access to safe and manageable drinking water and sanitation services by 
the year 2030 (WHO and UNICEF, 2014). Improved water and sanitation can significantly reduce 
water-borne illness associated with morbidities. With an increasing population and the looming 
negative effects of climate change, water conservation is key for survival. Many countries 
world-wide are searching for alternative water sources to ensure sustainability, and rainwater 
harvesting (RWH) serves as an alternative for the world to meet the MDGs by 2030 (WHO and 
UNICEF, 2014). 
RWH is a technology used for the concentration, collection and storage of rainwater from land 
surfaces, rooftops or rock catchments (Abdel Khaleq and Ahmed, 2007). There are three main 
types of RWH systems namely: 
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1) In situ RWH – it involves water storage in the soil profile by the entrapment of the 
rainwater where it falls; 
2) External water harvesting - involves the collection of rainwater that has run off a surface 
elsewhere and is stored offsite; both in situ RWH and external RWH is used for 
agricultural use; and 
3) Domestic RWH – is associated with the collection of run-off water from roofs, 
courtyards and streets. 
The main focus of this study is on DRWH and diseases commonly associated with the water 
collected and stored in these systems. 
2.3. Domestic Rainwater Harvesting Systems 
Domestic rainwater harvesting can be defined as the collection of rainwater which has runoff 
from ground or roof-top surfaces and is used as a domestic water supply for purposes such as 
drinking, cooking and washing (Worm and van Hattum, 2006).  There are a number of 
advantages for the collection and storage of rainwater (RW) for domestic use, which include: 
1) It is a simple, low cost technology that makes use of inexpensive material to store RW; 
2) In rural areas in particular, water sources are traditionally situated a distance away from 
the community, DRWH provides point-of-use for added convenience; 
3) RW is a renewable resource with low impact to the environment; and 
4) RW may be used as a supplementary water resource along with more ‘conventional’ 
water supply technologies to balance existing water supplies in rural communities and 
even in areas of the world where adequate water resources are available to combat 
ever growing water demands. 
Many countries including Australia, Canada, Denmark, Germany, India, Japan, New Zealand, 
Thailand and the United States have recognised RWH as an alternative water resource for non-
potable uses (Despins et al., 2009). The Department of Science and Technology (DST) and the 
Department of Water Affairs (DWA; now Department of Water and Sanitation) has distributed 
domestic rainwater tanks throughout Limpopo, KwaZulu-Natal, the Eastern Cape, the Free State 
Stellenbosch University  https://scholar.sun.ac.za
9 
 
and the Western Cape (de Lange, 2006). However, only 0.4% of households are currently 
equipped with DRWH systems (Statistics South Africa, 2010).  
Although DRWH is a simple, low cost technology that conserves water and is convenient, 
flexible, adaptable, and provides better water quality than groundwater, there are some 
disadvantages associated with DRWH systems. The system is prone to contamination via air 
pollution, animal and bird droppings, insect, dirt, and organic matter that could pose a serious 
health risk. The greatest challenge for the 21st century is microbial pathogens within the water 
that easily goes undetected due to the lack of available methodology to quantify these 
organisms and the lack of knowledge of RW consumers.  
2.3.1. Microbial Quality of Water found in DRWH systems 
Waterborne pathogens such as Legionella species (spp.), some mycobacterial species, 
Naegleria fowleri, Pseudomonas aeruginosa and “enteric” pathogens such as Salmonella, 
Campylobacter, Giardia and Cryptosporidium species associated with faecal matter, are 
commonly found in polluted water and are easily adaptable to the low nutrient, chemical, 
physical and biological conditions found in water. Water plays an essential role for these 
pathogens by acting as a vehicle of transmission. The lifespan of the pathogen and the period of 
time it survives in water is greatly dependent on the pathogen itself (Percival et al., 2014). For 
example, pathogens such as Cryptosporidium spp. and Giardia spp. have extended periods of 
survival in water because of their resistant cysts/oocysts; whereas pathogens such as 
Escherichia coli O157 and Vibrio cholera were previously believed to be host-dependent for 
replication and their growth in water, was only exhibited under special conditions (Vital et al., 
2007; 2008).  
Fundamentally, harvesting RW prior to contamination is key. However, this is difficult to 
achieve as pollution may take place through cross-contamination of raindrops through polluted 
air, on the collection surface or in the storage container. It is thus important to treat harvested 
rainwater before consumption to reduce the occurrence of infection. The most commonly used 
techniques used to treat RW is by coagulation, flocculation, sedimentation, filtration and 
disinfection (WHO, 1982). DRWH systems may also be fitted with first flush filters to clean the 
catchment area inside of the storage tank and to divert the first few millilitres of RW to improve 
water quality (Mwenge Kahinda et al., 2007). These type of devices may not always be made 
available to rural communities and most DRWH users make use of their own storage tank 
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systems and disinfect the RW by boiling or chlorination to kill any bacteria present in the RW 
(Dillaha and Zolan, 1985). Chlorination in turn also has its disadvantages as it may form 
dangerous by-products when interacting with organic matter found in sludge which settles at 
the bottom of the water storage tanks. While chlorination and boiling inactivates many 
waterborne pathogens, it does not kill Mycobacterium spp. and Cryptosporidium parvum 
oocysts (Gordon et al., 1995).  
Most waterborne pathogens form biofilms to protect themselves against stress factors such as 
organism density, nutrient depletion, changes in temperature and other abiotic and biotic 
factors (Al-Azemi et al., 2010; Garny et al., 2009). Biofilms are slimy coatings which form under 
unhygienic practices; they are formed by the combination of bacterial organisms which excrete 
exopolysaccharides and attach themselves to surfaces for further replication. These biofilms 
can also form on the water surfaces as ‘floating biofilms’ and can offer refuge to viruses and 
protozoa which cannot actively form biofilms. The biggest challenge associated with these 
biofilms is sampling and detection of waterborne pathogens as biofilms are considered the 
place in which different species form close contact with each other. This enables these 
organisms to communicate via signals, internalise smaller microorganisms and transfer genetic 
material with each other which in turn helps in the survival of the pathogen in water. Increased 
resistance to disinfection and other stress factors are often observed when biofilms are present 
making it problematic to treat water containing these biofilms (Percival et al., 2014).  
In general, waterborne pathogens are transmitted via the faecal-oral route. Other means of 
transmission can be through healthy hair, skin, urine, wounds, mucus, sputum and saliva; this is 
most likely to occur by inhalation of aerosols. Assessing the safety of harvested RW by testing 
for numerous pathogens would thus be technically and economically impractical.  Currently, 
there are no standards put into place for RW quality in South Africa. Guidelines for assessing 
the microbial quality of potable water involve the use of indicator organisms to monitor the 
quality of water by detecting the presence or absence of pathogens in the water. The downside 
of testing for indicator organisms is that there is no single indictor organism which meets all of 
the water specification requirements. A combination of indicators are used to allow for reliable 
indication of probable risks of infection – these include heterotrophic bacteria, total coliforms, 
total faecal coliforms, E. coli, and somatic- and male-specific coliphages. The microbial 
requirements for drinking water harvested from DRWH systems are presented in Table 2.1 
(Kempster et al., 1997; SABS, 2001; DWAF, 1996). 
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Table 2.1:  The microbiological requirements for drinking water in South Africa 
Indicator Organism Units Allowable Compliance 
Heterotrophic plate count 
Colony forming units (CFU) 1 
mL-1 
100 
Total coliform bacteria CFU 100 mL-1 10 
Faecal coliform bacteria CFU 100 mL-1 1 
Escherichia coli CFU 100 mL-1 0 
Somatic bacteriophages CFU 10 mL-1 1 
Enteric viruses Plaque forming units (PFU) 100  1 
Protozoan parasites (Giardia/ 
Cryptosporidium) 
Count 100 0 
Key: Total coliform bacteria – Primary indicator of general hygienic quality of harvested rainwater; Total faecal coliform bacteria 
– primary indicator of faecal pollution of the harvested rainwater; Escherichia coli – very specific indicator of faecal pollution of 
the harvested rainwater; Bacteriophages – the incidence and survival of bacterial viruses in harvested rainwater; somatic 
coliphages – bacteriophages which infect and replicate in E. coli and related species; male- specific (F-RNA) coliphages – very 
specific indicator of sewage pollution, these coliphages cannot replicate in water bodies.   
 
Limited information about the microbial and chemical quality of harvested RW is available. 
Indicator organisms were used to determine the microbial quality of harvested RW worldwide 
and the results of these studies are represented in Table 2.2. Ahmed et al. (2011) reported the 
percentage of positive samples for faecal indicator bacteria and total bacteria in water samples 
collected from harvested RW from data collected from 18 different research studies (Table 2.2); 
de Kwaadsteniet et al. (2013) contributed to the data with an additional six more studies found 
in literature. 
Table 2.2: Percentage of DRWH system samples testing positive (> 1 CFU 100 mL-1) for total faecal 
indicators and total bacteria (adapted from Ahmed et al., 2011; de Kwaadsteniet et al., 2013). The 






E. coli Enterococci Total bacteria Reference 
Australia 
 
52 (100) 38 (100) * * * 
Verrinder and 
Keleher, 2001 
90 (49) * 33 (49) 73 (49) * 
Spinks et al., 
2006 
* * 63 (27) 78 (27) * 
Ahmed et al., 
2008 
* * 58 (100) 83 (100) * 
Ahmed et al., 
2010 
* * 63 (15) 92 (22) * 
Ahmed et al., 
2012a 
91 (46) 78 (41) 57 (67) 82 (67) 100 (67) 




* 83 (6) * * * Thomas and 
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* Not reported, # not determined 
The compilation of research data by Ahmed et al. (2011) highlights the poor correlation 
between pathogenic bacteria and faecal indicators. According to Simmons et al. (2001), 30% 
and 57% of the 155 and 176 RWH samples surveyed in Micronesia had no detectable numbers 
of faecal coliforms and total coliforms, respectively. Lye (1987) also reported good quality RW 
according to WHO drinking water standards (total coliform numbers should be <10 CFU 100 mL-
1) in 95% of water samples collected from a particular water origin in the USA. In Kentucky, 
USA, 3% of samples had faecal coliform numbers < 10 CFU 100 mL-1. In contrast, a number of 
studies revealed higher numbers of faecal coliforms in harvested RW which does not meet the 
drinking water requirements of the WHO. In a study by Lee et al. (2010), in South Korea, 72% 
and 92% of harvested RW samples tested positive for E. coli and total coliforms, respectively, 
with all samples containing indicators above WHO standards. In Victoria, Australia, out of the 
49 RW tanks surveyed, 73% of samples tested positive for enterococci and 33% of samples 
tested positive for E. coli. These numbers exceeds the Australian Drinking Water Guidelines of 
zero CFU 100 mL-1 (ADWG, 2004). Albrechtsen (2002) determined that the harvested RW in 
Greene, 1993 
63 (81) 63 (81) * * 100 (77) 
Evans et al., 
2006 
Canada 31 (360) 14 (360) * * * 
Despins et al., 
2009 
Greece 80 (156) * 41 (156) 29 (156) * 
Sazakil et al., 
2007 
Denmark * * 79 (14) * 100 (14) 
Albrechtsen, 
2002 
Micronesia 43 (155) 70 (176) * * * 
Dillaha and 
Zolan, 1985 
New Zealand * 56 (125) * * * 
Simmons et al., 
2001 
Nigeria 100 (6) # * # 100 (6) 
Uba and 
Aghogho, 2000 
South Korea 92 (90) * 72 (90) * * Lee et al., 2010 
Thailand * * 40 (86) * * 
Pinfold et al., 
1993 
USA 93 (30) * 3 (30) * 100 (30) Lye, 1987 
US Virgin 
Islands 
57 (45) 36 (45) * * 86 (45) 




* 59 (17) * * * 
Rushin and 
Krishna, 1990 
Bermuda 90 (102) * 66 (102) * * 




95 (100) 57 (100) * * * 
Al-Salaymeh et 
al., 2011 
49 (255) * 17 (255) * * 
Abo-Shehada 
et al., 2004 
Hawaii, USA * 89 (9) * * * 
Fujioka et al., 
1991 
Zambia 100 (5) 100 (5) * * * Handia, 2005 
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Danish RW systems are not safe for human consumption: it was determined that the water 
contained high numbers of E. coli ranging from 4 – 900 CFU 100 mL-1 in 11 out of 14 systems 
tested. High numbers of enterococci and E. coli ranging from 5 – 200 CFU 100 mL-1 and 4 – 800 
CFU 100 mL-1, respectively, was reported by Ahmed et al. (2008) in RW collected from systems 
in Queensland, Australia. Twenty-seven samples were tested during this study – 78%, 63% and 
48% were positive for enterococci, E. coli and Clostridium perfringens, respectively.  
In South Africa, a study by Dobrowsky et al. (2014) to determine the prevalence of virulence 
genes associated with E. coli was performed. Isolates were sampled from RW tanks in 
Kleinmond, South Africa, during the low- and high-rainfall periods. Ninety two organisms were 
confirmed as E. coli species, with 6% of these being positively identified as E. coli 0157:H7 (16S 
rRNA gene sequencing). Out of the 80 samples which were collected from 10 DRWH systems, 
3% of the samples tested positive for virulent pathogenic E. coli namely enteropathogenic E. 
coli (EPEC) and enterohemorrhagic E. coli (EHEC), and 16% of the samples tested positive for 
enteroaggregative E. coli (EAEC). In another study by Dobrowsky et al. (2014), 29 RW tanks 
situated in Kleinmond, South Africa, were monitored for the presence of pathogenic bacteria 
during periods of high-rainfall. One hundred and sixteen samples were collected from the 
DRWH tanks during the sampling period. 16S rRNA gene sequencing confirmed the identity of 
the potential pathogenic bacteria in the RW samples with 19% of the sample being positive for 
Pseudomonas spp. Other dominant genera detected, were Aeromonas (16% of samples) and 
Enterobacter (11% of the samples). Other bacteria from various other genera were also 
isolated, namely Legionella spp., Salmonella spp., Shigella spp., Yersinia spp., and Giardia spp.  
2.4. Diseases associated with water from DRWH systems 
A number of infectious diseases are linked to the consumption of water that is known to be 
contaminated with faecal matter (Leclerc et al., 2002; Theron and Cloete, 2002). Enteric 
pathogens are responsible for waterborne diseases and include bacteria, parasites and viruses 
– these pathogens are transmitted via the faecal–oral route (Grabow, 1996; Leclerc et al., 2002; 
Theron and Cloete, 2002). Table 2.3 shows a number of bacteria, parasites and viruses 
associated with waterborne diseases.  
Typically, infections can be caused by bacteria ranging between 107-108 cells/mL while some 
enteric bacteria can cause diseases at low doses of 101 cells/mL (Edberg et al., 2000; Leclerc et 
al., 2002). A number of the organisms presented in Table 2.3 are highly resistant to most 
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antiseptics and disinfectants used to treat water for domestic use (Kümmerer, 2004; Xi et al., 
2009). A recent study by Dobrowsky et al. (2015) showed the importance of sterilising 
harvested RW prior to consumption. The study involved solar pasteurisation of RW at 
temperatures ranging from 55°C – 91°C. The study was conducted on the Welgevallen 
experimental farm of Stellenbosch University, South Africa, whereby RWH tanks were set-up 
with ApolloTM solar pasteurisation systems attached to it. The pasteurisation resulted in the 
reduction of indicator organisms – E. coli, heterotrophic bacteria and total coliforms were all 
below the detection limit. However, Legionella spp., Yersinia spp., and Pseudomonas spp. were 
still detected in the harvested rainwater samples treated at temperatures above 72°C. 
Table 2.3: Diseases associated with waterborne pathogens (Bifulco et al., 1989; Grabow, 1996; WHO, 
1996; Guerrant, 1997; Leclerc et al., 2002; Theron and Cloete, 2002; Yatsuyanagi et al., 2003; NRC, 2004) 
Pathogen Diseases 
Bacteria 
Campylobacter spp. Acute gastroenteritis and diarrhoea 
Enteropathogenic E. coli Diarrhoea 
E. coli 0157:H7 Haemolytic syndrome and bloody diarrhoea 
Salmonella spp. Diarrhoea, Typhoid fever 
Shigella spp. Diarrhoea, Dysentery 
Vibrio cholera Diarrhoea, Cholera 
Yersinia spp. Gastrointestinal infections, Diarrhoea 
Protozoan 
parasites 
Crytosporidium parvum Diarrhoea, cryptosporidiosis 
Entamoeba hystolytica Amoebic dysentery 
Giardia spp. Diarrhoea, Giardiasis 
Viruses 
Adenoviruses Conjunctivitis, respiratory disease, diarrhoea 
Astroviruses Diarrhoea 
Coxsackie viruses (Enterovirus) 
Meningitis, diabetes, respiratory, vomiting, skin 
rashes, diarrhoea 
Echovirus 68-71 
Diarrhoea, rashes, acute enteroviral haemorrhagic 
conjunctivitis, meningitis, respiratory diseases 
Hepatitis viruses (A; E) Hepatitis (jaundice), gastroenteritis 
Caliciviruses Vomiting, diarrhoea 
Polioviruses (Enteroviruses) Poliomyelitis 
Rotaviruses Vomiting, diarrhoea 
Small round structured viruses Vomiting, diarrhoea 
Emerging Acinetobacter spp. Meningitis, endocarditis, septicaemia 




Over the past few years, several outbreaks of diseases caused by pathogens were reported that 
cannot be inhibited by conventional water treatment. In 1987 and 1983, an outbreak of 
waterborne Campylobacter spp. in two communities in Canada and the USA were reported, 
respectively (Alarly and Nadeau, 1990; Sacks et al., 1986). In a more recent study, waterborne 
E. coli 0157:H7 resulted in infection of 2 300 hundred people in 2000 in Walerton, Canada 
(Hrudey et al., 2003). Due to flooding that occurred in Bangladesh, 67 718 people reported 
having diarrhoea of which nine people died as a result of waterborne diseases (International 
Water Association, 2004). Similarly, these disease causing pathogens have been reported in 
harvested RW used for domestic use (Table 2.4). 
 
Table 2.4: Cases of diseases reported in literature which is associated with the consumption of 









Australia Campylobacter spp. Diarrhoea, vomiting 1 
Broadribb et al., 
1995 
Australia Campylobacter fetus 
Diarrhoea, abdominal 
pain 
23 Merritt et al., 1999 
Australia C. botulinum N/S 3 
Murrell and Stewart, 
1983 
New Zealand L. pneumophila Legionnaires disease 1 Simmons et al., 2008 
U.S Virgin Islands 
L. pneumophila 
Serogroup 1 
Legionnaires disease 27 Schlech et al., 1985 
West Indies S. arechevalata 
Diarrhoea, headache, 
fever 
48 Koplan et al., 1978 
Australia S. typhimurium phage 9 
Vomiting, diarrhoea, 
abdominal pain, nausea 
27 Franklin et al., 2009 
New Zealand S. typhimurium phage 1 Diarrhoea 2 
Simmons and Smith, 
1997 
N/S, not specified 
Other bacteria commonly isolated from harvested RW belong to the genera Bacillus, 
Enterobacter, Enterococcus, Escherichia, Klebsiella, Pseudomonas, Staphylococcus and 
opportunistic 
pathogens 
Aeromonas spp. Gastroenteritis, diarrhoea 
Cyclospora spp. Abdominal cramping, fever, diarrhoea 
Isospora spp. Diarrhoea 
Legionella spp. Pontiac fever, Legionnaires disease 
Microsporidia spp. Diarrhoea, gastrointestinal infection 
Non-tuberculosis mycobacteria 
Cervical lymphadenitis, skin infections, 
nontuberculosis Mycobacterium disease 
P. aeruginosa Wound and eye infections, septicaemia 
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Salmonella. Efuntoye and Apanpa (2010), reported that out of all species isolated, E. coli was 
the most predominant species constituitng 36.5% of all bacteria isolated. Klebsiella aerogenes, 
Staphylococcus aureus and P. aeruginosa constituted 26%, 14.6% and 7.3% of all isolates, 
respectively. Bacillus cereus was also isolated from 200 samples collected from well water in 
Ayo-Iwoye, Nigeria (Akharaiyi et al., 2007), but in low quantity. S. aureus, P. aeruginosa and E. 
coli were isolated from water stored in storage tanks in homes in Tanke area, Ilorin, Nigeria 
(Sule et al., 2011). Hussain et al. (2015) also reported on the isolation of E. coli, P. aeruginosa, S. 
aureus and Salmonella typhi from thirteen environmental samples collected from RW that 
collected on ground surfaces during the rainy season and which was used for domestic 
purposes. In addition, Ofukwu et al. (2014) collected 126 samples from reservoirs in Ogbadibo, 
Nigeria, and found that 104 of those samples were positive for Enterobacter spp., 83 of the 
samples contained Klebsiella spp., 29 out of 126 samples contained E. coli, and 15 samples were 
positive for Salmonella spp.  
The aforementioned genera/species were the focus of the study reported in this thesis as very 
high rates of resistance to first- and second-line antimicrobials used to treat infections caused 
by these organisms have recently been observed. A brief profile of each these microorganisms 
are detailed below. 
Bacillus cereus 
Bacillus cereus is an aerobic-to-facultative, Gram-positive spore-forming, rod-shaped bacterium 
that is ubiquitous in nature and bears a close genetic and phenotypic relationship to a number 
of other Bacillus spp., particularly Bacillus anthracis (Ash et al., 1991). B. cereus is typically 
known as a foodborne pathogen, but is commonly detected in sources of water (Jensen et al., 
2003). The consumption of water and food contaminated with B. cereus may lead to human 
intestine transient colonisation (Ghosh, 1978). B. cereus is a notorious pathogen for nosocomial 
infections (Avashia et al., 2007; Barrie et al., 1992; Bryce et al., 1993; Van Der Zwet et al., 2000). 
Environments such as fog droplets, dust, plants, sediments, soil, and water in clouds have also 
been identified as a typical source of B. cereus – commonly polluting ground and roof-
harvested RW used for domestic purposes and irrigation (Amato et al., 2007; DeLeon-Rodriguez 
et al., 2013). A number of B. cereus strains have been reported to be resistant to β-lactam type 
antibiotics, especially penicillin, and have been implicated in a number of eye infections such as 
endophthalmitis.  




Enterobacter cloacae occur in the gastrointestinal tract of 40-80% of healthy humans where it 
acts as normal gut flora and is ubiquitous in nature. However, Enterobacter spp. are 
opportunistic pathogens and are typically implicated in blood infections acquired in a hospital 
setting (Diekma et al., 2002). Members of the family Enterobacteriaceae are rod-shaped or 
cocco-bacilli, Gram-negative, facultative anaerobes that contribute to approximately 50% of 
isolates associated with hospital acquired infections (Karlowsky et al., 2003). Entire families of 
antimicrobial agents (such as penicillins and aminoglycosides) are ineffective in the treatment 
of diseases caused by this bacterium. Intrinsic resistance to narrow-spectrum cephalosporins 
and ampicillin are exhibited by E. cloacae (Diekma et al., 2002). 
Enterococcus faecalis 
Enterococci commonly inhabit the oral cavity, the vagina and the gastrointestinal tract in 
human beings as normal bodily bacterial flora. However, virulent strains are capable of causing 
diseases such as urinary tract infection, infection of the abdomen, biliary tract, endocardium, 
bloodstream, and burn wounds, to name a few (Jett et al., 1994). E. faecalis are small cocci, 
Gram-positive bacteria with high levels of antibiotic resistance caused by intrinsic factors. In 
RW, Enterococcus spp. are commonly used as faecal indicators when testing the microbiological 
quality of water used for domestic purposes. E. faeccalis are highly prevalent among clinical 
isolates and human wastewater, and are often resistant to antibiotics such as vancomycin, 
which is the first-line drug used in the treatment of diseases caused by this bacterium (Ahmed 
et al., 2012b).    
Escherichia coli 
Gram-negative, short rod-shaped E. coli are ubiquitous in nature and are generally linked to 
faecal contamination. E. coli is largely present in normal intestinal flora in human beings and 
animals – in some parts of the body however, E. coli can pose a health threat. Some conditions 
caused by E. coli include bacteraemia and urinary tract infections (Cotruvo et al., 2004). Acute 
diarrhoea is caused by a limited number of E. coli classified as enteropathogenic strains, these 
include: enterotoxigenic E. coli (ETEC), enterohaemorrhagic E. coli (EHEC), enteropathogenic E. 
coli (EPEC), enteroaggregative E. coli (EAEC), enteroinvasive E. coli (EIEC) and diffusely adherent 
E. coli (DAEC) (Natano and Kaper, 1998).  




Klebsiella spp. are non-motile bacilli, Gram-negative bacteria belonging to the family 
Enterobacteriaceae. K. pneumoniae is predominantly isolated from clinical and faecal 
specimens and amount to approximately 60 – 80% of all isolates. Klebsiella spp. thrive in water 
environments and increase to high numbers in nutrient-rich waters, such as sugar cane 
processing operations, waste from pulp mill and textile finishing plants. This bacterium is also 
known to grow well in drinking-water distribution systems and easily colonise washers found in 
taps. Nosocomial infections are caused by Klebsiella when water contaminated with this 
bacterium is consumed or via inhalation of faecal coliform aerosols (Ainsworth, 2004). 
Pseudomonas aeruginosa 
P. aeruginosa is ubiquitous in nature – colonising humans, soil, plants and industrial surfaces. P. 
aeruginosa forms part of the family Pseudonadaceae and is an aerobic, rod-shaped, Gram-
negative, polarly flagellated bacterium. This organism is easily identified on optimal medium by 
its non-fluorescent pyocyanin bluish pigment or fluorescent green pyoverdin pigment (De 
Victoria and Galván, 2001). P. aeruginosa is considered harmless, inhabiting the pharyngeal and 
nasal mucosal surfaces as natural flora. However, if the bacterium penetrates to submucosal 
tissue or if individuals’ immune systems are compromised, P. aeruginosa may persist as an 
opportunistic pathogen. Infections caused by P. aeruginosa are treated using a broad spectrum 
of antibiotics such as β-lactams, fluoroquinolones and aminoglycosides. However, due to 
changes in the resistance mechanism of the organism, strains of P. aeruginosa has become 
multi-drug resistant with no new drugs to treat diseases caused by this bacterium presently 
available on the market (Page and Heim, 2009).  
Salmonella enterica 
Salmonella spp. form part of the Enterobactemiaceae family. They are Gram-negative, motile 
bacilli that produce hydrogen sulphide but, do not ferment lactose. S. enterica consists of six 
subspecies namely: S. enterica subsp. enterica, S. enterica subsp. arizonae, S. enterica subsp. 
salamae, S. enterica subsp. houtenae, S. enterica subsp. diarizonae, and S. enterica subsp. 
indica. The differences in antigen surfaces [somatic (O) and flagella (H) antigens] allow for 
differentiation of the Salmonella species. Salmonella is involved in a number of clinical 
manifestations, namely: bacteraemia, typhoid or enteric fever, gastroenteritis and septicaemia. 
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Salmonella spp. are ubiquitous in nature – they gain access to water systems by means of faecal 
contamination through livestock, sewage discharges, and wild animals. Livestock are typically 
infected by Salmonella spp., but a wide range of animals such as pigs, sheep, birds, poultry and 
even reptiles can also be infected by Salmonella spp. Humans may become infected via the 
spread of the bacterium by the faecal-oral route through the consumption of food and water 
contaminated with Salmonella (Kim et al., 2006; Koplan et al., 1978) 
Staphylococcus aureus 
Staphylococcus aureus is a facultative anaerobic, Gram-positive, cocci, non-spore forming, 
coagulase- and catalase-positive microorganism. The genus Staphylococcus comprises of 
approximately fifteen different species. S. aureus is associated with a normal gut flora and skin 
of humans; however, disease may arise via two varying mechanisms. One mechanism of action 
is via the multiplication and spread of the microbe in tissues, and the other mechanism of 
action is based on the microorganism’s ability to produce extracellular toxins and enzymes. 
Staphylococcus spp. are widespread in nature, but is predominantly found on the mucous 
membranes and skin of animals. Staphylococci are commonly detected in sewage and water 
environments mainly due to the release of the organism from the gastrointestinal tract (Antal, 
1987). 
The discovery of antimicrobials have revolutionised medicine and have saved countless lives 
since its discovery. However, the use of these drugs resulted in the rapid appearance of 
resistant organisms. In order to combat resistance, new antimicrobials are required with broad 
spectrum mechanisms of action; this topic is further elaborated upon in the following section. 
2.5. Antimicrobials  
Antimicrobials are low molecular weight compounds produced during secondary metabolism of 
a producing organism (Demain, 1992). The term ‘antimicrobials’ may be used interchangeably 
with the term ‘secondary metabolite/s’ in this study; however, it is not a synonym of the term. 
The term ‘antimicrobial’ is a collective term to describe antibacterials, antivirals, antifungals 
and antiprotozoals. Antimicrobial products include antibiotics, toxins, pigments, pheromones, 
effectors of symbiosis and ecological competition, growth promoters of plants and animals, 
anticancer agents, enzyme inhibitors, receptor agonists and antagonists, and immune-
modulating agents (Demain, 1992). Antimicrobials can be defined as both natural and synthetic 
Stellenbosch University  https://scholar.sun.ac.za
20 
 
agents, which may inhibit growth or even destroy microorganisms at particular concentrations 
(Waksman, 1973). Antimicrobial products in natural or semisynthetic form are grouped into a 
single class based on similarities in its chemical structure and is named after a fundamental 
chemical property or after the first discovered member (Todar, 2009).  
2.5.1. Antimicrobial Resistance (AMR)  
Bacterial resistance can be caused by various means, such as intrinsic factors whereby genes 
existing in the genome of a particular bacterium could create a resistance phenotype. Other 
means, which is important to this study, is resistance as a result of anthropogenic activities 
(Figure 2.2). 
As early as the 1940s, an increase in the number of antibiotics selected for human applications 
have been produced for clinical use and further released into the environment where it is 
widely disseminated. A number of types of anthropogenic activities which includes the use of 
antibiotics in aquaculture and agriculture, waste disposal and other non-human applications of 
antibiotics (Figure 2.2) generates major reserves of environmental resistance (Doyle, 2006); as 
well as virulence genes and organisms which contain them (Moura et al., 2010). It was 
estimated that millions of antibiotic compounds in metric tons have been distributed over the 
last half century, into the biosphere (Gottlieb, 1976). This provides an endless maintenance and 
selection pressure of resistant organisms in all environments, particularly rivers, reservoirs, 
ground and rain harvested water used for domestic purposes. As a result, putative antibiotic 

















Figure 2.2: Dissemination of antibiotic resistance due to antibiotic resistance within the community, 
wastewater treatment, hospital, agriculture and associated environments (Doyle, 2006; Liebert et al., 
1999). 
 
The expression of resistant genes is genetically regulated by the action of the antibiotics, and 
bacterial cells expend a great deal of genetic space and energy to actively resist antimicrobial 
agents (Wright, 2005). Bacterial cells achieve resistance against secondary metabolites (SMs) 
via a number of routes (Figure 2.3).  
Route 1: Pumping proteins associated with the membrane of the cell are involved in the efflux 
of the antimicrobial agent from the cell; Route 2: the antibiotic target is modified through the 
mutation of important binding elements (i.e. ribosomal RNA) or by reprogramming the 
biosynthetic pathways (e.g. to gain resistance against glycopeptide antibiotics); and Route 3: 
modifying enzymes are synthesised to selectively target and destroy the active site of the 
antimicrobial agent (Wright, 2005). 




Figure 2.3: Schematic representation of resistance mechanisms elucidated by a bacterial cell (adapted 
from Kotra et al., 2000). 
 
2.5.2. Actinomycetes as a novel source of antimicrobials 
The discovery of the first known antimicrobial produced by a Streptomyces spp., was 
streptothricin in 1942, two years after which streptomycin was discovered. Figure 2.4 shows 
the key findings and dates of antimicrobial agents produced by actinobacterial species, mainly 
Streptomyces spp. (Watve et al., 2001; de Lima Procópio et al., 2012), showing the diversity of 
classes of antimicrobials produced by this genus.  
Gram-positive actinomycetes have been identified as the most prolific known producer of 
antimicrobials to-date, accounting for the bulk of SM production (Lam, 2006). Actinomycetes 
belong to the order Actinomycetales, they are predominantly soil bacteria which form filaments 
or branching hyphae and asexual spores for reproduction (Goodfellow, 1988). Actinomycetes, 
predominantly the genus Streptomyces [which contains more than 600 species (Parte, 2015)] 
with a high G+C content of approximately 57-75 % (Lo et al., 2002) account for more than 70 % 
of known antimicrobials (Lam, 2006). Approximately 15 % of industrially important metabolites 
are also produced by the related members of actinomycetes namely: Actinomadura, 
Actinoplanes, Micromonospora, Nocardia, Streptosporangium, Streptoverticullum and 
Thermoactinomycetes (Okudoh, 2001). This is accomplished as actinomycetes transcribe more 
than 3300 genes in its circular genomes. Most of these genes encodes for SMs and complex 
differentiation of morphology (Hopwood et al., 1985). Antimicrobial resistance and 
antimicrobial biosynthetic gene transfer among species within the various actinomycete genera 









Figure 2.4: Antimicrobial compounds discovered since 1941. Twenty-two of the 34 commercial 




Some classes of antimicrobial compounds discovered so far are presented in Figure 2.5, most of 
which are produced by members of the genus Streptomyces and are discussed in a greater 
detail below.  
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Figure 2.5: An overview of various antimicrobial classes produced by Streptomyces spp. http://www.compoundchem.com.   
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2.5.3. Antimicrobials produced by actinomycetes 
β-lactams 
β-lactam-type SMs consist of penicillins such as flucloxacillin and amoxicillin, and 
cephalosporins such as cephalexin (Figure 2.6). β-lactams consist of a β-lactam ring structure – 
penicillin’s ring structure contain a fused thiazolindine ring and is termed 6-aminopenicillanic 
acid. The spectrum of activity of penicillins is dependent on the amide-bonded side chains 
which is different for each common backbone it is connected to (Batchelor et al., 1965). 
Penicillin’s mechanisms of action is via the inhibition of the synthesis of important structural 
components of the cell wall of the target bacterium (such as peptidoglycan – which is absent in 
mammalian cells).  
Penicillins are considered the most efficacious and safest class of antibiotics for the use against 
bacterial infections due to the metabolism of the host cell being unaffected. Penicillins exhibit 
poor antibacterial activity against aerobic rod-shaped Gram-negative microbes, however they 
have a broad spectrum of activities against Gram-positive microorganisms. Penicillins are 
widely used to treat infections caused by susceptible staphylococci, streptococci, Neisseria, 
clostridia and Pasteurella multocida (Park and Strominger, 1957). Streptomyces lavendulae has 
been reported as a producer of high levels of penicillin V acylase (Torres et al., 1999). 
Cephalosporins also contain a β-lactam ring consisting of a fused 6-membered dihydrothiazine 
ring. The modes of action of cephalosporins are by interference of the synthesis of the bacterial 
cell wall. Cephalosporins are commonly used to treat infections caused by Gram-positive and 
Gram-negative bacteria such as Proteus mirabilis, Klebsiella spp. and E. coli. Cephalosporins 
have been reported to be produced by Streptomyces clavuligeris (Rius and Demain, 1997; Xiao 
et al., 1991; Depestel et al., 2003). 
 
 
Figure 2.6: Examples of β-lactam type antibiotics (Williams, 2015). 
 




Aminoglycosides are comprised of a dibasic cyclitol with one or more aminated sugars attached 
to it via glycosidic linkages (Figure 2.7) (Mingeot-Leclercq et al., 1999). Aminoglycosides’ 
mechanism of action is via binding directly to the ribosomal RNA causing translocation 
inhibition and a decrease translation accuracy of the ribosome (Davies et al., 1965; Davies and 
Davis, 1968). In Gram-negative bacteria, aminoglycosides cause protein synthesis inhibition 
which results in bactericidal activity which is concentration-dependent (Bryan and van der 
Elzen, 1977). Aminoglycosides are typically isolated from Streptomyces spp. such as 
Streptomyces kanamyceticus, Streptomyces tenjimariensis and Streptomyces spectabilis, and 
some Micromonospora spp. When isolated from Streptomyces spp. the aminoglycosides name 
ends with the suffix – “mycin”, whereas aminoglycosides derived from Micromonospora spp. 
have names ending with the suffix – “micin” (Benveniste and Davies, 1973).  
 
Figure 2.7: Examples of aminoglycoside antibiotics (Williams, 2015). 
 
Quinolones 
Quinolones are heterocyclic in structure consisting of a bicyclic core which aids in the inhibition 
of bacterial topoisomerase (Figure 2.8) (Hardman et al., 1996). Depending on the concentration 
of this class of antibiotics, quinolones exhibits bactericidal activity. Quinolones target the 
topoisomerase IV and DNA gyrase of a bacterium – these enzymes are important for 
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transcription and DNA replication, respectively. Limited activity was exhibited by early 
quinolones, such as nalidixic acid, and was mainly used for urinary tract infections caused by 
Gram-negative bacteria. Next generation quinolones – the fluoroquinolones (ofloxacin, 
norfloxacin, ciprofloxacin, enoxacin and lomefloxacin) show wide range activity against other 
Gram-negative bacteria. Enhanced activities against a number of Gram-positive and Gram-
negative microorganisms were displayed by newer fluoroquinolones such as trovafloxacin, 
levofloxacin, sparfloxacin and grepafloxacin. Quinolones show potent activity against 
Helicobacter pylori and have been reportedly isolated from an actinomycete strain, a 
Pseudonocardia sp. (Smith, 1986; Dekker et al., 1998; Siegmund et al., 2005). 
 
Figure 2.8: Structures of quinolone type antibiotics (Williams, 2015). 
 
Tetracyclines 
Tetracyclines are comprised of four (tetra) hydrocarbon rings (cycle) and consist of a linear 
fused tetracyclic nucleus whereby a number of functional groups attach (Figure 2.9). 
Tetracyclines act by inhibiting protein synthesis in cells by blocking the aminoacyl-tRNA from 
attaching itself to the ribosomal acceptor (A) site. Tetracyclines were first discovered in 1945 by 
Benjamin Duggar from the producing strain Streptomyces aureofaciens and has a broad 
spectrum activity against Gram-positive and Gram-negative organisms associated with 
especially rickettsiae, mycoplasms and chlamydiae (Darken et al., 1960; Blackwood et al., 1963; 
Chopra and Roberts, 2001).  




Figure 2.9: Examples of tetracycline antibiotics (Williams, 2015). 
 
Macrolides 
Macrolides are easily recognised by their large lactone ring which contains 12-16 atoms linked via 
glycosidic bonds (Figure 2.10) (Mazzei et al., 1993). Macrolides are typically used in the treatment of 
infections of the skin and soft tissue, genital tract and respiratory tract caused by Gram-positive 
microorganisms, some Gram-negative microorganisms, anaerobic bacteria and mycoplasma. Macrolides 
act by inhibiting the protein synthesis on ribosomes in bacteria. They are produced by a number of 
Streptomyces spp., particularly Streptomyces venezuelae (Xue et al., 1998) and are commonly used as a 
replacement antibiotic for penicillin in penicillin-sensitive patients (Brisson-Noel et al., 1988). Some 
commonly used macrolides are  azithromycin, erythromycin and its related agents, dirithromycin, 
clarithromycin, flurithromycin, roxithromycin, josamycin, kitasamycin, rokitamycin, mirosamycin, 
mycinamycin, oleandomycin, spiramycin, tylosin and rosaramicin (Alvarez-Elcoro and Enzler, 1999). 
 
Figure 2.10: Examples of structures of macrolide antibiotics (Williams, 2015). 
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Another class of natural products produced by Streptomyces spp. not mentioned in Figure 2.5 
are the polyketides. 
Polyketides 
Polyketide synthases (PKS) are enzymes involved in the production of peptide polyketide (PK) 
antibiotics. PKs are commonly biosynthesised in an assembly line fashion from acyl–coenzyme 
A (CoA) monomers and amino (also termed hydroxyl) acids.  
Bacterial derived PKs are subdivided into two major pathways namely: type I PKS – which 
consist of large multifunctional proteins with each active site capable of catalysing one cycle of 
PK modification and elongation; and type II PKSs which are very similar to non-ribosomal 
peptide synthetase (NRPS) pathways in terms of their assembly. However, Type II PKSs contain 
an active site which is situated on either mono- or bi-functional proteins. Genes clustered in 
large operons of approximately 150 kb code for large enzymatic complexes. These operons 
code for biosynthetic genes as well as other genes such as regulators, export systems and 
mechanisms of resistance (Hertweck et al., 2007).  Type III PKSs are commonly found in plants, 
but several fungi and bacteria have also been found to possess type III PKSs. Type III PKS is 
made up of one multi-modular protein for the synthesis of molecules; this type of polyketide is 
not known for exceptional bio-activity and will not be further discussed in this review (Moore et 
al., 2002).  
PKs represent the largest family of natural products; pathways are ubiquitous among 
actinobacteria and fungi, but are also found in higher animals and plants. PK compounds 
contribute a high economic importance, one example of this is in the case of doxorubicin 
(Adriamycin), an anthracycline antibiotic used as an anti-tumour drug, which has generated 
well over 156 million dollars in 1993 (Dickens, 1996). 
Modules within each PKS consist of two or more core domains (Figure 2.11). These domains are 
namely: acyltransferase (AT) domain, which transfer the appropriate extender unit to the 
domain called an acyl carrier protein (ACP), where the formation of a thioester bond occurs to 
fix the extending polyketide to the synthase and a domain called ketosynthase (KS). The KS 
domain catalyses a condensation reaction which occurs between the extender unit situated on 
the ACP domain of the module of interest, and the intermediate polyketide, which is bound to 
the ACP domain of the module preceding it (Meurer, 1997). The growing polyketide molecule is 
modified with the addition of secondary domains namely dehydratase (DH), enoylreductase 
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(ER), ketoreductase (KR), methylation (M) and methyltransferase (MT) domains (Meurer, 1997). 
A cyclase (Cy) domain is often featured in the type II PKS molecule which commonly leads to 
aromatic structure formation (Meurer, 1997). The final module consists of a thioesterase (TE) 
domain which catalyses the termination and release of the final product from the enzyme 
(Meurer, 1997). 
 
Figure 2.11: A hypothetical polyketide synthase consisting of four distinct modules, represented 
schematically. A) PKS composed of one multi-modular protein which is encoded by a gene made up of 
the four enzymatic modules, this is characteristic of type I PKS. B) Type II PKS has each module situated 
on a singular monofunctional protein. Key: Acyltransferase (AT), acyl carrier protein (ACP), ketosynthase 
(KS), dehydratase (DH), ketoreductase (KR) and thioesterase (TE) 
 
Interestingly, the gene cluster for hedamycin produced by Streptomyces griseoruber represents 
an organisation of module domains. Hedamycin, an antitumor polyketide, is assembled by type 
I / type II hybrid PKS and causes intercalation between DNA nucleotides. Upon characterisation 
of this anti-tumour agent it was seen that the gene cluster within hedamycin contains two type 
I and six type II genes (Billign et al., 2004), showing the versatility of polyketides as 
antimicrobials. This versatility may be further exhibited by their diversity in terms of biological 
activities and structures. The antimicrobial, erythromycin for example, inhibits the synthesis of 
proteins by binding to the 50S subunit situated on the bacterial 70S RNA complex (Brisson-Noel 
et al., 1988). The insecticidal and anti-parasitic drug avermectin’s inhibitory mechanism is 
caused by the selective binding to glutamate-gated chloride ion channels in nerve cells and 
muscle in vertebrates. This in effect increases the permeability of the cell membrane to 
chloride ions and as a result the cell becomes hyperpolarised which leads to paralysis and death 
of the parasite (Shoop et al., 1995). The antifungal, nystatin, causes inability of the cell 
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membrane to function as a selective barrier when bound to sterols found in the cell membrane, 
resulting in the loss of essential cellular components (Rècamier et al., 2010). 
Even though there has been much success with the discovery and advances in the production of 
antimicrobials, diseases caused by pathogenic bacteria still remain one of the leading causes of 
death worldwide. Seventeen million annual deaths are as a result of bacterial infections which 
mainly affect the elderly and children (Watve et al., 2001). This is due to failure in treatment 
options when first- and second-line antibiotics cannot treat the infection caused by pathogenic 
bacteria as a result of resistance built up by the bacterium or due to the unavailability of 
medications particularly in rural areas worldwide. Consequently, more toxic antibiotics are used 
to treat resistant bacteria which frequently is less effective and often more expensive. The 
effective treatment and prevention of an ever-increasing spectrum of infections caused by 
bacteria, viruses, fungi and parasites are thus threatened by antimicrobial resistance (AMR) 
(CDC, 2013).  
2.5.4. Production of Antimicrobials  
SMs produced by actinomycetes depend on a number of biochemical, physical and 
environmental factors (Table 2.5). Components added to media which may elicit or enhance 
the production of a wide array of SMs is not known. However, there are indications that 
additives that limit the release of nutrients that can be easily assimilated, promote the 
induction of novel SMs by the entrapment of inhibitory compounds. Compounds such as 
magnesium phosphate, which is a natural zeolite, can be included as these compounds form 
complexes with ammonium salts (Shapiro, 1989; Masuma et al., 1983). Similarly, research has 
shown that organic sources of nitrogen such as soya-based fermentation media can be used in 
the induction of certain classes of SMs (Hessler et al., 1997; Gouveia et al., 1999). 
Table 2.5: Factors affecting the production of secondary metabolites in actinomycetes 
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a) Effect of Fermentation Media Components on Secondary Metabolite Production 
Species-specific variation is displayed in actinomycetes when exposed to carbon sources; this 
affects the cell growth as well as secondary metabolism (Dekleva et al., 1985; Demain, 1989; 
Platas et al., 1999). Certain carbon sources may cause negative repressive effects on the 
production of SMs, mainly due to repression of gene expression typically associated with 
carbon catabolites. Carbon sources which are rapidly assimilated (e.g. glucose) are good 
components for cell growth, but may also repress the production of essential enzymes involved 
in the biosynthesis of SMs. Oils (e.g. methyloleate, soybean), oligosaccharides (e.g. lactose), 
polyalcohols (e.g. glycerol), and polysaccharides (e.g. starch), are commonly used in 
combination as non-repressing carbon sources (Trilli, 1990; Demain and Fang, 1995). These 
carbon sources are used as it is more slowly released by hydrolysis (Demain and Fang, 1995).  
Fermentations for the production of SMs commonly include organic nitrogen sources, as these 
compounds are easily broken down into small units for the ease of transportation into bacterial 
cells (e.g. ammonia (NH+4) and amino acids) (Dunn, 1985). The NH
+
4 ion is favoured as an 
inorganic nitrogen source in actinomycete fermentations; these sources of ammonia are added 
as ammonium chloride (NH4Cl) or ammonium sulphate (NH4)2SO4 (Dunn, 1985). However, 
excessive amounts of easily assimilated nitrogen sources causes repression of the formation of 
SMs, and is generally caused by amino acids and ammonium salts (Ōmura and Tanaka, 1984). 
This problem may be alleviated by using complex nitrogen sources such as soyabean meal or 
peptones (Bhattacharyya et al., 1998; Demain and Fang, 1995). 
The regulation of inorganic phosphate (PO4
3-) is known to influence the production of 
numerous SMs produced by actinomycetes. However, the biosynthesis of SMs in liquid media 
are inhibited or repressed by phosphate concentrations above 1mM (Martin, 1989). In some 
cases, excess phosphate and glucose act in a synergistic manner causing the repression of SM 
biosynthesis. 
The quantity and types of SMs produced by actinomycetes are influenced by 
micronutrients/trace elements (Weinberg, 1989). Although, trace elements are essential for 
biological activities to occur within the cell, excess amounts of these micronutrients may be 
toxic and elements such as manganese (Mn2+) and chromium (Cr2+) in high concentrations can 
cause an inhibitory effect against the production of SMs, thus a small range of the amounts of 
micronutrients is beneficial for SM production (Weinberg, 1989).  
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b) Effect of Fermentation Conditions on Secondary Metabolite Production 
Shifts in temperature   
The expression of biosynthetic genes involved in secondary metabolism and the rate of decay 
of SM products are influenced by temperature (Votruba and Vaněk, 1989). The temperature at 
which SMs are produced is independent of the temperature at which the microorganism grows. 
Typically, the range associated with optimal growth temperature can be as wide as 20°C 
whereas the optimal temperature for the production of SMs may be as narrow as 5-10°C (Iwai 
and Ōmura, 1982). Take for instance, streptomycin produced by Streptomyces griseus, an 
increase in temperature of 1°C at the threshold temperature produces a reduction of 
antibacterial agent production by 80% (Dunn, 1985).  
The effects of pH 
The rate of growth, mycelium morphology and SM production by actinomycetes are also 
affected by the pH of the medium (Braun and Vecht-Lifshitz, 1991). Actinomycetes have a wide 
pH optima range for growth, whereas SM production is influenced by high pH and can only 
tolerate a narrow pH range within 0.2 pH units (James et al., 1991; Chen et al., 1999). According 
to Hayakawa et al., (1995), the increase in pH value from pH 5.5 to pH 7.5 increased the 
antimicrobial activity of some Microbispora species, a relatively rare actinomycetes genus.  
2.6. Developing novel antimicrobials 
As a result of poor antimicrobial stewardship and the increase in antimicrobial resistance due to 
the natural process of evolution by pathogenic bacteria or opportunistically infectious bacteria 
– new antimicrobials with new mechanisms of action are required to keep up with resistant 
microorganisms, along with new diagnostic tests to track the development of resistance. The 
number of new antibacterial agents from the year 1980 – 2012 that has been developed and 
approved for clinical and agricultural use has decreased steadily over the past three decades, 











Figure 2.12: *Intervals from 1980–2009 are 5-year intervals; 2010–2012 is a 3-year interval. Drugs are 
limited to systemic agents. Data courtesy of FDA’s Center for Drug Evaluation and Research (CDER). 
 
The most successful products to date, have been produced by soil-dwelling actinomycetes. The 
most famous example involved the collection of soil from a golf course in Tokyo in the early 
1970s and the isolation of the avermectin producing strain, Stretomyces avermitilis by 
professor Satoshi Ōmura of the Kitasato institute. Other examples include spinosad produced 
by Saccharopolyspora spinosa isolated from soil in a defunct sugar mill rum still in the Virgin 
Islands (Waldron et al., 2001); and erythromycin, produced by Saccharopolyspora erythraea in 
1949 in Turkey (Eisenstein et al., 2010).  
In the first 30 years (1940s – 1970s) of antimicrobial discovery, the Waksman group at Rutgers 
developed systematic screening of actinomycetes which led to the discovery of streptothricin, 
actinomycin and, most notably, streptomycin. Due to their discoveries, pharmaceutical 
companies began screening extracts of fungi and actinomycetes for compounds with 
bioactivities primarily against pathogenic bacteria. This process involved the isolation of 
microorganisms of interest, fermentation, isolation of prodct and then testing of the 
fermentation broths and purified compounds against various test organisms using phenotypic 
screening in terms of bioassays (Katz and Baltz, 2015). Although this approach has led to finding 
a number of novel medicinally important metabolites, this approach is often very taxing due to 
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its high rate for rediscovery of natural products that are already known (Newman and Cragg, 
2007). 
New approaches are required to accelerate the discovery of novel antimicrobial agents to avoid 
reverting to a pre-antibiotic era. These strategies are presented in Table 2.6.  According to Mian 
and Davies (2010), a collective study of the genomics, microbiology, biochemistry, genetics and 
modern natural product biochemistry will be required to find novel therapeutic agents in the 
next decade. Baltz (2006) also suggested that whole cell screening of the natural product be 
revisited but in a miniaturized version in order to increase throughput over conventional 
screening. 
The discovery of novel microbial natural products is costly, and currently, commercial attention 
has turned towards reducing expenses by the screening of novel groups of actinomycetes or by 
re-screening of culture collections which already exists (Kurtböke, 2012).  
Table 2.6: Approaches to accelerate the discovery of novel antimicrobial agents from actinomycetes 
(Baltz, 2006) 
High-throughput whole cell screening of terrestrial microorganisms  
Global soil sampling  
Pooling of soils and extraction of spores  
Miniaturized fermentations starting with spores  
Screening organisms resistant to common antibiotics  
Improved throughput with automation 
Enrichments and selections for uncommon terrestrial and marine microbes  
Antibiotics and taxon selective media  
Untapped random and exotic soils  
Untapped marine sediments 
Genome mining  
Sequencing multiple common microbes  
Sequencing rare and slow growing microbes  
Expression of new pathways in robust bacterial hosts 
Combinatorial biosynthesis  
NRPS pathways  
PKS pathways  
Glycosylations and other modifications 
 
In the current study, genome mining will be employed to explore the genome of a slow growing 
microbe – Streptomyces pharetrae CZA14T. S. pharetrae CZA14T was identified as a source of 
novel metabolites and forms part of the culture collection of the Biocatalysis and Technical 
Biology Research Group, CPUT, Western Cape Province, South Africa. Strain CZA14T was 
isolated from soil collected from the base of a giant quiver tree (Aloe pillansii) situated in the 
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Karoo Desert National Botanical Gardens in Worcester, Western Cape Province in South Africa 
(le Roes and Meyers, 2005). It was identified as a member of the genus Streptomyces by 16S 
rRNA gene sequencing as well as chemotaxonomic techniques. This strain was found to 
represent the type strain of a new species for which the name S. pharetrae was proposed: 
CZA14T (=DSM 41856T = NRRL 24333T) (le Roes and Meyers, 2005). Standard screening against 
various test strains for antibacterial activity showed weak antibiosis against Mycobacterium 
aurum A+, Bacillus coagulans ATCC 7050T and Acinetobacter calcoaceticus C91 (le Roes and 
Meyers, 2005). S. pharetrae CZA14T is a Gram-positive, aerobic actinomycete, capable of 
producing spores and melanin, which is associated with secondary metabolite activity (le Roes 
and Meyers, 2005).  
The genome of this actinomycete was previously sequenced; and the biosynthetic gene clusters 
encoding for secondary metabolites were detected using a bioinformatics programme called 
antiSMASH. Some of these genes were expressed during fermentation experiments performed 
during the course of this study. PKS pathways in particular and bio-active compounds were 
tested against multi-drug resistant organisms. The outcomes of these experiments are 
presented in chapters 3-6.        
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Optimisation of medium to larger scale 
production (0.5 L – 5 L) of secondary 
metabolites produced by strain CZA14T 
  




The production of secondary metabolites is influenced by the fermentation vessel and 
fermentation parameters used during production. A successful scale-up of fermentation 
processes is associated with a good selection of fermentation systems. In this study, flat-
bottom flasks, baffled flasks, a continuous stirred tank reactor (CSTR) and an airlift reactor (ALR) 
were used to determine the effect of flask/fermentation vessel type on the production of 
secondary metabolites (SMs) by strain CZA14T and to contribute to a successful scale-up of SM 
production. Previously defined antimicrobial production medium (153 + glycerol, pH 6.0) was 
used for the production of bio-active compounds by strain CZA14T. In this study, poor SM 
production was displayed in flat-bottom flasks (as determined by thin layer chromatography) 
and further scale-up processes were performed using baffled flasks. The inoculum volume was 
optimised in order to stimulate maximum SM production at a larger scale. A 15% (v/v) inoculum 
size was selected to optimally produce maximum amount of SM compounds during scale-up. 
Maximum SM production was observed in 2 L baffled flasks over the 1 L baffled flasks. A 
decrease in SM production occurred upon scale-up from 2 L baffled flasks to CSTR (5 L) and ALR 









Key words: Fermentation vessels, Flat-bottom flasks, baffled flasks, CSTR, ALR 




Streptomyces species are Gram-positive, mostly filamentous soil bacteria which grow as 
vegetative mycelia with branching aerial hyphae that emerge from the surface of the colony 
(Madigan et al., 2000). Clinically important antimicrobials are commonly produced by 
streptomycetes and as a result, several studies are directed toward the isolation of new 
Streptomyces species from various habitats (Mansour, 2003; Chater, 2006; Bon et al., 2008). 
The production of antimicrobials can be enhanced or initiated by manipulating growth/culture 
conditions (Omura and Tanaka, 1984). To fully understand the biosynthetic potential of micro-
organisms of interest, solid-state/substrate and shaken-flask/submerged fermentations are 
commonly performed in parallel. Submerged fermentation was the focus of the current study.  
 
Fermentation under submerged conditions aims to offer a homogenous environment with 
specific stress factors and limitations. Initial fermentation systems and conditions are selected 
to fulfil the requirements of a particular ecological or taxonomic group of micro-organisms, 
which in the current study was an actinomycete. Besides considering the suitable processes for 
a specific organism group, it is also essential to consider whether the fermentation process and 
production of antimicrobials can be replicated, as well as the subsequent ease of scale-up by 
number or volume. In order to optimise the probability that fermentation at a larger-scale can 
be repeated, the initial fermentation process parameters are maintained. A set of standard 
parameters are defined for small-scale fermentations in order to achieve successful re-
fermentation and is further translated into a set of standard process parameters for the scale-
up to medium and larger scale fermentation (Whitaker, 1992).  
 
In the current study, various concentrations of carbon and nitrogen sources were 
supplemented into culture media for optimal antimicrobial production. Angular baffled flasks 
were used to provide effective mixing of fermentation broth over a range of viscosities, while 
simultaneously limiting the splashing of the broth that promotes wall growth in the flask 
(Katzer et al., 2001). In a study by Katzer et al. (2001), similar culture morphology in terms of 
shape and size of pellets in shake-flask fermentation was observed compared to fermentation 
in stirred vessels. This may aid in the high success rate for re-fermentation under submerged 
conditions, which is generally 80%. In terms of other bioreactor vessels such as the airlift 
bioreactor used in the current study, aeration plays a major role in the production of high yields 
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of secondary metabolites. Adequate oxygen supply is a major problem when using shake flasks 
(Buchs, 2001). Shake flasks with angular baffles or indents are used for actinomycetes, as these 
indentations help in increasing oxygen transfer. The oxygen supply in stirred tank reactors are 
mostly better than baffled shake flasks, but mechanical shearing may take place in stirred 
vessels due to the impellers fitted inside of the stirred vessel which in turn may affect 
antimicrobial production. The airlift bioreactor was used to overcome the aforementioned 
limitations (Merchuk. 2002). An insignificant difference between shake-flask fermentation and 
fermentation in stirred-vessels upon scale-up suggests comparability of process conditions in 
these fermentation vessels, while results may vary in other bioreactor types.  In the current 
chapter, secondary metabolite (SM) production by a Streptomyces species was scaled up from 
fermentation in 0.5 L baffled flasks to 3 L air lift reactor and 5 L continuous stirred tank reactor 
volumes (Figure 3.1). 
 
Optimisation of the effect of aeration on the production of secondary metabolites (SMs) by 
strain CZA14T was performed using various fermentation vessels. The scale of SM production 
was gradually increased with each experiment in different fermentation vessels to test if any 
product loss would occur upon scale-up. SM production was performed in 2L baffled flasks, an 
airlift reactor and a continuous stirred tank reactor. Compounds were extracted from the 
fermentation broth from each vessel type using ethyl acetate and visualised as bands under 
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Maximum production of antimicrobials 
produced by Streptomyces pharetrae CZA14T 
0.5 L flat bottom- 
vs baffled- flask 
optimisation  
Sampling days: 3, 5, 7 and 10.  
1: 1 v/v ethyl acetate (EtOAc) 
solvent extraction 
Active and inactive 
compounds visualised as 
bands under shortwave UV 
(254 nm) and longwave UV 
(365 nm) light 
1 L and 2 L baffled flasks 
3 L airlift reactor (ALR)  
5 L Continuous stirred tank 
reactor (CSTR) 
Inoculum volume 





















Figure 3.1: Flow-chart of methods used for the maximum production of antimicrobials produced by 
Streptomyces pharetrae CZA14T. 
Materials and Methods 
3.1. Materials 
Most of the chemicals used in this study were purchased from Merck Millipore or Sigma-Aldrich 
unless otherwise stated. All solvents used were of analytical grade. 
3.2. Methods 
3.2.1. Maintenance of Streptomyces pharetrae CZA14T  
S. pharetrae  CZA14T previously isolated by le Roes and Meyers (2005), was stored as spore and 
mycelial suspension stock cultures in 20% (v/v) glycerol at -20°C and the strain was maintained 
on International Streptomyces Project (ISP) #2 agar (g/L): 4 glucose, 10 malt extract, 4 yeast 
extract and 20 bacteriological agar, pH 7.2 (Shirling and Gottlieb, 1966). 
Stellenbosch University  https://scholar.sun.ac.za
54 
 
3.2.2. Preparation of Pre-Cultures  
Strain CZA14T was cultured on ISP #2 agar (refer to section 3.2.1) and incubated at 30°C for 7–
12 days (Figure 3.2). Approximately 2-3 loopfulls of spores were inoculated into 5 mL sterile 
deionised water (dH2O) to produce a spore suspension and 500 μL spore suspension per 10 mL 
medium was used to inoculate liquid ISP #2 medium. Inoculated liquid medium was incubated 
at 30°C, shaking at 160 rpm on a Labcon orbital shaker (Advanced African Technology) for 









Figure 3.2: Streptomyces pharetrae CZA14T on ISP #2 agar after 14 days of incubation at 30 °C. 
 
3.2.3. Medium-scale Secondary Metabolite Production  
3.2.3.1. Flat-bottom flask VS baffled flask optimisation in 0.5 L flask volume 
SM production volume was scaled-up from 50 mL to 100 mL small-scale media volume in 0.5 L 
flat-bottom and baffled flasks (20% [v/v] media volume/flask volume; 5% [v/v] inoculum 
volume/media volume). Previously determined optimal production medium 153 + glycerol (g/L: 
20 glycerol, 5 peptone, 5 meat extract, 3 CaCO3, pH 6.0; unpublished results: Durrell, 2013) was 
used throughout the duration of this study. Pre-cultures were prepared as described in section 
3.2.2 and were used to inoculate experimental flasks (in duplicate) containing sterile production 
medium. Un-inoculated control flasks (in duplicate) were prepared, and both controls and 
inoculated experimental flasks were placed at optimal submerged fermentation conditions 
(30°C, 160 rpm). Fermentation was conducted over a period of 10 days and 5 mL samples were 
collected at days 3, 5, 7 and 10.  Solvent extraction was performed as described in section 3.2.5 
and thin layer chromatography (TLC) (see section 3.2.6) was used to determine which flask type 
was suitable for maximum SM production. 
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3.2.3.2. Optimisation of inoculum volume in 0.5 L baffled flasks 
It was determined that baffled flasks were best suited for maximum SM production by strain 
CZA14T and these flasks were further used in optimisation studies. Various inoculum volumes 
were tested to determine optimal inoculum volume for maximum SM production by strain 
CZA14T, medium volume was kept constant (20% [v/v]) while the inoculum volume varied by 
5%, 10%, 15% and 20% [v/v]. Pre-cultures were prepared as in section 3.2.2 and were 
inoculated into the main experimental flasks (in duplicate) at varying inoculum volumes as 
indicated above. Un-inoculated control flasks (in duplicate) were prepared, and both controls 
and inoculated experimental flasks were placed at optimal submerged fermentation conditions 
(30°C, 160 rpm). Fermentation was conducted over a period of 10 days and 5 mL samples were 
collected at days 3, 5, 7 and 10. Solvent extraction was performed as described in section 3.2.5 
and TLC (section 3.2.6) was used to determine optimal inoculum volume for maximum SM 
production. 
3.2.3.3. 1 L and 2 L baffled flask optimisation 
SM production was further scaled-up from 100 mL to 200 mL and 400 mL media volume in 1 L 
and 2 L baffled flasks, respectively (20%, media volume; 15%, inoculum volume) (Figure 3.3). 
Pre-cultures were prepared as described in section 3.2.2 and were used to inoculate 
experimental flasks (in duplicate) containing sterile optimal production medium. Un-inoculated 
control flasks (in duplicate) were prepared, and both controls and inoculated experimental 
flasks were placed at optimal submerged fermentation conditions (30°C, 160 rpm). 
Fermentation was conducted over a period of 10 days, and 10 mL and 20 mL samples were 
collected from 1 L and 2 L baffled flask fermentation broth respectively, at days 3, 5, 7 and 10.  
Solvent extraction was performed as described in section 3.2.5 and TLC (section 3.2.6) was used 



















Figure 3.3: Strain CZA14T cultured in A) 2 L baffled flask containing 153 + glycerol (on the left), 153 + 
glycerol control (on the right); and B) on 153 + glycerol agar (1) substrate mycelium, (2) aerial mycelium.   
 
3.2.4. Larger-Scale Secondary Metabolite production 
During the scale-up procedure from 2 L baffled flasks to 3 L airlift reactor and 5 L continuous 
stirred tank reactor, both fermentations were performed twice to determine the reproducibility 
of compounds produced by CZA14T. The results from the second round of fermentations are 
presented in the study. 
3.2.4.1. 3 L Airlift reactor (ALR) fermentation optimisation 
Figure 3.4 shows the airlift reactor (ALR) used in the current study. This ALR is an internal-loop 
concentric tube reactor consisting of a riser, downcomer, base and gas separator. A 4 day old 
pre-culture was prepared (refer to section 3.2.2) and used to seed (15% v/v inoculum) sterile 
production medium, modified 153 + glycerol (g/L: glycerol 40, peptone 10, beef/meat extract 
10 and CaCl2 6, pH 6.0).  
Prior to inoculation of the production medium, an air compressor was used to facilitate the 
input of air into the fermenter at aeration ~ 3 L. min-1 (or ~ 3 vvm - where air flow rate is at 1 
volume of air/ volume of liquid/minute). The temperature was set to 30°C using manual 
heaters; the pH was neither controlled nor monitored anytime during this experiment. Sterile 
antifoam 204 (Sigma) was added as needed at 0.2 μL of antifoam per 1 mL of culture. Thirty 
millilitre samples were collected daily for 0-20 days; the broth culture was made up to volume 
after each sampling session using sterile dH2O. The cell mass production vs SM production was 
monitored with every sampling session (refer to section 3.2.4.1.1). 
1 2 













Figure 3.4: Different types of air lift reactors – the internal loop concentric tube airlift reactor was used 
in this study (Merchuk and Gluz, 2002). 
 
3.2.4.1.1. Monitoring the cell mass production 
To monitor growth, 1.5 mL Eppendorf tubes were dried at 60°C overnight (O/N) and placed into 
a desiccator O/N to remove any moisture. The tubes were weighed using an analytical balance 
to obtain the mass of individual tubes used during this experiment. Five hundred microliter 
aliquots were removed daily from the main culture and were centrifuged at 10 000 rpm for 10 
minutes. The cell mass was dried at 60°C O/N and placed in a desiccator, after which the 
respective tubes were weighed and the mass was recorded. The initial weight of the tubes was 
subtracted from the final weight of the tubes containing dried cell mass to determine the actual 
mass. A growth curve was constructed to determine optimal growth for antimicrobial 
production. 
3.2.4.2. Continuous stirred tank reactor (CSTR) fermentation optimisation 
BIOFLO 3000 fermenter 
Figure 3.5 shows the components of the BIOFLO 300 continuous stirred tank reactor (CSTR) 
used in the current study. The fermenter had a removable baffle assembly with six Rushton 
impellers along the rotor shaft and was equipped with automated monitoring systems for 
control over agitation, pH, temperature, and dissolved oxygen concentrations. Only the 
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agitation and temperature were controlled in this study. The temperature was maintained 
within set limits by circulating water for cooling and with an electric jacket wrapped around the 
vessel for increasing the temperature when needed. The working maximum volume of the 
fermenter was 5 L, and 4.25 L of optimal antimicrobial production medium was prepared (at 
double the concentration to ensure enough nutrients were available throughout the duration 
of the fermentation); also CaCO3 was replaced with CaCl2, as CaCO3 is insoluble in fermentation 
processes and will cause difficulty during purification by liquid solvent extraction of products.  
 
The fermenter, its components and media, was sterilised by autoclaving at 121°C for 20 
minutes and a 4 day old pre-culture (section 3.2.2) served as an inoculum to seed the 
production medium (15%, v/v inoculum) after the media has cooled. Prior to inoculation of the 
production medium an air compressor was used to facilitate the input of air into the fermenter 
at an aeration of ~ 4 vvm. The temperature was set to 30°C and the agitation was set at 150 
rpm. Sterile antifoam 204 (Sigma) was added as needed at 0.2 μL of antifoam per 1 mL of 
culture. Forty millilitre samples were collected daily for 0-20 days. The broth culture was made 
up to volume after sampling sessions using sterile dH2O. A sterile media control was placed on a 
shaker at 30 °C, 150 rpm for the same duration as the fermentation. The cell mass production 











Figure 3.5: Graphic representation of a continuous stirred tank reactor (Williams, 2002). 
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3.2.5. Medium to Larger Scale Fermentation: Solvent Extraction  
For the 50 mL, 100 mL and 200 mL culture flask volumes, 2 mL, 5 mL and 10 mL samples were 
collected, respectively. Samples were collected at days 3, 5, 7 and 10; and for ALR and CSTR 
fermentation, 30 mL and 40 mL samples were collected, respectively at days 0 - 20. SNF and 
mycelial mass were separated by centrifugation at 10 000 rpm for 10 minutes. Ethyl acetate 
(EtOAc) (1:1, v/v) was used to extract metabolites from both the supernatant filtrate (SNF) 
(extracellular) and mycelia (intracellular). For complete SM extraction, the samples were 
incubated at 37°C with shaking at 160 rpm, O/N. The organic phase was placed into sterile 
universal glass bottles and evaporated to dryness under a fume hood. Extracts were 
reconstituted with EtOAc to a 50x concentrate and used in bio-activity assays to determine bio-
activity profiles and band profiling by TLC (section 3.2.6). 
3.2.6. Thin Layer Chromatography (TLC) 
TLC was used for the separation of secondary metabolites isolated from fermentation broth. 
Five microlitres of 50x concentrated extract was spotted onto the base line created on a silica 
gel plate and dried with the use of a handheld hairdryer. Silica gel 60 with an aluminium back 
support and a fluorescent indicator (F254) TLC plates were used as the solid phase, while the 
mobile phase consisted of chloroform: EtOAc: formic acid: n-hexane at a ratio of 5:4:1:0.02 
(v/v/v/v). The TLC plates were developed for ± 10-20 minutes in an airtight glass tank. The 
plate/s was/were dried under a fume hood for 1-2 hours. Bands were visualised at a 
wavelength of 254 nm and 365 nm using a UV light and their retention time (Rf) values were 
calculated as follows:  
 
 
𝑅𝑓 = 𝐷𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝑓𝑟𝑜𝑚 𝑠𝑡𝑎𝑟𝑡 (𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒) 𝑡𝑜 𝑐𝑒𝑛𝑡𝑟𝑒 𝑜𝑓 𝑠𝑢𝑏𝑠𝑡𝑎𝑛𝑐𝑒 𝑠𝑝𝑜𝑡 (𝑚𝑚)
÷ 𝐷𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝑓𝑟𝑜𝑚 𝑠𝑡𝑎𝑟𝑡 (𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒) 𝑡𝑜 𝑠𝑜𝑙𝑣𝑒𝑛𝑡 𝑓𝑟𝑜𝑛𝑡 (𝑚𝑚) 
 
Standard deviation (SD) were ±0 for all of the results in this study as duplicate samples 
represented experimental replicates and samples showed the same number of SM bands under 
UV light. 
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3.3. RESULTS  
3.3.1. Medium-scale antimicrobial production  
Strain CZA14T used in the current study has the potential to produce a number of bio-active 
compounds when conditions for production are optimised. Previously identified optimal 
medium (153 + glycerol, pH 6.0) and fermentation conditions (30°C, 160 rpm) for maximum SM 
production by CZA14T were scaled-up from medium to larger scale production in 0.5 L, 1 L, and 
2 L baffled flasks to 3 L airlift reactor (ALR) and 5 L continuous stirred tank reactor (CSTR) 
fermentation vessels. The effect of aeration and type of fermentation vessel was investigated 
and SM production was monitored over time. 
3.3.1.1. Flat-bottom flask vs baffled flask optimisation in 0.5 L flask volume 
The results relating to the maximum production of SMs by CZA14T cultured in 153 + glycerol in 
flat bottom vs baffled flasks are presented in Table 3.1. Compounds were separated on TLC 
using a four component solvent system and bands were visualised under 254 nm and 365 nm 
UV light, respectively (Appendix A, Figures A1 – A4). Rf values were calculated (example in 
Appendix B, Figure B1) for compounds produced extra- and intra-cellularly and are presented in 
Table 3.1. 
Using a standard 5% inoculum volume, 0.5 L flat-bottom Erlenmeyer and baffled flasks were 
compared to determine which flask type resulted in the maximum number of SM production as 
visualised by TLC. Optimal fermentation flask type for maximum SM production were displayed 
using baffled flasks with CZA14T cultured in 153 + glycerol media, pH 6.0 at 30°C, 160 rpm over 
a period of 3-10 days. A maximum production of seven compounds was produced 
extracellularly at day 7, whereas eight compounds were produced intracellularly at day 10 in 
flat-bottom flasks. Four out of the seven compounds were produced extra- and intra-cellularly 
over a period of 3 – 10 days and had similar Rf values. Compounds with similar Rf values were 
also produced extra- and intra-cellularly in baffled flasks. While a number of similar compounds 
were produced in flat-bottom flasks and baffled flasks, as observed using UV Vis visualisation 
more compounds were observed for the baffled flasks compared to the flat bottom flasks 
(Figure 3.6). A maximum production of seven compounds at day 5 was produced extracellularly, 
whereas nine compounds at day 3 were produced intracellularly.  
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Table 3.1: Rf values of bands visualised under 254 nm UV light on a developed TLC of 0.5 L flat-bottom- 
and baffled- flask supernatant filtrate (SNF) (extracellular production) and cell mass (cell) (intracellular 
production) EtOAc extracts. 
 
 
3.3.1.2. Optimisation of inoculum volume in 0.5 L baffled flasks 
The maximum number of compounds produced was observed in baffled flask submerged 
fermentation, this prompted inoculum volume optimisation tests in 0.5 L baffled flasks to 
determine the optimal inoculum volume for maximum antimicrobial production. The results 
relating to optimal inoculum volume for the maximum production of SMs by CZA14T cultured in 
153 + glycerol in 0.5 L baffled flasks are presented in Figure 3.6. Compounds were separated on 
TLC using a four component solvent system and bands were visualised under 254 nm and 365 
nm UV light (Appendix C, Figures C1 – C8). Rf values were calculated for compounds produced 
extra- and intra-cellularly and are presented in Table 3.2. 
Day Flat-bottom flask (Rf value) No. of bands 
 SNF CELL SNF CELL 
3 
0.95, 0.80, 0.67, 0.39, 
0.28 
 
0.97, 0.90, 0.83, 0.25 5 4 
5 0.95, 0.80, 0.67, 0.40, 0.28 0.96, 0.78, 0.38, 0.25 5 4 
7 
0.97, 0.80, 0.71, 0.66, 
0.53, 0.41, 0.28 
0.94, 0.78, 0.38, 0.25 7 4 
10 0.79, 0.71, 0.66, 0.40 
0.95, 0.90, 0.77, 
0.39, 0.26, 0.12, 
0.08, 0.04 
4 8 
Day Baffled flasks (Rf value) No. of bands 
 SNF CELL SNF CELL 
3 0.97, 0.80, 0.66, 0.41 
0.96, 0.86, 0.76, 
0.38, 0.25, 0.19, 
0.12, 0.07, 0.03 
4 9 
5 
0.96, 0.80, 0.67, 0.42, 
0.29, 0.21, 0.13 
0.96, 0.90, 0.76, 
0.38, 0.25, 0.12, 
0.08, 0.04 
7 8 
7 0.80, 0.72, 0.66, 0.40 




0.97, 0.80, 0.70, 0.66, 
0.40, 0.28 
0.97, 0.91, 0.78, 
0.68, 0.39, 0.27, 0.04 
6 7 











Figure 3.6: Column graph representing number of bands visualised under 254 nm short-wave UV light 
on a developed TLC of 0.5 L baffled flask supernatant filtrate (SNF) – extracellular production and cell 
mass (cell) – intracellular production EtOAc extracts from experiments at different inoculum volumes (% 
v/v). 
 
The inoculum volume was optimised in 0.5 L baffled flasks. Compounds with similar Rf values 
were observed throughout this experiment at varying inoculum volumes. The maximum 
number of compounds produced was observed during intracellular production using 15 %, v/v 
inoculum volume and on day 10. This % v/v inoculum volume was used throughout the 
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Table 3.2: Rf values of bands visualised under 254 nm short-wave UV light on a developed TLC of 0.5 L 
baffled flask supernatant filtrate (SNF) (extracellular production) and cell mass (cell) (intracellular 
production) EtOAc extracts from experiments at different inoculum volumes (X % v/v) 
Day 5 % (v/v) inoculum volume (Rf value) 
 SNF CELL 
3 0.76, 0.69, 0.56 0.96, 0.78, 0.43, 0.29, 0.06 
5 0.94, 0.73, 0.57 0.95 
7 0.74, 0.71, 0.58, 0.38 0.95, 0.92, 0.86, 0.68, 0.64, 0.38 
10 0.75, 0.62 
0.95, 0.90, 0.85, 0.70, 0.64, 0.57, 
0.39, 0.27, 0.15, 0.10, 0.06 
Day 10 % (v/v) inoculum volume (Rf value) 
 SNF CELL 
3 0.92, 0.69, 0.64, 0.56, 0.38 0.96, 0.78, 0.43, 0.29, 0.06 
5 0.24, 0.94, 0.89, 0.76, 0.63 0.95 
7 0.73, 0.71, 0.58, 0.38 
0.96, 0.93, 0.90, 0.85, 0.68, 0.64, 
0.45, 0.38, 0.26, 0.14, 0.10, 0.06 
10 0.94, 0.75, 0.71, 0.66, 0.59 
0.95, 0.92, 0.90, 0.69, 0.64, 0.56, 
0.26, 0.14, 0.09, 0.06 
Day 15 % (v/v) inoculum volume (Rf value) 
 SNF CELL 
3 0.92, 0.69, 0.64, 0.56, 0.38 0.95, 0.62, 0.39, 0.29 
5 Smear 0.95, 0.47 
7 0.73, 0.71, 0.58, 0.38 
0.95, 0.90, 0.85, 0.64, 0.56, 0.54, 
0.38, 0.26 
10 0.73, 0.68, 0.58, 0.42, 0.29, 0.05 
0.97, 0.92, 0.89, 0.66, 0.63, 0.58, 
0.57, 0.54, 0.53, 0.51, 0.42, 0.38, 
0.25, 0.09, 0.06 
Day 20 % (v/v) inoculum volume (Rf value) 
 SNF CELL 
3 0.92, 0.69, 0.67, 0.64, 0.56, 0.38 0.94, 0.63, 0.41, 0.38, 0.29 
5 0.71, 0.59, 0.38 0.95 
7 0.38 
0.95, 0.90, 0.85, 0.64, 0.56, 0.38, 
0.26 
10 0.73, 0.68, 0.60 
0.99, 0.95, 0.90, 0.69, 0.64, 0.59, 
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3.3.1.3. 1 litre and 2 litre baffled flask optimisation 
A 15 %, v/v, optimal inoculum volume for maximum SM production by CZA14T was used during 
the rest of this study (in conjunction with 20 %, v/v media volume). SM production was further 
scaled-up to 1 L and 2 L baffled flask submerged fermentation. Maximum SM production was 
monitored over a period of 3-10 days by separating compounds on TLC (Appendix D, Figures D1 
– D4) to determine the success of the fermentation. Rf values were calculated for compounds 












Figure 3.7: Column graph representing number of bands visualised under 254 nm short wave UV light on 
a developed TLC of 1 litre and 2 litre baffled flask EtOAc extracts from the supernatant filtrate (SNF) 
(extracellular production) and cell mass (cell) (intracellular production). 
 
 
Table 3.3: Rf values of bands visualised under 254 nm short wave UV light on a developed TLC of 1 litre 
and 2 litre baffled flask EtOAc extracts from the supernatant filtrate (SNF) (extracellular production) and 
cell mass (cell) (intracellular production) 
Day 1 Litre baffled flask (Rf value) 
 SNF CELL 
3 
0.73, 0.67, 0.62, 0.56, 0.51, 0.38, 
0.26 
0.92, 0.54, 0.49, 0.24 
5 0.73, 0.67, 0.56, 0.51, 0.38, 0.26 0.92, 0.54, 0.51, 0.37, 0.25 
2 L baffled flasks 1 L baffled flasks 
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7 0.73, 0.67, 0.56, 0.51, 0.37, 0.26 
0.92, 0.54, 0.51, 0.37, 0.25, 0.10, 
0.06 
10 
0.73, 0.67, 0.56, 0.51, 0.44, 0.37, 
0.26 
 
0.92, 0.73, 0.56, 0.51, 0.37, 0.25, 
0.10, 0.06 
Day 2 Litre baffled flasks (Rf value) 
 SNF CELL 
3 0.74, 0.67, 0.54, 0.37, 0.24 
0.90, 0.85, 0.71, 0.63, 0.59, 0.37, 
0.25, 0.10, 0.08, 0.05 
5 0.73, 0.66, 0.55, 0.38, 0.24 
0.90, 0.85, 0.71, 0.63, 0.59, 0.36, 
0.25, 0.10, 0.08, 0.05 
7 
0.87, 0.73, 0.66, 0.61, 0.55, 0.52, 
0.38, 0.25, 0.10 
0.90, 0.85, 0.71, 0.63, 0.60, 0.52, 
0.36, 0.25, 0.10, 0.08, 0.05 
10 0.92, 0.72, 0.54, 0.52 
0.90, 0.85, 0.71, 0.65, 0.62, 0.52, 
0.45, 0.37, 0.24, 0.10, 0.08, 0.05 
 
In accordance with the results at 0.5 L scale, the maximum number of compounds produced 
was observed during intracellular production after 10 days of fermentation at 1 L and 2 L scale. 
While the number of bands increased upon scale-up, most of these bands were also present at 
0.5 L scale; furthermore the majority of the bands detected during extracellular production 
were also present intracellularly. 
3.3.2. Larger-scale secondary metabolite production 
After successful medium-scale SM production, larger-scale production in 3 L and 5 L 
fermentation vessels was tested. The larger-scale production of SMs depends greatly on the 
fermentation processes. During fermentation, large volumes of the antimicrobial-producing 
organism are grown to produce the SMs. The whole process of finding a new compound can 
take years and the manufacturer should be able to produce the compound in high yields during 
the fermentation process and the isolation of the compound should be feasible. Extensive 
research is required prior to commercially scaling up the production of a new antimicrobial. 
Sections 3.3.2.1 and 3.3.2.2 gives an insight of the capabilities of strain CZA14T to produce SM 
compounds at a larger-scale. 
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3.3.2.1. Airlift reactor (ALR) fermentation optimisation 
Figures 3.8a and b shows the changes in culture fermentation broth colour after 3 days of 
















The results relating to the maximum production of SMs by CZA14T cultured in 153 + glycerol in 
an airlift reactor (ALR) is presented in Figure 3.9; furthermore the effect of cell mass production 
on SM production is presented in Figure 3.10. Compounds were separated on TLC using a four 
component solvent system and bands were visualised under 254 nm and 365 nm UV light 
(Appendix E, Figure E1). Rf values were calculated for compounds produced extra- and intra-




Figure 3.8b: 3 L Airlift Bioreactor after 10 
days of fermentation of CZA14T in an ALR in 
153 + glycerol medium, pH 6.0 at 30°C. 
Figure 3.8a: Control media on the left, 
experimental broth on the right after 3 
days of fermentation of CZA14T in an ALR 
in 153 + glycerol medium, pH 6.0 at 30°C. 










Figure 3.9: Column graph representing number of bands visualised under 254 nm short wave UV light on 
a developed TLC of EtOAc extracts from the supernatant filtrate (SNF) (extracellular production) and cell 






Figure 3.10: Line graph of cell mass production vs antimicrobial production over a period of 0-20 days 
during fermentation of CZA14T in a 3L airlift bioreactor 
 
 
Day 0 Day 2 Day 5 Day 7 Day 10 Day 13 Day 15 Day 17 Day 20
SNF 0 3 8 5 3 4 5 9 9
CELL 0 3 5 1 1 3 4 4 2
SD 0.000 0.009 0.021 0.009 0.001 0.000 0.004 0.012 0.018
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Table 3.4: Rf values of bands visualised under 254 nm short wave UV light on a developed TLC of ALR 
EtOAc extracts from the supernatant filtrate (SNF) (extracellular production) and cell mass (cell) 
(intracellular production). 
Day ALR (Rf value) 
 SNF CELL 
3 0.94, 0.38, 0.26 0.94, 0.26, 0.10 
5 
0.94, 0.85, 0.77, 0.73, 0.38, 0.26, 
0.13, 0.10 
0.94, 0.38, 0.26, 0.13, 0.10 
7 0.85, 0.38, 0.26, 0.13, 0.10 0.90 
10 0.85, 0.38, 0.26 0.90 
13 0.94, 0.85, 0.38, 0.26 0.90, 0.38, 0.26 
15 0.94, 0.85, 0.77, 0.38, 0.26 0.94, 0.77, 0.38, 0.26 
17 
0.94, 0.90, 0.85, 0.77, 0.73, 0.64, 
0.59, 0.38, 0.26 
0.94, 0.77, 0.38, 0.26 
20 
0.94, 0.90, 0.85, 0.77, 0.73, 0.64, 
0.59, 0.38, 0.26 
0.94, 0.26 
 
All compounds produced intracellularly were also produced extracellularly. A maximum 
production of eight and nine compounds was produced extracellularly at day 5 and days 17-20, 
respectively, whereas five compounds were produced intracellularly at day 5. Cell growth was 
monitored throughout the fermentation alongside SM production by CZA14T to determine the 
effect of biomass on the number of SMs produced. An increase in biomass production occurred 
at day 5 and decreased thereafter. An unexpected increase occurred at day 15 followed by a 
decrease at day 17 and a sudden increase again at day 20. SM production follows a similar 
trend compared to the growth curve of CZA14T. Cell growth was the same across the time 
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3.3.2.2. Continuous stirred tank reactor (CSTR) fermentation optimisation 










Figure 3.11: BIOFLO 3000 Continuous Stirred Tank Reactor. 
The results relating to the maximum production of SMs by CZA14T cultured in 153 + glycerol in 
a continuous stirred tank reactor (CSTR) is presented in Figure 3.12; furthermore the effect of 
cell mass production on SM production is presented in Figure 3.13. Compounds were separated 
on TLC using a four component solvent system and bands were visualised under 254 nm and 
365 nm UV light (Appendix F, Figure F1). Rf values were calculated for compounds produced 







Figure 3.12: Column graph representing number of bands visualised under 254 nm short wave UV light 
on a developed TLC of EtOAc extracts from the supernatant filtrate (SNF) (extracellular production) and 
cell mass (cell) (intracellular production) extracted from fermentation broth collected from continuous 





























Figure 3.13: Line graph of cell mass production vs antimicrobial production over a period of 0-20 days 
during fermentation of CZA14T in a continuous stirred tank reactor. 
 
Table 3.5: Rf values of bands visualised under 254 nm short wave UV light on a developed TLC of ALR 
EtOAc extracts from the supernatant filtrate (SNF) (extracellular production) and cell mass (cell) 
(intracellular production) 
Day CSTR (Rf value) 
 SNF CELL 
3 0.59, 0.56 NA 
5 0.90, 0.60, 0.56, 0.38, 0.26 NA 
7 
0.90, 0.69, 0.60, 0.56, 0.49, 
0.38, 0.26 
0.94, 0.90, 0.69, 0.60, 0.56, 
0.38, 0.26 
10 
0.90, 0.69, 0.60, 0.56, 0.49, 
0.38 
0.94, 0.90, 0.69, 0.60, 0.56, 
0.38, 0.26 
13 0.90, 0.69, 0.60, 0.56, 0.49 
0.94, 0.90, 0.69, 0.60, 0.56, 
0.38, 0.26 
15 
0.90, 0.60, 0.55, 0.51, 0.49, 
0.42, 0.38, 0.26 
0.94, 0.90, 0.55, 0.38, 0.26, 
0.17 
Day 0 Day 3 Day 5 Day 7 Day 10 Day 13 Day 15 Day 17 Day 20
SNF 0 2 5 7 6 5 8 5 5
CELL 0 0 0 7 7 7 6 5 6
SD 0.001 0.002 0.001 0.014 0.009 0.007 0.004 0.005 0.010
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17 0.90, 0.55, 0.48, 0.38, 0.26 0.94, 0.55, 0.38, 0.26, 0.17 
20 0.90, 0.55, 0.48, 0.38, 0.26 
0.94, 0.55, 0.42, 0.38, 0.26, 
0.17 
 
A maximum of seven and eight compounds were produced extracellularly at days 7 and 15, 
respectively. Whereas seven compounds were produced intracellularly at days 7-13. Five out of 
the seven compounds produced intracellularly had similar Rf values to compounds produced 
extracellularly. Three out of the eight compounds produced during fermentation using the CSTR 
had similar Rf values compared to compounds produced during fermentation with the ALR. An 
increase in biomass occurred at day 7 and decreased thereafter, followed by an increase in 
biomass at day 17. Intra- and extra-cellular SM production follows a similar line pattern 
compared to the CZA14T growth curve, however a sudden increase in extracellularly produced 
compounds occurred at day 15.     
3.4. DISCUSSION 
Previously defined optimal media and fermentation conditions were selected based on the 
premise that SM production by actinomycetes are enhanced or initiated by manipulating 
fermentation media components and conditions (Zhang and Greasham, 1999). The media type 
(153 + glycerol) used in the current study consists of glycerol, meat extract, peptone and CaCO3. 
Glycerol was used as a carbon source to provide a stabilising effect on biosynthetic enzymes 
and SMs which in turn causes an increase in SM yield in actinomycetes (Amoyo et al., 2000; 
Chen et al., 2002). Meat extract and peptone were used as nitrogen sources. The combination 
of these two components was to reduce the problems associated with easily assimilated 
nitrogen sources, which may repress SM production caused by amino acids and ammonium 
salts (Omura and Tanaka, 1984). CaCO3 was used as a micronutrient, which is essential for 
biological activities; excess amounts of this micronutrient may be toxic and was used in small 
concentrations. Maximum SM production by CZA14T in 153 + glycerol was achieved at media pH 
of 6.0. Generally actinomycetes produce SMs best at optimal growth pH and in this case, 
CZA14T has a growth optima of pH 7.0 (Le Roes and Meyers, 2005). The optimal fermentation 
conditions for the growth and maximum SM production by CZA14T was at 30°C, shaking at 160 
Stellenbosch University  https://scholar.sun.ac.za
72 
 
rpm. It has been reported that actinomycete producing SMs are mesophilic and have optimal 
SM production as well as growth optima at about 28°C (Iwai and Omura, 1982).  
Submerged fermentation was used to produce SMs by CZA14T. The primary concerns in utilising 
submerged fermentations for SM production by filamentous actinomycetes are the 
fermentation vessel and the speed of the shaker to provide adequate oxygen supply 
(Whittaker, 1992). SM production in 0.5 L flat-bottom Erlenmeyer flasks and baffled-flasks 
(Table 3.1) were compared to determine the best flask type for maximum SM production. 
These flasks were shaken at 160 rpm – the speed at which the shaker is moving should be 
adequate enough to provide sufficient oxygen supply without shearing the mycelia (required 
for SM production) which is associated with high agitation rates (Whittaker, 1992). One band 
visualised under UV on a developed TLC plate could constitute one or more compounds, but to 
quantify the production of SMs the number of bands visualised under UV was used as a 
measurement of the success of a particular fermentation and is referred to as a SM compound. 
Comparison of the two flask types showed that higher amounts of SM compounds were 
produced in baffled flasks (Table 3.1). Seven compounds were produced extracellularly at day 5 
and nine compounds were produced intracellularly as early as day 3 in baffled flasks, whereas 
seven compounds were produced extracellularly at day 7 and eight compounds were produced 
intracellularly at day 10 in flat-bottom flasks (Appendix A, Figure A1 – A4). SM production in 
flat-bottom flasks was different to that of baffled flasks. This could be due to the level of 
dissolved oxygen present within these respective flask types. Shake flasks with angular baffles 
or indents are used for actinomycetes as these indentations help in increasing oxygen transfer 
and also aids in efficient mixing (Katzer et al., 2001).  
A number of similar compounds produced in flat-bottom flasks were also produced using 
baffled flasks. Minor variations in Rf values may have occurred throughout this study due to 
slight fluctuations in the solvent system, temperature and technical error during measuring the 
Rf values of the compounds. Compounds with identical Rf values do not necessarily imply that 
compounds are identical and further analysis (by more sensitive equipment such as LC/MS) 
should be performed before those conclusions can be made. Based on the results obtained, 
baffled flasks were further used in the optimisation experiments. 
Other factors influencing antimicrobial production by actinomycetes is the size of the inoculum. 
Whittaker (1991) investigated the influence of the concentration of viable spores in the 
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inoculum on the morphological form of actinomycetes. He found that a high concentration of 
viable spores produces a dispersed growth form compared to pellet formation when spores are 
at low concentration in the inoculum. In this study, the concentration of spores was not taken 
into account. A number of compounds with similar Rf values were produced using 5% - 20%, v/v 
inoculum volumes (Figure 3.6; Table 3.2; Appendix C, Figures C1 – C8). The maximum number 
of SMs produced was observed using a 15%, v/v inoculum size at days 7 and 10 which was three 
times higher than the initial inoculum volume previously used. It was thus found that the 
increase in SM production was directly proportional to the increase in inoculum size. However, 
fewer SMs were produced with a 20% inoculum volume – this may be due to nutrient 
limitation.  A study by Tresner et al. (1967), reported the higher degree of fragmentation of the 
mycelia of Streptomyces aureofaciens when inoculum volume was increased from 1 to 15%. 
Sufficient mycelium fragmentation results in abundant spore formation in actinomycetes – 
spore production in actinomycetes are associated with SM production.  
Baffled flasks were used to achieve a less fragmented mycelial morphology – mycelial 
fragmentation results in a loss in SM production. These flasks however cause splashing of the 
culture against the flask wall at high shaker speeds as observed in Figure 3.3. Filamentous 
mycelial morphology with little to no fragmentation results in more abundant spore formation. 
Under these conditions of growth (baffled flasks), CZA14T produces a blue-green diffusible 
pigment and spores between 1-2 days of growth (Figure 3.3). In this study, CZA14 uses 
nutrients quickly and produces a diffusible pigment at the beginning of the fermentation. 
Limitation of nutrients, specifically nitrogen causes the production of spores, melanin or 
diffusible pigment production due to stress; the reproductive phase is coordinated with the 
secretion of SMs which protect the colony against invading bacteria during aerial growth and 
sourcing of new nutrient sources (Behal, 2000).  
More compounds were produced intracellularly than extracellularly in the 1 L and 2 L baffled 
flasks (Figure 3.7; Table 3.3). A number of different compounds were produced during 
extracellular production compared to intracellularly produced compounds in 1 L and 2 L baffled 
flasks. More compounds were produced in the 2 L baffled flasks with a maximum of nine 
compounds produced extracellularly at day 7 and twelve compounds produced intracellularly at 
day 10 (Appendix D, Figures D3 – D4). Six to seven compounds were produced extracellularly in 
1 L baffled flasks over a period of 3–10 days and 5 to 8 compounds were produced 
intracellularly over a period of 3-10 days (Appendix D, Figures D1 – D2). This could be due to 
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increased oxygen uptake rate in 2 L baffled flasks compared to 1 L baffled flasks. In 2 L baffled 
flasks the bottom of the flask has a bigger surface area than that in 1 L baffled flasks causing 
more improved mixing without causing heavy splashing. Adequate mixing in 2 L baffled flasks 
helps to achieve similar pellet shape and size that is observed in stirred fermentations for 
optimal SM production.  
Throughout the scale-up of fermentation vessels from 0.5 L flat-bottom flasks to 2 L baffled 
flasks compounds detected under short-wave UV light (254 nm) had similar Rf values of those 
compounds detected under long-wave UV light (365 nm). Most of these compounds fluoresced 
blue, yellow and orange in colour under 365 nm UV light depending on the flask type CZA14T 
was cultured in.  
A decrease in intracellular SM production occurred upon scale-up to 3 L airlift reactor (ALR), 
however the extracellular SM production is on par with SM production in 2L baffled flasks. A 
number of different compounds were produced by CZA14T in the ALR compared to other 
fermentation vessels in this study and could be due to sufficient biomass production. Biomass 
production is related to good gas/liquid mass-transfer at increased concentrations of dissolved 
substances. While a limitation in oxygen supply may be detrimental to biomass production, low 
biomass production may also be attributed to large amounts of nutrients inhibiting SM 
production. A fed batch system technique was used to overcome this problem where a certain 
volume of culture medium is first inoculated with the SM producing organism and over time 
another dosage of nutrients is supplied to the fermenter (in this study, sterile water was used 
to supplement the fermentation) for prolonged cultivation to increase SM production (Behal, 
2000). This was performed as dry air is introduced into the system causing evaporation of the 
fermentation broth; water was used to maintain a constant volume of fermentation broth in 
the airlift reactor to aid in sufficient biomass production. This technique was used in both the 
ALR and continuous stirred tank reactor (CSTR) used in the study. However, the number of SMs 
produced in the CSTR was lower than that produced in the ALR and 2 L baffled flasks. This could 
be as a result of the mechanical shearing of the mycelial cells by the impellers in the CSTR. No 
diffusible pigment was observed during fermentation with the CSTR, the media changed from 
tan to brown suggesting low melanin production. Interestingly, during fermentation with the 
ALR, a dark red-brown pigment was produced from 3 – 20 days of growth (Figure 3.8a and b). It 
appears as if melanin is being produced after 3 days of growth and red and yellow compounds 
were observed after preparation of solvent extracts of samples taken after 7 – 10 days of 
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growth during the production of the red culture pigment, with the compounds becoming 
lighter in colour after 10 days of SM production.  
A growth curve of strain CZA14T was performed to determine effect of biomass on the number 
of SMs produced in the ALR and CSTR. In the ALR, an increase in biomass production occurred 
around day 5 and decreased thereafter with an increase in SM products following the same 
development. This translates to 5 days of log growth after which the culture entered stationary 
phase and began death phase after day 15. In the CSTR, after 7 days of log growth the culture 
entered stationary phase and began death phase after day 17. In both the ALR and CSTR, 
variation in the biomass and production occurred around day 15 – day 20. This could be 
attributed to the phenomenon of autophagy – this involves a cellular process in which proteins, 
organelles and lipids are targeted towards lysosomes for degradation. These are reused to fulfil 
energy requirements of the cell under nutrient-limiting conditions (Huang and Brumell, 2014). 
The scale-up from flask-type fermentation vessels to bioreactor systems were moderately 
successful. ALR and CSTR systems present their own advantages and limitations, but by 
definition, involve similar processes. Most bioreactor systems allow for improved cultivation of 
the microorganism of interest in a controlled manner over shake-flasks; these systems involve 
the conversion of materials via specific reactions into valuable by-products. The CSTR was 
selected as it results in continuous production and output. This system allows for automation of 
processes so it reduces labour expense. Production time used to empty, fill and sterilise the 
reactor is reduced. Due to operating parameters, the quality of the products formed is 
consistent. CSTR has a number of limitations associated with its use such as, negligible 
robustness due to slight process variation – it is an automated system. Uniform raw material 
quality is required to guarantee that the process remains continuous. The costs associated with 
purchasing and maintaining these systems are high. Higher risk of cell mutation and 
contamination of the culture is associated with the CSTR due to cultivation periods required 
within the CSTR (Williams, 2002). 
The ALR was selected for further study as it provides more advantages over the CSTR (as 
observed in this study). Some of these advantages include less maintenance, easier sterilisation 
and reduced risk of defects as the design of the ALR is simpler and contains no agitator or 
moving parts. The risk of shearing of the mycelia is lower in the ALR, which results in greater 
robustness. It also provides low energy input due to large, specific interfacial contact-area. 
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Efficient mixing and well-controlled flow provide well-defined habitation time for all growth 
phases and enhanced oxygen transfer in solution results in an increase in mass-transfer rate. 
Lastly, the ALR provides greater heat-removal compared to the CSTR (Williams, 2002).  
3.5. CONCLUSION 
Figure 3.14 presents a summary of the use of various fermentation vessels and the maximum 
SM production in those vessels.  
Figure 3.14: Summary of maximum secondary metabolite production in various fermentation vessels. 
 
0.5 L flat-bottom flasks were compared to 0.5 L baffled flasks. Overall, more SM compounds 
were produced intracellularly in baffled flasks at a faster rate compared to production in flat-
bottom flasks. This was attributed to poor oxygen supply in flat-bottom flasks.  
The production was successfully scaled-up from 0.5 L baffled flasks to 1 L and 2 L baffled flasks. 
More SM compounds were produced extra- and intra-cellularly in 2 L baffled flasks compared 
to 1 L baffled flasks. It was concluded that this could be a result of reduced pellet formation 
(which limits SM production) in the 2 L baffled flasks. Dispersed mycelium formation occurred 
in 2 L baffled flasks in this study due to larger surface area of the flask causing higher aeration 
during agitation of the culture medium and in turn resulting in an increase in production of SM 
products.  
Extracellular SM production in the ALR is comparable with extracellularly produced compounds 
in the 2 L baffled flasks. Intracellular compound production, however, was less than half of that 
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produced in 2 L baffled flasks. CZA14T produced a number of compounds in the CSTR of similar 
Rf values to those produced in the ALR, but fewer compounds compared to both the ALR and 2 
L baffled flasks. Optimization of the CSTR could be performed in future as a number of the 
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Testing the inhibitory efficacy of crude 
extracts against a number of known 
pathogenic bacteria 
  




The introduction of antimicrobial therapy approximately 70 years ago has since saved the lives 
of millions of people and majorly reduced premature death caused by microbial infection. Due 
to this reduction it was assumed that high mortality associated with infectious disease was a 
thing of the past. However, resistance profiles were observed soon after the introduction of 
antimicrobial compounds. Resistance caused by horizontal gene transfer between and among 
species of both Gram-positive and Gram-negative bacteria were responsible for the 
development of multidrug resistant bacteria. The driving engine of this process can be 
accredited to the selective pressure of the use of antimicrobials in community, hospital and 
agricultural settings. The lack of new therapeutic options to replace those antimicrobial agents 
that have lost their efficacy against resistant bacteria is a growing concern. The search for new 
antimicrobials from rare and/or existing sources such as strains in culture collections have been 
given much attention over the last decade. In this study, antimicrobials produced by CZA14T 
exhibited broad spectrum antibacterial activities against Bacillus cereus ATCC 10876, 
Enterobacter cloacae subsp. cloacae ATCC BAA-1143, Enterococcus faecalis ATCC 29212, 
Eschericia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, Staphylococcus aureus 
subsp. aureus ATCC 29213, E. faecalis ATCC 51299, Klebsiella pneumoniae subsp. pneumoniae 
ATCC 700603, Salmonella enterica subsp. arizonae ATCC 13314, and S. aureus subsp. aureus 
ATCC 33591. It also exhibited anti-fungal activity against Candida krusei ATCC 34135. These 
compounds were also active against environmental domestic rainwater harvesting (DRWH) 
system isolates, E. coli K4 CCA, E. cloacae 11, E. cloacae 20, E. cloacae 22, E. faecalis C513, K. 
pneumoniae 1, K. pneumoniae 2, K. pneumoniae 4, K. pneumoniae 5, P. aeruginosa, S. enterica 




Key words: Broad-spectrum, antimicrobial therapy, bio-activity, ATCC, DRWH 
 




Antimicrobial resistance poses a major health risk due to infections caused by resistant 
bacteria. Over time, a number of these pathogenic bacteria have gained resistance to multiple 
classes of antimicrobials available on the market. Reduced amount of effective antimicrobial 
agents against common infections currently threaten our ability to fight against infectious 
diseases and to manage complications caused by these infections, especially in immuno-
compromised patients. The development of new antimicrobial compounds and new diagnostic 
tests are desperately needed for use against resistant bacteria. 
 
There are a number of types of microbiological tests used to determine the inhibitory effects of 
an antimicrobial agent on a particular test organism. These tests are commonly referred to as 
antimicrobial assays. A biological assay is a practical method whereby the effectiveness of a 
material of unknown bio-activity is assessed by comparing the efficacy in a biological system 
against a reference standard of known potency. Ideally, a homogenous biological system is 
required so that the reference standard and unknown would be reacting under similar 
conditions (Hewitt, 2003). 
 
Infections caused by bacteria and the comparative analysis of antimicrobials are successfully 
managed by accurately determining the bacterial susceptibility to antimicrobial agents. A 
number of techniques can be employed to do this, such as diffusion, dilution and 
bioautography assays (Mishra et al., 2006). The agar diffusion method is used for the 
quantitative detection of inhibitory agents. The method can be performed by means of disk 
diffusion, cylinder diffusion and the hole-plate assay. The most commonly used diffusion 
method is the disk diffusion assay (used in this study), whereby an antimicrobial substance is 
placed on a filter disk and allowed to diffuse into the agar medium containing the test organism 
of interest. This leads to the inhibition of the growth of the organism in the area of the source 
antimicrobial to form clear ‘zones’ without any bacterial lawn/growth. The effectiveness of 
antimicrobial agents can be evaluated by means of their ability to suppress the growth of the 
test organism described by dilution method – minimal inhibitory concentration (MIC). The 
minimum lethal concentration (MLC) is characterized by the lowest concentration of an 
antimicrobial agent to kill the test organism of interest (Macias et al., 1994; Abraham et al., 
1992). Lastly, the quantitative bioautography assay may be performed by means of contact, 
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immersion and direct bioautography. In this study, direct thin layer chromatography (TLC) – 
bioautography was used for the detection of compounds in the form of bands (e.g. visualisation 
by UV) and/or a chromogenic spray substance, and bio-activity.  The aforementioned assays 
provide a quick screen for novel antimicrobial compounds by bioassay-guided isolation 
(Moreno et al., 1999).  
 
In the search for new antimicrobials with novel mechanisms of action, a comparative study 
between clinical test strains obtained from the American Type Culture Collection (ATCC) and 
environmental strains isolated from domestic rainwater harvesting (DRWH) systems was 
performed to determine the antimicrobial profiles of secondary metabolite (SM) producing 
strain CZA14T using a number of bioassay strategies. SMs produced by CZA14T were also tested 
against clinical yeast test strains to establish antimicrobial properties. 
 
This chapter describes the bio-activity profiles of crude compounds extracted from 
fermentation broth after fermentation of CZA14T in 2 L baffled flasks, airlift reactor (ALR) and 
continuous stirred tank reactor (CSTR). This chapter deals with the second and third objective 
of this study – to test the inhibitory efficacy of crude extracts against clinical ATCC test strains 
and environmental bacterial pathogens isolated from DRWH systems; the methodology 
employed to achieve these objectives are outlined in Figure 4.1. 
The agar overlay assay was used to determine the bio-activity potential of CZA14T against 
various Gram positive and Gram negative ATCC test strains and DRWH system isolates. The 
inhibitory efficacy of crude extracts produced by CZA14T in various fermentation vessels was 
tested using standard filter disk-diffusion assays against the ATCC test strains and DRWH 
system isolates; where a clear “zone of inhibition” indicates the killing potential of the 
compounds produced by CZA14T. The results obtained during standard filter disk-diffusion 
assays were confirmed using bioautography assays (Figure 4.1). 
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Inhibitory efficacy of crude extracts against American 
Type Culture Collection (ATCC) and Domestic Rainwater 




sp. strain CZA14T using 
the agar-overlay method 
against ATCC test strains 
and DRWH isolates 
 
ATCC: Bacillus cereus ATCC 10876, 
Enterobacter cloacae subsp. Cloacae ATCC 
BAA-1143, Enterococcus faecalis ATCC 
29212, Eschericia coli ATCC 25922, 
Pseudomonas aeruginosa ATCC 27853, 
Staphylococcus aureus subsp. aureus ATCC 
29213, Enterococcus faecalis ATCC 51299, 
Klebsiella pneumonia subsp. Pneumonia 
ATCC 700603, Salmonella enterica subsp. 
arizonae ATCC 13314, Staphylococcus aureus 
subsp. aureus ATCC 33591, Yeast strains: 
Candida albicans ATCC 24433, Candida 
albicans ATCC 90028, Candida krusei ATCC 
14243, Candida krusei ATCC 34135, Candida 
tropicalis ATCC 750 
DRWH isolates: Bacillus cereus, Escherichia 
coli K4 CCA, Escherichia coli Mi CCA, 
Enterobacter cloacae 11, Enterobacter 
cloacae 19, Enterobacter cloacae 20, 
Enterobacter cloacae 22, Enterobacter 
cloacae 23, Enterococcus faecalis C513, 
Klebsiella pneumonia 1, Klebsiella 
pneumonia 2, Klebsiella pneumonia 3, 
Klebsiella pneumonia 4, Klebsiella 
pneumonia 5, Klebsiella pneumonia 6, 
Klebsiella pneumonia 7, Klebsiella 
pneumonia 8, Pseudomonas aeruginosa, 
Salmonella enterica 4C, Salmonella enterica 
5J, Staphylcoccus aureus 1, Staphylcoccus 
aureus 2, Staphylcoccus aureus 3, 
Staphylcoccus aureus 4, Staphylcoccus 
aureus 5, Staphylcoccus aureus 6, and 
Staphylcoccus aureus 7 
 
Bioassays: Filter disk 
diffusion assay and 
bioautography to 
determine active 
compounds against ATCC 
test strains and DRWH 
isolates 
DNA isolation of DRWH test 
strains for the identification of 
these strains to genus level 
using phylogenetic analysis: 
Chromas 
DNAMAN 

















Figure 4.1: Flow-chart of methods used to determine the inhibitory efficacy of crude extracts from the 
supernatant filtrate (SNF) and cell mass (cell) extracted from fermentation broth from 2L baffled flasks, 
ALR and CSTR. 
 
Materials and Methods 
4.1. Materials 
Most of the chemicals used in this study were purchased from Merck Millipore or Sigma-Aldrich 
unless otherwise stated. All solvents used were analytical grade. 
4.2. Methods 
4.2.1. The overlay technique to determine CZA14T bio-activity potential against clinical ATCC 
control test strains and environmental DRWH isolates 
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4.2.1.1. Base layer agar for preparation of susceptibility testing 
Strain CZA14T was inoculated onto ISP #2 agar (g/L: 4 glucose, 10 malt extract, 4 yeast extract 
and 20 bacteriological agar, pH 7.2) for ± ten days at 30°C using the actinomycete streak 
technique (unpublished data: Kirby and le Roes-Hill, 2009). Mature CZA14T agar cultures were 
used to stab inoculate, 153 + glycerol (g/L: 10 glycerol, 5 peptone, 5 meat extract, 3 CaCO3, and 
20 agar bacteriological, pH 6.0) agar plates using sterile toothpicks. The plates were inverted 
and incubated at optimal temperature (30°C) for eleven days. 
4.2.1.2. Overlay layer – Part 1 - inoculation of test bacteria 
The test bacteria used in this study were inoculated onto optimal solid growth media, inverted 
and incubated for 24-48 hours at optimal growth temperature (Table 4.1). A loopful of test 
bacteria was inoculated (using aseptic techniques) into 10 mL sterile liquid optimal growth 
medium and incubated overnight at optimal growth temperature (Table 4.1) with shaking (160 
rpm, 16-20 hours). Overnight cultures were Gram-stained using a standard Gram-staining 
procedure prior to use to ensure no contamination of the test cultures took place. Test strains 
were stored as cell suspension stock cultures in 20% (v/v) glycerol at -20°C and further 
maintained on optimal growth media (Table 4.1). The Optical Density (OD) of the pure test 
cultures were measured at 600 nm using a RayLeigh UV-9200 spectrophotometer (sterile 
growth media was used as a blank) and the test cultures were diluted accordingly. The 
following dilutions were performed: fast growing bacteria such as Escherichia coli were diluted 
1-in-10 and slow growing bacteria such as Enterococcus faecalis (and most enteric bacteria) 
were diluted 1-in-4. 
4.2.1.3. Overlay layer – Part 2 - preparing the sloppy agar 
Optimal growth medium sloppy agar (0.7%, w/v agar) was prepared by dissolving all ingredients 
in dH2O in the microwave at full power and aliquoting the molten agar into McCartney bottles 
in 6 mL volumes using a 10 mL glass pipette. Metal caps with rubber stoppers were placed onto 
each McCartney bottle and sterilized by autoclaving the media for 15 minutes at 121°C. After 
autoclaving the media the bottles were placed at 60°C in a water bath to bring the media to 
temperature in order to add the test culture to the sterile sloppy agar medium. 
4.2.1.4. Overlay layer – Part 3 - overlaying 
To ensure that the same concentration of cells are in the sloppy agar when repeating or 
performing overlay experiments the OD600 was taken into account for each test culture. An 
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empirical formula varying for different test bacteria was used to determine the number of 
microliters (μLs) added to each sloppy agar tube.  
The number of μLs of test bacteria used per 6 ml overlay was such that when multiplying the 
number of μLs of bacterial culture used per sloppy agar by the OD600 of the broth culture 
approximate values of : 160 OD600-μL for M. aurum, 4 OD600 – μL for E. coli, and 160 OD600 – μL for E. 
faecalis was achieved.  
The calculated amount of test bacteria was added into a McCartney bottle containing optimal 
growth sloppy agar medium and vortexed gently to ensure homogenity. The 6 mL volume 
sloppy agar containing the test bacteria was poured onto the surface of the stab-inoculated 
CZA14T plate cautiously to avoid pouring directly onto the streptomycete colony (to avoid 
dispersion of spores all over the agar plate). The sloppy agar was allowed to set, the plates 
were inverted and incubated overnight at optimal temperature of the test strains (Table 4.1) 
and zones of inhibition were recorded to determine bio-activity potential of strain CZA14T. 
4.2.2. DNA isolation of Domestic Rainwater Harvesting test strains, PCR and phylogenetic 
analysis 
The DNA isolation method was adapted from Cheng and Jiang (2006) whereby the test strains 
of interest were grown in optimal media and under optimal conditions (Table 4.1). Cells were 
harvested from 1 mL of the cell suspension by centrifuging at 10 000 rpm for 2 minutes. The 
supernatant was discarded and the cells were washed twice with 400 μL STE buffer (100 mM 
NaCl, 10 mM tris-HCl, 1 mM EDTA, pH 8.0), centrifuging at 10 000 rpm for 2 minutes between 
each wash step. The buffer was discarded and the cells were resuspended in 200 μL Tris-EDTA 
(TE) buffer (10 mM tris-HCl, 1mM EDTA, pH 8.0). Resuspended cells were extracted with 100 μL 
tris-saturated phenol (pH 8.0) by lysing the cells using a vortex for 1 minute. 
Table 4.1: Optimal growth conditions and medium for optimal growth of test strains of interest 
American Type Culture Collection (ATCC) strains Culture Method 





Enterobacter cloacae subsp. cloacae ATCC BAA-1143, Enterococcus 
faecalis ATCC 29212, Eschericia coli ATCC 25922, Pseudomonas 
aeruginosa ATCC 27853, and Staphylococcus aureus subsp. aureus ATCC 
29213 
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Enterococcus faecalis ATCC 51299 Medium: Brain Heart 
Infusion agar/broth with 




Klebsiella pneumoniae subsp. pneumoniae ATCC 700603, Salmonella 
enterica subsp. arizonae ATCC 13314, and Staphylococcus aureus subsp. 
aureus ATCC 33591. 





Yeast strains: Candida albicans ATCC 24433, Candida albicans ATCC 
90028, Candida krusei ATCC 14243, Candida krusei ATCC 34135, Candida 
tropicalis ATCC 750 





*Domestic Rainwater Harvesting (DRWH) Strains Culture Method 
Bacillus cereus Medium: Nutrient 
agar/broth 
Temperature: 30 °C 
Escherichia coli K4 CCA, Escherichia coli Mi CCA, Enterobacter cloacae 
11, Enterobacter cloacae 19, Enterobacter cloacae 20, Enterobacter 
cloacae 22, Enterobacter cloacae 23, Enterococcus faecalis C513, 
Klebsiella pneumoniae 1, Klebsiella pneumoniae 2, Klebsiella 
pneumoniae 3, Klebsiella pneumoniae 4, Klebsiella pneumoniae 5, 
Klebsiella pneumoniae 6, Klebsiella pneumoniae 7, Klebsiella 
pneumoniae 8, Pseudomonas aeruginosa, Salmonella enterica 4C, 
Salmonella enterica 5J, Staphylcoccus aureus 1, Staphylcoccus aureus 2, 
Staphylcoccus aureus 3, Staphylcoccus aureus 4, Staphylcoccus aureus 5, 
Staphylcoccus aureus 6, and Staphylcoccus aureus 7 
Medium: Nutrient 
agar/broth 
Temperature: 37 °C 
*DRWH strains were previously isolated from RWH systems by members of the Khan laboratory, Stellenbosch University. These 
test strains were characterised phenotypically and biochemically to determine the genus it belongs to.  Note: Media were 
prepared as per the manufacturer’s instructions. 
The samples were centrifuged at 12 000 rpm for 5 minutes to separate the aqueous phase from 
the organic phase and ~ 160  μL of the upper phase was transferred into a sterile 1.5 mL 
Eppendorf tube after which 40 μL of TE buffer was added to the tube (this step was repeated 2–
3 times). One hundred μL of chloroform: isoamyl alcohol (24:1) was added to the extracted 
samples and centrifuged at 12 000 rpm for 5 minutes (this step was repeated three times). The 
samples were then precipitated with an equal volume of isopropanol and the lysate was further 
purified by chloroform extraction until a white interface was no longer present. Approximately 
180 μL of the upper phase was transferred into a sterile Eppendorf tube and 20 μL of TE was 
added to the sample. One hundred μL RNase A (100 μg/mL) was added to the samples and 
incubated at 37°C on a heating block for 30 minutes. 100 μL of chloroform was added to the 
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tube and centrifuged at 12 000 rpm for 5 minutes. ~ 150 μL of upper aqueous phase was 
transferred to a sterile 1.5 mL Eppendorf tube; this contained the gDNA that was used as a 
template for PCR with 16S rRNA primer sets (16S-F: 5’ – AGAGTTTGATCITGGCTCAG - 3’, 16S-R: 
5’ – ACGGITACCTTGTTACGACTT – 3’) (de Bruijn, 2011).  
Conditions for amplification of the 16S rRNA gene were: 96°C for 2 minutes (initial 
denaturation), 30 cycles of 96°C for 30 seconds (denaturation), 56°C for 30 seconds (annealing), 
72°C for 2 minutes (extension) and a final extension of 72°C for 5 minutes. PCR products were 
purified according to the manufacturer’s instructions using the Stratec Molecular MSB spin 
PCRapace kit. Samples were electrophoresed on a 1% (w/v) 1 X tris-acetate-EDTA (TAE) agarose 
gel (100 volts (V) for 1 hour (hr) and viewed under UV (Appendix G, Figures G1 and G2). The 
product of samples with low intensity bands were re-amplified using the same conditions and 
primer sets and samples were sequenced at Inqaba Biotec (http://www.inqababiotec.co.za/) 
for sequencing. Chromatograms received from Inqaba Biotec were edited in Chromas (the 
Chromas Lite program (Technelysium) can be downloaded from: 
http://www.technelysium.com.au/chromas.html), exported as a FASTA format file and a 
consensus sequence was produced using the multiple sequence alignment tool in DNAMAN 
(Lynnon Biosoft; www.lynnon.com). For those sequences where no successful consensus 
sequence was produced, the sequence generated using the forward primer only was used to 
identify the organism of interest. Forward/consensus sequences were uploaded onto the 
EzTaxon website (http://www.eztaxon.org/; Chun et al., 2007) to determine the identity of the 
DRWH system isolates. The EzTaxon database makes use of basic local alignment search tool 
(BLAST) (using the BLASTn function) using the NCBI database 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) to compare nucleotide sequences to sequence 
databases. Phylogenetic analysis was performed on the sequences from the BLAST and EzTaxon 
analysis, and Corynebacterium diphtheria strain ATCC 27010 was used as an out-group. The 
sequences were aligned using the ClustalW function of MEGA6 
(http://www.megasoftware.net/mega.html) and the overhanging parts were deleted to 
produce sequences of equal length. A neighbour-joining phylogenetic tree was produced using 
MEGA6 (bootstrap setting of 1000) and the relationship of the strains were confirmed by 
creating phylogenetic trees using the minimum evolution and/or maximum parsimony 
functions. Conserved regions were indicated with an asterisk at the node of the branching 
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region of the tree. The degree of similarity between the tested sequences is determined by 
conserved regions.   
4.2.3. Bioassay methods 
4.2.3.1. Filter disk assay of crude extract from the supernatant filtrate (SNF) and cell mass 
extracted from fermentation broth from 2L baffled flasks, CSTR and ALR. 
Antimicrobial activity of EtOAc culture extracts were determined using filter-disc diffusion agar 
assay method (Eckwall and Schottel, 1997). Sterile Whatman filter paper discs (Cat. No. 2501-
150) were spotted with 10 μL EtOAc culture extracts (prepared as described in Chapter 3) and 
allowed to dry. Test strains were prepared (refer to section 4.2.1.2), and 0.1 mL 0.5 OD600 
culture were spread plated onto Mueller Hinton agar (MHA) medium (g/L: 2 beef/meat extract, 
17.5 casein hydrolysate, 1.5 starch and 17 bacteriological agar, pH 7.3) and left for 5–7 minutes. 
Impregnated filter disks were placed onto the surface of an inoculated MHA plate. The agar 
plates were incubated at optimal temperature (Table 4.1) for 24-36 hours and the diameter of 
zones of growth inhibition were measured. The assay was performed in duplicate and control 
plates contained a sterile filter disk control, EtOAc control, commercial antibiotic controls 
(ampicillin, chloramphenicol and vancomycin at 1 mg/mL) and test organism control without a 
filter disk.  
4.2.3.2. Bioautography assay of crude extracts from the SNF and cell mass obtained from 
fermentation broth from 2 L baffled flasks, CSTR and ALR. 
The bioautography assay was adapted from Betina (1973). Compounds of interest were 
analysed using TLC and visualised under ultraviolet (UV) light. Silica gel G F254 TLC plates were 
developed in a solvent system containing chloroform: EtOAc: formic acid: n-hexane (5: 4: 1: 
0.02, v/v/v/v) and allowed to dry O/N under a fume hood. Test bacteria were prepared (refer to 
section 4.2.1.2) and applied to the surface of the TLC plates with sterile absorbent cotton wool. 
Sealable plastic containers were lined with moist paper towel and the TLC plates covered with 
test bacteria were placed in containers and incubated O/N at optimal temperature (Table 4.1). 
A final concentration of 0.25 w/v thiazolyl blue tetrazolium blue (MTT) was prepared by 
dissolving MTT in a phosphate buffered saline solution (g/l): 2.26 Na2HPO4, 2.27 KH2PO4 and 
8.00 NaCl at pH 7.0. After incubation, MTT was applied to the surface of the TLC plates using 
sterile non-absorbent cotton wool and the plates were incubated for ± 2-3 hours at optimal 
temperature (Table 4.1).  This method relies on a staining using tetrazolium salts for 
visualisation of active bands. Living organisms have the ability to perform dehydrogenase 
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reactions which converts the tetrazolium salt into formazan which is intensely coloured (in this 
case, purple). The presence of antimicrobial activity results in a cream spot appearing around a 
purple background on the surface of the TLC plate, indicating the lack of dehydrogenase activity 
and hence the death of the test strain.  
4.3. RESULTS  
4.3.1. The overlay technique to determine CZA14T bio-activity potential against clinical ATCC 
control test strains and environmental DRWH isolates 
The bio-activity potential of CZA14T was tested by performing an agar overlay method. CZA14T 
showed antimicrobial activity against a broad range of ATCC and DRW isolated Gram-positive 
and Gram-negative bacteria as well as against a yeast strain (Table 4.2). CZA14T exhibited broad 
spectrum bio-activities against all of the bacterial clinical ATCC test strains, a number of DRWH 
isolates and one of the yeast clinical ATCC test strains. 
Table 4.2: Antimicrobial activity of Streptomyces pharetrae CZA14T on 153 + glycerol agar, pH 6.0 at 30°C 
after 10 days of growth against bacterial and yeast ATCC strains as well as environmental DRWH system 
isolated bacterial pathogens  
Bacterial ATCC Strains Average 
(mm²) 







B. cereus ATCC 10876 137 C. albicans ATCC 
24433 
NI B. cereus 1247 
E. cloacae ATCC BAA-
1143 
253 C. albicans ATCC 
90028 
NI E. coli Mi CCA NI 
E. faecalis ATCC 29212 76 C. krusei ATCC 14243 NI E. coli K4 CCA 106 
E. faecalis ATCC 51299 81 C. krusei ATCC 34135 176 E. cloacae 11 110 
E. coli ATCC 25922 262 C. tropicalis ATCC 
750 
NI E. cloacae 19 NI 
K. pneumoniae ATCC 
700603 
54   E. cloacae 20 275 
P. aeruginosa ATCC 
27853 
311   E. cloacae 22 123 
S. enterica ATCC 13314 94   E. cloacae 23 NI 
S. aureus ATCC 29213 427   E. faecalis C513 NI 
S. aureus ATCC 33591 556   S. enterica 4C 2133 
    S. enterica 5J NI 
    P. aeruginosa NI 
    S. aureus (1) 1376 
    S. aureus (2) 1866 
    S. aureus (3) ND 
    S. aureus (4) 368 
    S. aureus (5) 263 
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    S. aureus (6) NI 
    S. aureus (7) NI 
    K. pneumoniae (1) 64 
    K. pneumoniae (2) NI 
    K. pneumoniae (3) 204 
    K. pneumoniae (4) NI 
    K. pneumoniae (5) NI 
    K. pneumoniae (6) NI 
    K. pneumoniae (7) NI 
    K. pneumoniae (8) NI 
Key (Table 4.2): VW (very weak): <100 mm
2
; W (weak), 100-1000 mm
2
; M (moderate), 1001-2000 mm
2
; S (strong), 2001-3000 
mm
2
; VS (very strong), >3000 mm
2
; NI: no inhibition. 
4.3.2. DNA isolation of Domestic Rainwater Harvesting; PCR and phylogenetic analysis 
The 16S rRNA genes of the environmental strains isolated from DRWH systems were amplified 
using PCR and sequenced. Only strains against which CZA14T showed the best antimicrobial 
activity during agar overlay bioassay were included in this experiment. The F1 primer sequences 
and consensus sequences were uploaded onto the EzTaxon server and the BLASTn function was 
used to identify the organisms most closely related to the DRWH isolate of interest. The results 
are presented in the form of a phylogenetic tree in Figure 4.2.   
The identity of the DRWH system isolates used in this study was determined using 16S rRNA 
gene sequencing. S. aureus 2 was confirmed as Staphylococcus argenteus MSHR1132T with 100 
% identity. S. aureus 4 was identified as S. aureus DSM 20231T with a 100 % identity. E. faecalis 
C513 was identified as E. faecalis ATCC 19433 with a 97 % identity. P. aeruginosa was confirmed 
to be a P. aeruginosa strain with an identity of 97 %. B. cereus was identified as an 
Ochrobactrum spp. with an identity of 87 %. S. enterica 4C strain isolated from a DRWH system 
was identified as Providencia rettgeri strain DSM 4542T with a 97 % identity rating. K. 
pneumoniae 3 was identified as Raoultella ornothinolytica strain JCM 6096T (formerly known as 
Klebsiella ornothinolytica) with an identity of 97 %; K. pneumoniae 3 is further grouped with 
three Klebsiella species with two of the three being K. pneumoniae. E. cloacae 11 was identified 
as Kosakonia cowanii CIP 107300T, also known as Enterobacter sp. with an identity of 93 %. E. 
cloacae 20 and E. cloacae 22 were grouped with the E. cloacae species with a 28 % and 46 % 
sequence identity, respectively. E. coli K4 CCA, S. aureus 1, S. aureus 5 and K. pneumoniae 1 are 
related to Klebsiella and Enterobacter lineage which are of the family Enterobacteriaceae and 
could not be accurately classified due to poor sequence quality.  
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Figure 4.2: Neighbour-joining tree, bootstrap test of phylogeny of domestic rainwater isolates, 768 bp in length. An asterisk at the node of the tree is 
indicative of conserved relationships between species. The more conserved the groupings are, the greater the degree of similarity between sequences tested.  
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4.3.3. Bioassay method 
4.3.3.1. Filter disk assay of crude extract from the supernatant filtrate and cell mass 
extracted from fermentation broth from 2 L baffled flasks, CSTR and ALR. 
Filter disk diffusion assay was performed to determine the diffusibility and activity of the 
compounds of interest. Experiments were performed in duplicate. Sterile filter disks and EtOAc 
controls were included in the assay, as well as antibiotic controls (10 μl of 1 mg/ml stock) – 
vancomycin, ampicillin and chloramphenicol. The results are presented in Figure 4.3 (against 
ATCC clinical control strains) and Figure 4.4 (against environmental DRWH isolates). 
 
Figure 4.3: Filter disk assay of various extracts tested against ATCC clinical control strains. 
Key: Experiment - A = EtOAc extract from SNF from ALR fermentation; B = EtOAc extract from cell mass from ALR fermentation; 
C = EtOAc extract from SNF from CSTR fermentation; D = EtOAc extract from cell mass from CSTR fermentation; E = EtOAc 
extract from SNF from 2L baffled flask fermentation; F = EtOAc extract from cell mass from 2 L baffled flask fermentation. 












































































































































































































Figure 4.4: Filter disk diffusion assay of various extracts tested against environmental DRWH strains.  
Key: Experiment - A = EtOAc extract from SNF from ALR fermentation; B = EtOAc extract from cell mass from ALR fermentation; 
C = EtOAc extract from SNF from CSTR fermentation; D = EtOAc extract from cell mass from CSTR fermentation; E = EtOAc 
extract from SNF from 2L baffled flask fermentation; F = EtOAc extract from cell mass from 2 L baffled flask fermentation. 
Controls – G = ampicillin; H = vancomycin; I = chloramphenicol; sterile filter disk; and EtOAc control filter disk. 
 
Crude extracts from various fermentation vessels (2 L baffled flasks, ALR and CSTR), exhibited 
bio-activity against all of the bacterial and yeast clinical ATCC test strain/s). However, these 
crude extracts were active against all of the DRWH isolates except S. aureus 4 and K. 
pneumoniae 1. Larger zones of inhibition were detected against the DRWH system isolates, 
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4.3.3.2. Bioautography assay of crude extracts from the SNF and cell mass extracted from 
fermentation broth from 2 L baffled flasks, CSTR and ALR. 
Bioautography assay was performed to determine the antimicrobial profiles of the crude 
extracts against a number of ATCC clinical control strains and DRW isolated bacteria. 
Experiments were performed in duplicate and results are presented in Tables 4.3 and 4.4, 
respectively. 
 
Table 4.3: Rf values of bands which exhibited inhibition against ATCC test strains during bioautography 
assay 
Key: A: EtOAc extract from ALR fermentation, SNF; B: EtOAc extract from ALR fermentation, cell mass; C: EtOAc extract from 
CSTR fermentation, SNF; D: EtOAc extract from CSTR fermentation, cell mass; E: EtOAc extract from 2L baffled flask 
fermentation, SNF; and F: EtOAc extract from 2 L baffled flask fermentation, cell mass. N/I: No inhibition 
 
  
Gram positive ATCC test strains Gram negative ATCC test strains 
Test strain 
Rf values of active 
compounds: samples 
A-F (in duplicate SD±0) 
Test strain 
Rf values of active 
compounds: samples 
A-F (in duplicate SD±0) 
B. cereus ATCC 10876 
B0.94, D0.91, A,B0.61, 
C0.56, A,B0.26, E,FN/I 
S. enterica ATCC 13314 
B0.84, A0.52, A,B0.47, 
A0.26, C,D, E, FN/I 
S. aureus ATCC 29213 
A,B,C,E.F0.94, A,B,D,F0.91, 
B0.52 
E. coli ATCC 25922 
B0.94, D,F0.91, A0.61 - 
0.26, A,B0.47, C,EN/I 
S. aureus ATCC 33591 
A,B,D0.94, F0.91, A,B0.84, 
B0.62, A,B0.52 - 0.26 
P. aeruginosa ATCC 
27853 
B0.84, B0.52, A,C,D,E,FN/I 
E. faecalis ATCC 29212 
E0.91, A,B,D0.84, A,B0.57 - 
0.26, C,D,FN/I 
K. pneumoniae ATCC 
700603 
B0.91, B,C0.52,A,D,E,FN/I 
E. faecalis ATCC 51299 
D0.94, B,D0.91, B0.84, 
D0.55, A,B0.47, C,E,FN/I 
E. cloacae ATCC BAA-
1143 
B,C,D0.91, B0.57 - 0.26, 
A,E,FN/I 
Test strain 
Rf values of active compounds: samples A-F (in 
duplicate SD±0) 
Yeast strain: C. krusei ATCC 34135 B,D,F0.94, A,B0.52 - 0.26, C,EN/I 
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Table 4.4: Rf values of bands which exhibited inhibition against DRWH isolates during bioautography 
assay 
Gram positive DRWH isolates Gram negative DRWH isolates 
Test strain 
Rf values of active 
compounds: samples 
A-F (in duplicate SD±0) 
Test strain 
Rf values of active 
compounds: samples 
A-F (in duplicate SD±0) 
E. coli K4 CCA 
(Enterobacteriaceae) 
A,B0.94, B,D0.91,  A,B0.84, 
B0.81, A,B0.47 - 0.26, 
C,E,FN/I 
B. cereus (Ochrobactrum 
spp.) 
A,B,F0.94, A,B0.47 - 0.26, 
C,D,EN/I 
E. faecalis C513 
B0.94, B0.91, B0.84, 
A0.81, A,B0.52 - 0.26, 
C,D,E,FN/I 
E. cloacae 11 
F0.94, A,B,D,E0.91, 
B,D,F0.84,  A0.81, A,B0.52 - 
0.26, CN/I 
S. aureus 1 
(Enterobacteriaceae) 
A,B,D,F0.94, B,D0.91, F0.84, 
A,B0.84 – 0.34, C,EN/I 
E. cloacae 20 
(Enterobacteriaceae) 
A,B0.52 - 0.26, C,D,E,FN/I 
S. aureus 2 
A,E,F0.94, B,D0.91, 
A,B,D,F0.84, B0.52 – 0.34, 
A0.52 – 0.26, CN/I 
E. cloacae 22 
A,B,F0.94, D0.91 - 0.47, 
A,B0.84, A,B0.52 - 0.26, 
C,D0.47, EN/I 
S. aureus 4 
A,B,C,D,E,F0.94, B,D0.91,  
A,B,D,F0.84, A0.60, A,B0.51, 
A,B0.49, A,B0.46, A,B0.45, 
A,B0.42, A,B0.40, A,B0.37, 
A,B,F0.34 
K. pneumoniae 1 
(Enterobacteriaceae) 
A,B,C0.94, B,C0.84, D,E,FN/I 
  K. pneumoniae 3 
A0.57 – 0.10, B0.56 – 
0.23, C,D,E,FN/I 
  P. aeruginosa 
A,B0.57 – 0.34, C,D,E,FN/I 
  
S. enterica 4C (P. 
rettgeri) 
A,B,C0.91, A0.57 – 0.26, 
B0.57 – 0.34, D,E,FN/I 
  
S. aureus 5 
(Enterobacteriaceae) 
B0.94, B0.56 – 0.34, 
A0.57 – 0.26, C,D,E,FN/I 
 
Key: A: EtOAc extract from ALR fermentation, SNF; B: EtOAc extract from ALR fermentation, cell mass; C: EtOAc extract from 
CSTR fermentation, SNF; D: EtOAc extract from CSTR fermentation, cell mass; E: EtOAc extract from 2L baffled flask 
fermentation, SNF; and F: EtOAc extract from 2 L baffled flask fermentation, cell mass. N/I: No inhibition 
 
Day three to day 20 EtOAc extracts were pooled as similar bands were observed under short-
wave length (UV254nm). A comparative study of the bio-activity profiles of the compounds 
produced by CZA14T were performed between clinical ATCC control strains and environmental 
DRWH isolates. These results are presented in Tables 4.3 and 4.4, respectively. See Appendix H, 
Figures H1 – H25, for figure representation of information in the aforementioned Tables. 
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During the bioautography assay a number of active bands were observed against all of the test 
strains used in this study. Active bands with similar Rf values were detected from the various 
fermentation vessels used. More active compounds were observed during the bioautography 
assay than what was determined during the filter disk diffusion assay. Active bands were also 
more frequently observed in the crude extracts from the ALR.  
4.4. DISCUSSION 
Agar overlay assay 
During bio-activity testing against a number of ATCC test strains using the agar overlay method 
with CZA14T cultured on optimal media – 153 + glycerol, pH 6.0 at 30°C for 10 days; CZA14T 
showed very weak bio-activity against the Enterococcus ATCC strains, K. pneumoniae ATCC 
700603 and S. enterica ATCC 13314. Weak activity was exhibited against B. cereus ATCC 10876, 
E. cloacae ATCC BAA-1143, E. coli ATCC 25922, P. aeruginosa ATCC 27853 and the S. aureus 
ATCC test strains. Poor bio-activity was displayed against the four yeast ATCC test strains with 
weak activity exhibited against C. krusei ATCC 34135 only.  
Out of the twenty seven DRWH isolates received, fourteen strains were sensitive to compounds 
produced by strain CZA14T and was used further in this study. No bio-activity was exhibited 
against the following DRWH isolates: E .coli Mi CCA, E. cloacae 19 and 23 isolates, E. faecalis 
C513, S. enterica 5J, S. aureus 3, 6 and 7 isolates, K. pneumoniae 2, 4, 5, 6, 7 and 8 isolates, and 
P. aeruginosa. These test strains, except E. faecalis C513 and P. aeruginosa, were not further 
used in this study. Regrowth around the CZA14T colony was observed during agar overlay assay; 
these organisms are typically drug resistant and were thus included in this study. Very weak 
bio-activity was exhibited against K. pneumoniae 1 DRWH isolate. Weak bio-activity was 
displayed against E. coli Mi CCA, E. cloacae 11, 20 and 23 isolates, S. aureus 4, 5 and 6 isolates, 
and K. pneumoniae 3 DRWH system isolates. Moderate bio-activity was displayed against B. 
cereus, S. aureus 1 and 2 isolates, and strong bio-activity was displayed against S. enterica 4C 
DRWH system isolate.   
On solid media, actinomycetes reproduce by sending up specialised aerial branches, which 
forms spores. Nutrient limitation causes the production of spores, melanin or diffusible 
pigment production due to stress; the reproductive phase is coordinated with the secretion of 
antibiotics which protect the colony against invading bacteria during aerial growth and sourcing 
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of new nutrient sources. Diffusibility in the agar medium may, however, be limited, thereby 
resulting in the low levels of bio-activity detected in this study when the agar-overlay technique 
was used. 
Identification of DRWH isolates 
ATCC test strains used in this study are well-characterised in literature; however, isolates from 
environmental sources are not as well-characterised and are considered more virulent than 
clinical isolates as they are found in natural sources, where the probability of mutation and its 
ability to cause disease is much higher (Engering et al., 2013).  Environmental strains isolated 
from DRWH systems used in this study were identified to genus level using universal F1 and R5 
primers for 16S rRNA gene sequencing. The results are presented in the form of a neighbour-
joining phylogenetic tree in Figure 4.2. Seven out of the fourteen DRWH isolates were 
confirmed for what it was previously identified as with the use of biochemical and phenotypic 
testing. The other seven species - B. cereus, S. enterica 4C, K. pneumoniae 3 were identified as 
Ochrobactrum spp., Providencia rettgeri DSM 4542T and Raoultella ornithinolytica JCM 6096T 
respectively; and K. pneumoniae 1, E. coli K4 CCA, S. aureus 1 and S. aureus 5 were identified as 
members of the family Enterobacteriaceae. These isolates are common waterborne pathogens. 
A study by Dobrowsky et al. (2014) (from which some of these samples were received) 
determined that of the bacteria isolated from DRWH systems situated in Kleinmond, South 
Africa, Enterobacteriaceae represented the largest family found in one of the sampling sessions. 
During two of the four sampling sessions, a number of Providencia spp., Raoultella spp. and 
Ochrobactrum spp., were also isolated.  S. aureus 2 16S rRNA gene sequence show 100% 
similarity to S. argenteus, this is a newly described species that have near identical 16S rRNA 
gene sequences and are phenotypically similar to S. aureus (Tong et al., 2015). This can be seen 
by the arrangement of the phylogenetic tree (Figure 4.2), with S. aureus DSM 20231T 
(AMYL01000007) being grouped with the S. aureus 2 DRW isolate and S. argenteus. The S. 
argenteus strain has distinct differences – it demonstrates a lack of admixture, phylogentically 
distant at a whole-genome level, an average nucleotide identity of less than 95% and inferred 
DNA-DNA hybridisation of less than 70%. K. pneumoniae 3 shows 97% similarity to R. 
ornithinolytica, formally classified in the genus Klebsiella. K. pneumoniae 3 also shows similarity 
to two K. pneumoniae species and another species of Klebsiella. Further sequencing of the 16S 
rRNA gene could be performed to confirm the identity of this species. E. cloacae 11 shows 93% 
similarity to Kosakonia cowanii also known as Enterobacter cowanii. This is a novel species 
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described by Inoue et al. (2000), with its closest neighbour being E. cloacae (which can also be 
seen by the arrangement of the phylogenetic tree in Figure 4.2). 
After determining the antimicrobial bio-active profiles of CZA14T, bioassays were performed on 
the crude extracted compounds from the various fermentation vessels to assess whether 
similar bio-activities will occur when CZA14T is cultured in liquid media. 
Filter disk diffusion assay 
Extra- and intracellularly produced compounds extracted as crude compounds from 
fermentation broth from 2 L baffled flasks, CSTR and ALR were used to test the efficacy of these 
crude extracts against a number of ATCC test strains and DRWH isolates using the filter disk 
diffusion assay. Similar compounds were produced during fermentation with these various 
fermentation vessels and crude compounds extracted at different sampling days from each 
fermentation vessel type were pooled together and used during bio-activity assays.  
Filter disk diffusion assay using pooled crude extracts from 2 L baffled flasks:  
Selected ATCC test strains and DRWH system isolates were used in the filter disk diffusion 
assay; selection was based on the strains which were inhibited by strain CZA14T when cultured 
on solid media. Activity was detected against S. aureus ATCC 29213 of compounds produced 
both extra- and intracellularly. Extracellularly produced compounds were active against E. 
faecalis ATCC 29212 and B. cereus DRWH system isolate which was re-identified as 
Ochrobactrum spp., after 16S rRNA gene sequencing. No activity was detected against E. 
cloacae 11 DRWH isolate. Regrowth was observed where a halo formed around the 
impregnated filter disk for all aforementioned strains except for the vancomycin-resistant S. 
aureus (VRSA) ATCC 29213. Bactericidal activity was exhibited by compounds produced both 
extra- and intracellularly by CZA14T against the S. aureus ATCC 29213 test strain. An average 
zone of inhibition of 10 mm (SD±1.4) was observed for intracellularly produced compounds 
while an average 13 mm (SD±9.2) zone of inhibition was observed for extracellularly produced 
compounds.  
Filter disk diffusion assay using pooled crude extracts extracted from fermentation broth from 
CSTR:  
Extra- and intracellularly produced compounds produced during fermentation in a CSTR were 
active against the following ATCC test strains: B. cereus ATCC 10876, S. enterica ATCC 13314, P. 
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aeruginosa ATCC 27853, VRSA and E. cloacae ATCC BAA-1143. Only extracellularly produced 
compounds were active against E. faecalis ATCC 29212 and only intracellularly produced 
compounds were active against methicillin-resistant S. aureus ATCC 33591 (MRSA) and yeast 
ATCC strain C. krusei ATCC 34135. Poor bio-activity was detected against DRWH isolates.  
Extracellularly produced compounds were active against Ochrobactrum spp., E. coli K4 CCA 
(identified as a member of the family Enterobacteriaceae after 16S rRNA gene sequencing), E. 
cloacae 20 (Enterobacteriaceae), E. cloacae 22 isolate, S. aureus 1 (Enterobacteriaceae) and 2 
isolates. Intracellularly produced compounds were active against E. coli K4 CCA, E. cloacae 22, S. 
enterica 4C (identified as P. rettgeri strain DSM 4542T after 16S rRNA gene sequencing) and S. 
aureus 5 (identified as a member of the family Enterobacteriaceae after 16S rRNA gene 
sequencing). In most cases regrowth was observed, this can be defined as bacteriostatic activity 
whereby the antimicrobial agent (in this case, the crude extract) prevented the growth of the 
test bacterium by keeping it in the stationary phase of growth. The biggest zone of inhibition 
was detected against the VRSA strain, with an average zone of inhibition 13.5 mm (SD±2.1) for 
each replicate of compounds produced intracellularly. These compounds exhibited bactericidal 
activity, meaning that it has the ability to kill the test bacterium.   
Filter disk diffusion assay using pooled crude extracts extracted from fermentation broth from 
ALR:  
Larger zones of clearing/inhibition were observed against ATCC test strains and DRWH isolates 
with compounds produced during fermentation in the ALR compared to bio-activity results of 
crude compounds produced during fermentation in 2 L baffled flasks and the CSTR used in this 
study, respectively. Extracellularly produced compounds were active against seven ATCC test 
strains and nine DRWH isolates (Figure 4.3 and 4.4). Regrowth was observed in most cases 
during the filter disk-diffusion assay. The most interesting is the 9 mm – 9.5 mm zone of 
inhibition against the VRSA strain and E. faecalis ATCC 29212. Another interesting result is 
bactericidal activity exhibited against the DRWH isolates - E. cloacae 20 and E. faecalis C513. 
Intracellularly produced compounds were active against ten ATCC test strains and ten DRWH 
isolates (Figure 4.3 and 4.4). The most interesting of these is the 9 mm – 10 mm zone of 
inhibition against VRE and E. faecalis C513 DRWH isolate. Other interesting bio-activity results 
are the average 10 mm (SD±0) zone of inhibition against MRSA. Bactericidal and bacteriostatic 
activity was exhibited, respectively. An average of 12 mm (SD±1.4) zone of inhibition was 
detected against P. aeruginosa DRWH isolate and crude compounds exhibited bactericidal 
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activity. An average zone of inhibition of 15 mm (SD±0) was detected against S. aureus 5 (which 
was identified as a member of the family Enterobacteriaceae after 16S rRNA gene sequencing) 
and these intracellularly produced crude compounds displayed bacteriostatic activity.  
The commercial antibiotics used in this study fared well in inhibiting the growth of a number of 
ATCC test strains and DRWH isolates. Overall the filter disk-diffusion assay was successful in 
terms of eliminating the incidence of false-negative results as 0 mm zones of inhibition were 
detected for EtOAc control disks and sterile filter disk controls.  
Filter disk diffusion assays as a stand-alone bioassay tend to be unreliable in detecting the 
inhibitory effects of compounds against test organisms as a number of factors can cause false-
positive/negative results. False negative results with disk diffusion assays may be due to the 
rate at which the antimicrobial diffuses through the agar which is dependent on its chemical 
properties (i.e. polarity, etc.) as well as solubility properties of the antimicrobial in MH agar [in 
this study MH agar was used as it is considered the best medium for susceptibility testing as it 
shows acceptable batch-to-batch reproducibility; it provides satisfactory growth of most non-
fastidious pathogenic bacteria and it is low in tetracycline, trimethoprim and sulphonamide 
inhibitors (Hudzick, 2013)]. The molecular weight of the produced antimicrobial also plays a 
role as larger molecules typically diffuse at a slower rate than those with a lower molecular 
weight. Other factors involved may be the concentration of the extracts tested and the depth 
of the agar which may cause a false positive result, to name a few. If the agar is too shallow it 
will result in larger zones of inhibition as antimicrobials diffuses in three-dimensions. Thus a 
second or even a third bioassay should be performed to validate the filter disk diffusion assay 
results. Bioautography assay was used as a second bioassay in this study. 
Commercial antibiotics faired well against the ATCC test strains used in this study and produced 
larger zones of inhibition compared to the compounds produced by CZA14T. This could be due 
to the differences in concentration between the commercial antibiotics and compounds 
produced by CZA14T. The commercial antibiotics may be more targeted towards a certain group 
of organisms as they are pure compounds, compared to the crude CZA14T extracts. Activity 
with ampicillin against the MRSA strain and activity with vancomycin against the vancomycin 
resistant Enterococcus may be an anomaly as these antibiotics typically have no affect on these 
strains. This again may be attributed to poor drying of the compounds on the filter disk 
resulting in a false positive result. No inhibition was detected against the candida strain with 
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the commercial antibiotics, this was expected. Interestingly, crude intracellular compounds 
produced by CZA14T were active against the C. krusei ATCC test strain. 
Bio-activity of compounds from the airlift reactor was thus compared to activity with 
commercial antibiotics. Vancomycin was active against the Enterococcus rainwater harvesting 
system isolate, suggesting that this strain may be a non-vancomycin resistant Enterococcus sp. 
Vancomycin was active against most of rainwater system isolates except, Enterobacter sp., 
strain 11 and S. aureus strain 2. No activity was detected against S. aureus strain 2 with the 
commercial antibiotics; however activity was detected against this strain with intracellular 
crude CZA14 extracts. 
Bioautography assay 
Extra- and intracellularly produced compounds extracted as crude compounds from 
fermentation broth from 2 L baffled flasks, CSTR and ALR were used to test the efficacy of these 
crude extracts against a number of ATCC test strains and DRWH isolates using the 
bioautography assay. Similar compounds were produced during fermentation with these 
various fermentation vessels and crude compounds extracted at different sampling days from 
each fermentation vessel type were pooled together and used during bio-activity assays.   
Bioautography assay using pooled crude extracts from 2 L baffled flasks:  
No inhibition was detected against the following ATCC test strains and DRWH isolates:  
ATCC - B. cereus ATCC 10876, S. enterica ATCC 13314, P. aeruginosa ATCC 27853 and K. 
pneumonia ATCC 700603.  
DRWH - E. coli K4 CCA (Enterobacteriaceae), E. cloacae 20 (Enterobacteriaceae), E. faecalis 
C513, K. pneumonia 1 (Enterobacteriaceae) and 3, P. aeruginosa, S. enterica 4C (P. rettgeri 
strain DSM 4542T) and S. aureus 5 (Enterobacteriaceae).  
Extracellularly produced compounds were active against S. aureus ATCC 29213 and E. faecalis 
ATCC 29212. These compounds were also active against a number of DRWH isolates namely, E. 
cloacae 11 and S. aureus isolates 2 and 4. Intracellularly produced compounds were active 
against E. coli ATCC 25922, S. aureus ATCC 29213, MRSA and C. krusei ATCC 34135. These 
intracellularly produced compounds were also active against B. cereus (Ochrobactrum spp.), E. 
cloacae 11 and 22 isolates and S. aureus 1 and 4 isolates, all isolated from DRWH systems.   
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Bioautography assay using pooled crude extracts extracted from fermentation broth from 
CSTR:  
No inhibition was observed against the following ATCC test strains and DRWH isolates:  
ATCC - S. enterica ATCC 13314, P. aeruginosa ATCC 27853 and E. faecalis ATCC 29212. 
DRWH - B. cereus (Ochrobactrum spp.,), E. faecalis C513, K. pneumonia 3, P. aeruginosa and S. 
aureus 5 (Enterobacteriaceae).  
Extracellularly produced compounds were active against B. cereus ATCC 10876, K. pneumonia 
ATCC 700603, S. aureus ATCC 29213 and E. cloacae ATCC BAA-1143 ATCC test strains. These 
compounds were also active against a number of DRWH isolates such as E. cloacae 22, K. 
pneumonia 1 (Enterobacteriaceae), S. enterica 4C (P. rettgeri strain DSM 4542T) and S. aureus 4. 
Intracellularly produced compounds were active against ATCC test strains: B. cereus ATCC 
10876, E. coli ATCC 25922, S. aureus ATCC 29213, MRSA, VRE, E. cloacae ATCC BAA-1143 and 
yeast strain, C. krusei ATCC 34135. These compounds were also active against DRWH isolates: E. 
coli K4 CCA (Enterobacteriaceae), E. cloacae 11 and 22, and S. aureus 1 (Enterobacteriaceae), 2 
and 4.    
Bioautography assay using pooled crude extracts extracted from fermentation broth from ALR:  
More active compounds were produced during the culturing of CZA14T in the ALR used in this 
study compared to the number of active compounds produced during culturing of CZA14T in the 
2 L baffled flasks and CSTR. Crude solvent extracts from the fermentation broth from the ALR 
was active against all of the ATCC test strains and DRWH isolates (Tables 4.3 and 4.4). These 
crude extracts were thus further accessed for the bio-active potential and partially purified. The 
results pertaining to the purification of these crude extracts are presented in Chapter 5 of this 
study. 
Bioautography is a microbiological screening method that can be used to confirm results 
obtained with the filter disk diffusion assay. The method of bioautography used in this study is 
known as direct bioautography and is one of the bioautography methods most widely used as it 
is an inexpensive, simple and time-saving method that does not require sophisticated 
equipment and can easily be coupled with detection methods such as TLC. The method relies 
on a staining method using tetrazolium salts for visualisation of active compounds. Living 
organisms undergo dehydrogenase reactions which converts the tetrazolium salt into formazan 
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which is intensely coloured. This results in a cream coloured spot appearing around a purple 
background on the surface of the TLC plate which shows the presence of antimicrobial agents 
(Choma and Grzelak, 2011).  
Common bands observed to be active against the ATCC clinical test strains (Table 4.3) had Rf 
values of 0.94, 0.91, 0.84, 0.62, 0.61, 0.57, 0.56, 0.55, 0.52, 0.47, and 0.26 (Appendix H). Bands 
active against the environmental DRWH isolates had bands with the same Rf values as those 
active against the ATCC test strains. The only interestingly different active bands observed were 
the 0.81 Rf value band active against E. coli K4 CCA (identified as a member of the family 
Enterobacteriaceae), E. faecalis C513 and E. cloacae 11. A band with an Rf value of 0.34 were 
active against S. aureus 1 (Enterobacteriaceae), 2 and 4 as well as the P. aeruginosa DRWH 
isolate and S. enterica 4C isolate (identified as P. rettgeri) (Appendix H). Active bands with Rf 
values of 0.60, 0.51, 0.49, 0.46, 0.45, 0.42, 0.40, and 0.37 were active against S. aureus 4 DRWH 
isolate (Appendix H)   
Hospital acquired infections (HAIs) are commonly associated with Gram-positive pathogenic 
bacteria. These organisms are a key target for antimicrobial therapy. Gram-positives typically 
cause a spectrum of infections linked to/associated with skin structure and skin infections 
(SSSIs), endocarditis, bloodstream infections (BSIs), surgical site infections (SSIs), lower and 
upper respiratory tract infections, joint and bone infections, intestinal infections, diabetic foot 
infections, urinary tract infections (UTIs) and central nervous system infections. These 
organisms, as detailed in Chapter 1 and 2 of this study, are commonly associated with DRWH 
systems. Infections caused by these organisms may occur by consuming water polluted with 
Gram-positive bacteria, or due to contaminated artificial devices and central venous catheters 
associated with a hospital environment. The issue of antibacterial resistance is common amid 
Gram-positive bacterial pathogens, notably among enterococci and staphylococci. 
Staphylococcal resistance, especially MRSA are notorious examples of Gram-positive pathogens 
which are difficult-to-treat due to resistance to multiple classes of antibiotics. Members of this 
genus specifically are capable of global-scale diffusion causing various epidemics (EARS-Net, 
2010). Multidrug resistant enterococci, especially Enterococcus faecalis are susceptible to the 
antibiotic daptomycin, which is not approved for the use in treating enterococci but is used 
often to treat severe infections caused by enterococci. A study by Palmer et al. (2011) 
described the resistance mechanisms of a multidrug resistant E. facecalis strain following the 
development of DapR during serial passaging. No observed mutations occurred in yycE, rpoC, 
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rpoB and mprF genes, however mutations were observed in cls (CL synthase) which arose 
during the development of the respective three lines of selection. It was suggested that 
enhanced functions were displayed by CL synthase enzymes as two of the three mutations led 
to substitutions of single amino acids and one of the three mutations led to a three amino acid 
in-frame deletion.  
Gram-negative bacterial infections are an emerging threat to the immunocompromised and 
hospitalised patients, creating longer hospital stays or even mortality. The increasing crisis of 
Gram-negative bacteria with multidrug resistance has led to the use of an older polymyxin, 
colistin which is known to have nephrotoxicity and neurotoxicity (Rice, 2006; Kallel et al., 2006). 
However, resistance by several Gram-negative bacterial isolates to all available antibiotics as 
well as polymyxin have been reported (Falagas et al., 2008). Mechanisms of resistance are 
discussed in Chapters 1 and 2. 90 – 95% of all of the Gram-negative bacteria are pathogenic, 
whereas a number of Gram-positive bacteria are non-pathogenic. Gram-negatives are more 
resistant to antimicrobial agents whereas many Gram-positives are susceptible to 
antimicrobials. This could be as a result of the cell wall composition. Gram-negatives typically 
have cell walls that are 70 – 120 Armstrong thick. The cell wall is two layered with a high lipid 
content of 20 – 30% and a low Murein content of 10 – 20%. Gram-positives on the other hand 
are single layered with a cell wall 100 – 200 Armstrong thick. Low lipid content is observed in 
Gram-positives with a high Murein content of 70 – 80% (Silhavy et al., 2010). Most 
antimicrobials are targeted towards intracellular processes and their mechanism of action relies 
on its ability to penetrate the bacterial cell wall. Gram-negative bacteria provide formidable 
barriers which effect antimicrobial uptake into the bacterial cell. The protein and lipid content 
of the outer membrane play an important role on the sensitivity of bacteria to numerous types 
of antimicrobials; causing drug resistance involving modifications of these macromolecules 
(Delcour, 2009). 
Systemic candidiasis results in high rates of worldwide morbidity and mortality in 
immunocompromised people. This common fungal infection imposes a great burden in 
industrialised country health-care systems as the antifungal resistance of Candida spp., is 
mostly unknown. Resistance to the commonly used antifungal drug, fluconazole, varies 
substantially by species and country. Some countries have already reported emerging 
resistance to echinocandins. 
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In order to fight against the crisis of resistance, new targets (such as, antimicrobial peptides) 
are required for the development of novel antimicrobials to treat infections caused by 
extensively drug resistance (XDR), pan-drug resistance (PDR) and the well-known multidrug 
resistance (MDR) bacteria. The most frequent MDR pathogenic bacteria currently are 
recognised as emerging threats of this century and result in infamous hospital acquired 
infections. These pathogenic microorganisms were dubbed ‘ESKAPE’ following their first initial 
and include Enterococcus faecium/faecalis, Staphylococcus aureus, Klebsiella pneumonia, 
Acinetobacter spp., Pseudomonas aeruginosa and Enterobacter spp. (Kanj and Kanafani, 2011).  
Strain CZA14T produces antimicrobial compounds that inhibit the growth of the aforementioned 
pathogenic bacteria. Both clinical ATCC test strains and more virulent environmental DRWH 
isolates are inhibited by these antimicrobials. It’s suggested that strain CZA14T produces 
antimicrobial peptides, also known as bacteriocins. Bacteriocins are typically extremely potent 
even at low concentrations. The bioactivities may be broad or narrow spectrum which are 
capable of targeting microorganisms from different genera or same species. Antimicrobial 
peptide mechanism of action occur by directly destabilising or damaging the bacterial, fungal or 
viral membrane of the organism or act on other targets of the microorganism (adapted from 
Durrell, 2013, honours thesis).  
4.5. CONCLUSION 
A comparison between the number of secondary metabolites produced by CZA14T in various 
fermentation vessels (2L baffled flasks, ALR and CSTR; Chapter 3) and the number of 
compounds active against the test strains used in this study (Chapter 4) determined using the 



















































































Figure 4.5: Number of compounds active against ATCC clinical test strains compared to the number of 
secondary metabolites produced during fermentation processes with CZA14T in various fermentation 
vessels.  
Key: A: EtOAc extract from ALR fermentation, SNF; B: EtOAc extract from ALR fermentation, cell mass; C: EtOAc extract from 
CSTR fermentation, SNF; D: EtOAc extract from CSTR fermentation, cell mass; E: EtOAc extract from 2L baffled flask 
fermentation, SNF; and F: EtOAc extract from 2 L baffled flask fermentation, cell mass. 
Figure 4.6: Number of compounds active against environmental DRWH isolates compared to the 
number of secondary metabolites produced during fermentation processes with CZA14T in various 
fermentation vessels.  
Key: A: EtOAc extract from ALR fermentation, SNF; B: EtOAc extract from ALR fermentation, cell mass; C: EtOAc extract from 
CSTR fermentation, SNF; D: EtOAc extract from CSTR fermentation, cell mass; E: EtOAc extract from 2L baffled flask 
fermentation, SNF; and F: EtOAc extract from 2 L baffled flask fermentation, cell mass. 
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It was expected that antibacterial activity will be mostly against Gram-positive bacteria due to 
the classes of antimicrobials produced by actinomycetes which mainly target the bacterial cell 
wall of Gram-positive bacteria (Behal, 2000). Dominant antagonistic bio-activity was observed 
against Gram-positive ATCC clinical test strains and environmental DRWH system isolates 
during the bioautography assays. A number of compounds with the same Rf values were active 
against Gram-negative ATCC clinical test strains and environmental DRWH isolates and minor 
activity was detected against the yeast ATCC clinical test strain. The antimicrobial guided 
screening used in this study (overlays, filter disk assays and bioautography) showed that CZA14T 
possesses the ability to produce a number of different active antimicrobial compounds. A 
successful correlation between TLC bands and antimicrobial activity was performed, although 
standard filter disk assay showed less potential for bio-activity detection than what was found 
during bioautography. This may be attributed to poor diffusibility of the compounds or there 
are compounds binding to the filter disk into the agar medium, or there may be compounds 
binding to the filter disk. In addition, more bands were observed under UV light (TLC analysis) 
than what was active against the pathogenic strains used in this study. 
These bands may have concentration/detection limits or may have other properties and other 
functionalities and most likely represent other SMs produced by strain CZA14T. It is important 
to note that the number of active compounds produced by CZA14T in the ALR may be more 
than estimated in Figures 4.5 and 4.6 as large zones of clearing was visible during 
bioautography assay and the exact band responsible for the activity could not be pin-pointed. 
Purification techniques were thus directed toward the purification of crude compounds 
extracted from the fermentation broth from the ALR and is further elaborated upon in the next 
chapter. 
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The purification of selected compounds 
and the determination of their 
antimicrobial profiles 




The emergence of microbial resistance to current antimicrobial drugs have sparked the search 
for new drugs with novel mechanisms of action. Antimicrobial peptides are considered an ideal 
candidate to treat a vast array of microbial infections. These peptides are naturally occurring 
and they act by destroying the cell membrane of bacteria that it comes into contact with. They 
also have multiple cell targets resulting in the decreased likelihood of emerging resistance. In 
this study, a possible antimicrobial peptide was produced by strain CZA14T. A low molecular 
weight compound (determined to be 6.7 kDa in size) and a number of other active compounds 
were produced by CZA14T in the airlift reactor (ALR). These compounds exhibited a broad 
spectrum bactericidal activity against almost all of environmental domestic rainwater 
harvesting (DRWH) system isolates.  
A number of purification processes were applied in the attempt to purify specific bio-active 
compounds. pH purification - whereby the pH of the supernatant filtrate from ALR 
fermentation was adjusted from pH 3.0 – 9.0 prior to extraction processes with various 
solvents. Other forms of purification techniques used in this study involved small-scale silica gel 
column chromatography, which was performed on pooled extra- and intra-cellularly produced 
ethyl acetate (EtAOc) crude extracts, as well as ammonium salt precipitation and dialysis on 
extracellularly produced compounds produced by CZA14T in the ALR. A number of active bands 
with the same Rf values were detected during bioassays with the variously purified extracts. 
Many of these compounds were visualised under short- and long- wavelength UV light. Those 
that could not be visualised under UV were visualised using TLC staining techniques. Many of 
these compounds could be visualised using the universal iodine stain. Sugars, steroids and 
terpenes were detected with anisaldehyde-sulphuric acid stain. Amino acid, amine or amino 
groups were detected in one of the compounds when using the ninhydrin stain; and a number 
of higher alcohols, phenols, steroids and terpenes were detected with the vanillin-sulphuric 
acid stain. Bio-active antimicrobial compounds in liquid extract exhibited UV absorption 
between 280 – 570 nm. The tentative identification of curaymcin A, as identified by 
bioinformatics and molecular techniques (Chapter 6) were detected using liquid 
chromatography/mass spectrometry (LC/MS).  
Key words: Purification, Antimicrobial peptides, compounds, Solvent extraction, ammonium 
sulphate precipitation, dialysis, silica gel chromatography 




Purification techniques should be applied to isolate one or more compounds from a complex 
mixture. During the purification process, ‘non-active’ and ‘active’ components of a complex 
mixture may be separated in order to separate the desired compound from all other 
metabolites in the mixture. The process of purification is important for the characterisation of 
the structure, function and interactions of a compound of interest. Separation of the desired 
compound may be achieved by exploiting the differences in physico-chemical properties, 
protein/compound size, and biological activity using preparative and/or analytical purification 
procedures (Darnell et al., 1999). 
 
A number of purification techniques were utilised during this study to fractionate crude 
extracts into individual components. Crude extracts can be partially purified using a number of 
solvent types with varying polarity. Another means can be by salt precipitation to remove all 
unwanted proteins from the sample prior to extraction. Bioassay-guided isolation was 
employed in this study whereby compounds in a mixture was separated using various analytical 
methods, with results collected from biological experimentation. The method involves the 
testing of the crude extract to determine its activity, after which the crude extracts are 
separated and the fractions are tested for bio-activity. Further fractionation of compounds of 
interest can be carried out while inactive fractions are discarded or set aside. This process of 
fractionation and biological testing is repeated until pure compound/s are recovered (Maryam 
et al., 2012).  
 
Chromatographic techniques are used to achieve fractionation of products. The term 
chromatography refers to the analysis of a particular product in which a mobile phase passes 
over a stationary phase so that the mixture of substances is separated into components. Thin-
layer chromatography (TLC) is the primary chromatography method of separation, and involves 
isocratic chromatographic separation techniques wherein the stationary phase is made up of a 
thin layer which is applied to a solid support/substrate. In order for purification by liquid 
chromatography to be successful, the correct combination of operating conditions should be 
considered, such as the mobile phase and type of column packing, the diameter and length of 
the column, the flow rate of the column, sample size and elution temperature (Synder and 
Kirkland, 1979). Once an appropriate mobile phase is chosen, column chromatography is used 
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to fractionate products. In this study a gradient mobile phase was used to elute products off a 
silica gel column. This is commonly performed by mixing different solvents to change the 
polarity conditions in the column. TLC and classical chromatography methods are time 
consuming and laborious (Moreda et al., 2001), and requires the use of organic solvents in large 
quantities (Laczae et al., 2007). TLC have an advantage over classical column chromatography 
methods as the process is more rapid and the possibility of identifying the nature of the 
separated products by using specific reagents are much greater, but TLC also has a 
disadvantage over classical column chromatography methods as there is limited understanding 
of quantitative analysis of products given that the complete recovery of individual compounds 
are not sufficiently accurate (Moreda et al., 2001).  
 
In this chapter, crude compounds extracted from fermentation broth after fermentation with 
CZA14T in an airlift reactor were purified using various purification techniques such as: recovery 
of extracellularly produced compounds by adjusting the pH of the supernatant filtrate prior to 
extraction using various solvents, silica gel column chromatography, and salt precipitation using 
ammonium salt. This was performed to achieve objective four of this study. Methods employed 













Figure 5.1: Flow-chart of methods used for the purification of selected compounds of crude extracts and 
the determination of their antimicrobial profiles.  
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Materials and Methods 
5.1. Materials 
Most of the chemicals used in this study were purchased from Merck Millipore or Sigma-Aldrich 
unless otherwise stated. All solvents used were analytical grade. 
5.2. Methods 
5.2.1. pH purification of extracellularly produced compounds by strain CZA14T in an airlift 
reactor  
After fermentation in the airlift reactor (ALR) used in this study, the supernatant was separated 
from the mycelium by filtering it through 2X coffee filters followed by centrifuging the 
supernatant filtrate (SNF) at 10 000 rpm for 10 minutes. The SNF was separated from any 
remaining mycelia and the pH of the SNF was adjusted (by addition of 30 % HCl or 1M NaOH) to 
pH 3-9 in increments of 1 (the initial pH of the SNF was pH 8.28). 
The pH-adjusted SNF was extracted overnight (O/N) through automatic shaking (160 rpm) at 
37°C with various solvents such as n-butanol, chloroform, ethyl acetate, dichloromethane, 
benzene and petroleum ether at a 1:1 (v/v) ratio. The organic phase was removed, evaporated 
to dryness under a fume hood and reconstituted with the solvent it was extracted with to a 50 x 
concentrate. Silica gel G F254 TLC plates were developed in a solvent system containing 
chloroform: EtOAc: formic acid: n-hexane (5: 4: 1: 0.02 v/v/v/v) and allowed to dry O/N under a 
fume hood. The TLC containing separated crude extracts were bioassayed against domestic 
rainwater harvesting (DRWH) system isolate Staphylococcus aureus 4 as extra- and intra- 
cellular bio-activity was exhibited against this strain for almost all bands visualised under Ultra 
Violet (UV) light.  
5.2.2. Silica gel column chromatography 
Prior to small-scale purification of the crude EtOAc extracts, a 150 mL volume column with a 
diameter of 15 mm containing silica gel was used to purify the crude extracts using an isocratic 
elution containing a four component solvent system of  chloroform: EtOAc: formic acid: n-
hexane (5: 4: 1: 0.02, v/v/v/v). The extra- and intra-cellular crude EtOAc extracts of samples day 
0 - 20 were pooled at a 1:1 (v/v) ratio as bands with similar Rf values were visible under 
shortwave 254 nm UV light. The crude extracts were applied to a packed silica gel 60 column. A 
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150 mm length Pasteur pipette with a 4.5 mm diameter was used as a glass column for 
purification of the crude extracts. ~ 1 cm piece of cotton wool was placed into the lower end of 
the Pasteur pipette and ~ 1 cm level of sand was added to the top of the cotton wool. The acid-
based silica gel (10 g) was deactivated for ten minutes using deionised water (dH2O; 100 ml). 
Water was added to the column and once it reached one-third of column length the 
deactivated silica gel was added to the column and packed. The column was also gently flicked 
to encourage any bubbles to rise to the top; the column was filled to just below the indent of 
the pipette and the water was allowed to drain from the column. The column was equilibrated 
with a four component solvent system consisting of chloroform: EtOAc: formic acid: n-hexane 
(5: 4: 1: 0.02, v/v/v/v) and sand was added to the surface of the silica gel to stabilise the column 
bed. Once the solvent reached ~ 5 mm above the sand, the 50 x concentrated crude extracts 
were applied to the column and 35 0.5 mL fractions were collected. The column was eluted 
with the abovementioned four component solvent system using a pipette bulb to apply 
pressure until all of the visible yellow coloured residual crude extract was eluted from the 
column. Two column volumes of 100% chloroform, 95: 5, 75: 25, 50: 50 v/v chloroform: EtOAc, 
EtOAc containing 85: 15 v/v EtOAc: methanol and 100% EtOAc were added to the column 
sequentially. All products were successfully eluted from the column except a dark red/brown 
coloured residual compound that stayed absorbed to the silica even after elution with dH2O 
and absolute ethanol. The compound was removed along with some silica and will be freeze 
dried and tested for bio-activity in future studies.  
5.2.3. Salt purification of bio-active proteins/peptides produced extracellularly by strain 
CZA14T in an airlift reactor  
5.2.3.1. Ammonium sulphate precipitation  
The mycelium was separated from the supernatant by filtering the fermentation broth 
collected from the ALR after fermentation. Total proteins were slowly precipitated from the 
SNF using ammonium sulphate (A/S) at 80 % saturation (26.64 g per 50 ml volume of SNF; 
www.encorbio.com/protocols/AM-SO4.htm), stirring O/N at 4°C.  The protein precipitate was 
obtained after centrifuging the SNF at 12 000 rpm for 10 minutes at 4°C. The supernatant was 
stored for further analysis and the pellet was resuspended in two pellet volumes of 20 mM Tris-
HCl buffer, pH 7.5. Some of the sample was stored at 4°C for further analysis and the rest was 
dialysed. 
 




Dialysis against 20 mM Tris-HCl buffer, pH 7.5 (at 4°C) was used to remove salts from the 
sample. Snake skin dialysis tubing was used and 30 mL of sample was added to the tubing. 
Buffer was changed every hour for the first 3 hours then dialysed overnight. Some of the 
sample was stored at 4°C while the rest was used in solvent extraction with EtOAc (2:3 v/v) 
O/N, shaking at 160 rpm at 37°C. The stored SNF was also extracted in the same manner to 
determine whether any bio-active compounds were still present and reconstituted to 50x 
concentrate with EtOAc. 
5.2.3.3. Bradford’s assay to quantify the total protein content in salt purified samples 
The Bradford’s protein assay (Kruger, N.J. 2010) was used to determine the total protein 
content of extracellular proteins produced by CZA14T in an airlift reactor after salt precipitation, 
dialysis and solvent extraction. 1 mg/mL (bovine serum albumin) (BSA) (Sigma) stock was 
prepared by dissolving 1 mg BSA in 1 mL 0.15 M NaCl. A 1:10 dilution of the stock (with 0.15 M 
NaCl) was prepared to achieve a 100 μg/mL BSA working stock. Standards of known protein 
(BSA) concentrations were prepared as outlined in Table 5.1. 
 
Table 5.1: Standards of known protein (BSA) concentrations used to construct a standard curve (refer to 
Appendix I) for determination of total protein content.   
Standard  Vol 100 μg/mL BSA 
(μL)  
Vol 0.15 M NaCl (μL) [Protein] (μg/μL)  
Blank  0  100  0  
Standard 1  10  90  10  
Standard 2  20  80  20  
Standard 3  40  60  40  
Standard 4  60  40  60  
Standard 5  80  20  80  
Standard 6  100  0  100 
 
5.2.3.4. Sodium dodecyl sulphate – polyacrylamide gel electrophoresis (SDS-PAGE)  
A 16% separating/resolving gel with 4% stacking gel (Appendix J) was used to achieve optimal 
separation of proteins using the BIO-RAD PROTEAN mini gel system. The separating gel was cast 
and allowed to set and the stacking gel was cast on top of the separating gel. The comb was 
placed into the stacking gel solution to create wells and the stacking gel was allowed to 
polymerize. Twenty μL of each of sample was mixed with 5x sample loading buffer containing 
dithriothreitol (DTT) at a ratio of 2:1 (Appendix J). The samples were boiled for 10 minutes and 
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loaded onto the gel. Five μL of PageRuler pre-stained protein ladder (Fermentes) was loaded in 
wells on either side of the sample wells. Electropheresis buffer was prepared (Appendix J) and 
placed into the system. The gel was electrophoresed at 180 Volts (V) in electrophoresis buffer 
for 2–3 hours. The gel was then submerged in Page Blue (Coomassie) staining solution 
(Fermentes) and stained overnight on a rocking shaker. The gel was destained with a mixture of 
acetic acid, water and methanol (10:30:60, v/v/v) for ± 30 minutes. The molecular weight of the 
unknown proteins were extrapolated after constructing a standard curve using the molecular 
weights obtained during separation of the PageRuler pre-stained protein ladder.    
5.2.4. Bioassays 
The bioassays were performed as described in Chapter 4 (see sections 4.2.3 and 4.2.4). 
5.2.5. Visualisation of compounds developed on TLC plates 
5.2.5.1. Ultra Violet (UV) light 
UV light was used to visualize bands which are UV-absorbent. Extracts are separated using TLC 
in a solvent system consisting of chloroform: EtOAc: formic acid: n-hexane (5: 4: 1: 0.02, 
v/v/v/v) and visualised under short wavelength (254 nm) and long wavelength (365 nm) UV 
light. Organic molecules which absorb UV light will appear as a dark blue spot with a green 
fluorescent background under 254 nm wavelength and various coloured (e.g. blue, orange, 
pink) spots with a black background under 365 nm wavelength. 
5.2.5.2. Iodine stain 
A filter paper was placed at the bottom of a glass beaker, a few iodine crystals were added to 
the beaker and tightly closed with foil. The beaker containing the crystals was left at room 
temperature for 20 minutes to equilibrate and the developed TLC plate (see section 5.2.5.1) 
was placed in the chamber until light brown/yellow colour developed over the entire plate. 
Compounds that have an affinity for iodine will appear as dark brown spots on a lighter 
brown/yellow background. 
5.2.5.3. p–anisaldehyde – sulphuric acid stain 
0.5 mL of p–anisaldehyde was added to 50 mL glacial acetic acid and 1 mL 97% sulphuric acid 
was added to the solution. The stain reagent was sprayed on the developed TLC plate (see 
section 5.2.5.1) and heated to 110°C. Sugars produce blue, green and violet spots, whereas 
sugar phenylhydrazones produce yellow-green spots.   
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5.2.5.4. Ninhydrin stain 
1.5 g of ninhydrin was dissolved in 100 mL n-butanol and 0.3 mL acetic acid was added to the 
solution. The stain reagent was sprayed onto the developed TLC plate (see section 5.2.5.1) and 
heated to 110°C until reddish spots appeared for a positive result. 
5.2.5.5. Vanillin/sulphuric acid stain 
1% (w/v) solution of vanillin was prepared in absolute ethanol and concentrated with sulphuric 
acid (0.5 g vanillin in 100mL sulphuric acid/ethanol (40:10, v/v). The stain reagent was sprayed 
onto the developed TLC plate (see section 5.2.5.1) and heated to 120°C until the formation of 
triarylmethane dyes cause a colour formation. Fluorescent spots on a dark background was 
visualised under 365 nm UV light. 
5.2.6. Spectroscopic measurement 
UV absorption maxima of extra- and intra-cellular compounds extracted as crude compounds 
using EtOAc, as well as extracellular compounds partially purified using A/S precipitation and 
dialysis, were measured with a UV/Visible spectrophotometer plate-reader over a 200 – 900 
nm range (Molecular devices; SpectraMax M2). The solvent control and a plate control was 
taken into account during the scan.  
5.3. RESULTS 
5.3.1. pH purification of extracellular compounds produced by strain CZA14T in an airlift 
reactor  
Optimal fermentation conditions (153 + glycerol media, pH 6.0 at 30°C) for maximum 
production of antimicrobials from strain CZA14T was achieved using the airlift bioreactor. All 
purification studies were thus directed toward the use of fermentation broth from the airlift 
bioreactor. Antimicrobial compounds were extracted and partially purified by adjusting the pH 
of the supernatant prior to extraction of compounds using a number of different solvents. 
Crude solvent extracts were tested for inhibitory effects against Staphylococcus aureus ATCC 
33591 and DRWH system isolate 4. These results are presented in Table 5.2 (Appendix K, 
Figures K1 – K18). 
A number of similar compounds were extracted using different solvents at various pH values 
which was active against both the methicillin-resistant S. aureus ATCC 33591 test strain and the 
S. aureus 4 DRWH isolate. 
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5.3.2. Small - scale partial purification of crude extra- and intra-cellularly produced 
compounds  
A yellow coloured residual crude extract was obtained from the extraction of metabolites from 
the mycelia (intracellular production) when using EtOAc and a dark red coloured residual crude 
extract was obtained from the extraction of metabolites from the SNF (extracellular 
production) (Figure 5.2). 
Table 5.2: Bioautography assay on partially pH purified supernatant filtrate (SNF) using various solvents 
at a 1:1, v/v ratio 
Test strain Solvent pH Rf value of bio-active band 




6-7 and 9 0.94, 0.91 
8 N/I 
Chloroform 
3 - 7 0.94, 0.91, 0.84 
8 - 9 I/C 
Dichloromethane 
3 - 6 N/I 
7 0.91, 0.62 
8 0.91, 0.62, 0.57 
9 0.91, 0.84, 0.62, 0.57, 0.52 
Ethyl acetate 3 - 9 0.91, 0.62 – 0.34 
n-butanol 
3 - 7 0.57, 0.55 – 0.32 
8 - 9 I/C 
Petroleum ether 
pH 3 0.94, 0.62 – 0.36 
pH 4 0.94, 0.62, 0.57 
pH 5 0. 62, 0.57 
pH 6 0.62 – 0.36 
pH 7 - 9 0.91, 0.62 – 0.52 
S. aureus 4 
Benzene 
pH 3 - 9 0.62 – 0.34 
pH 8 N/I 
Chloroform 
pH 3 - 9 0.62, 0.57 
pH 5 N/I 
Dichloromethane 
pH 3 0.57, 0.52 – 0.38 
pH 4 and 6 0.57, 0.52 
pH 5 0.57 
pH 7 0.57, 0.52 – 0.38 
pH 8-9 0.52 
Ethyl acetate pH 3 - 9 0.62, 0.57 – 0.38 
n-butanol 
pH 3 - 6 
pH 7 
pH 8 - 9 





pH 4 and 9 
pH 5 
pH 6 and 8 
pH 7 
0.62, 0.57 – 0.26, 0.18 – 0 
0.62, 0.57 
0.62, 0.57 – 0.26, 0.14 – 0 
0.62, 0.57 – 0.32 
0.62, 0.57 – 0.42 
Key: N/I: No inhibition; I/C: Inconclusive  




 Figure 5.2:  Red coloured (left) and yellow coloured (right) residual crude bio-active extracts.  
Upon elution from the column with the four component solvent system of chloroform: EtOAc: 
formic acid: n-hexane (5: 4: 1: 0.02, v/v/v/v) only the yellow compounds were eluted. The red 
compounds were further separated into red and orange compounds and absorbed to the silica 
even after applying pressure with presurised dry air (Figure 5.3). The column was plugged and 
solvent system was left in contact with the bound compounds. Absolute ethanol was used to 
elute all the bound compounds and all the remaining compounds eluted from the column 
simultaneously. The purification was deemed unsuccessful and a small-scale purification 
method was developed using a gradient elution (Figure 5.4). Silica gel column chromatography 
was utilised for the preliminary purification of secondary metabolites (SMs) produced by strain 
CZA14T. 35 fractions were collected; fractions with similar Rf values were pooled and used 
during bioassay tests. Bioassay results are presented in Figure 5.5 (filter disk diffusion assay) 
and Table 5.3 (bioautography assay). Figures relating to this data are in Appendix L; Figures L1 – 
L12. 
                                   











Figure 5.4: 4.5 mm diameter glass Pasteur pipette containing 10 % v/v water deactivated silica.  
Compounds were eluted with a gradient elution method. 
 
 
Figure 5.5: Filter disk assay against environmental DRWH system strains. Experiment (average of 
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Fraction F; G – Fraction G; H – Fraction H. Controls – ampicillin; vancomycin; chloramphenicol; sterile 
filter disk; EtOAc control filter disk. 0 = No inhibition. 
 
Poor diffusibility of the partially purified pooled extracts were displayed during the filter disk 
diffusion assay compared to the results achieved with the filter disk diffusion assay with the 
crude extracts from the ALR fermentation broth.  
Table 5.3: Rf values of bands which exhibited inhibition against DRWH system isolates during 
bioautography assay 
Test Strain Zone of inhibition (Rf value) 
B. cereus (Ochrobactrum spp.) 
A,B,C,D0.96, E,F,H0.94, A,E,F0.91, B0.62 – 0.56, 
C0.62 – 0.46, D0.60 – 0.46, E,F0.56 – 0.42, 
G0.42 – 0.26, H0.40 – 0.22 
E. coli K4 CCA (Enterobacteriaceae) 
A,B0.94, A,E,F0.91, E,F,G0.84, C,D0.57, D0.57 – 0.36, 
B,C,E,F0.52, E0.52 – 0.38, F0.52 – 0.26, G0.38 – 
0.16, H0.36 – 0.13 
E. cloacae 11 
A,B0.96, A,E,F,H0.94, E,F0.91, C0.57 – 0.47, 
B,D,F0.52, D0.52 – 0.42, F0.52 – 0.36, E0.50 – 
0.38, G0.42 – 0.26 
E. faecalis C513 
A,B,E,F0.94, A,E,F0.91, D0.57 – 0.42, H0.57 – 0.26, 
A,C,G0.52, G0.52 – 0.36 
K. pneumoniae 1 (Enterobacteriaceae) 
A,E,F,H0.94, A,B0.91, E,F0.84, D0.56 – 0.40, C,F0.52, 
F0.52 – 0.24, B,E0.50, E0.50 – 0.36, C0.48, G0.40 
– 0.24, H0.40 – 0.13 
K. pneumoniae 3 
A0.94, A,E,F0.91, E,F0.84, C0.57 – 0.45, B,D0.55, 
D0.55 – 0.42, F0.52 – 0.24, E0.50 – 0.24, G0.38 
- 0.24, H0.36 – 0.13 
Pseudomonas aeruginosa 
A,E,F0.94, B0.91 – 0.50, E,F0.84, C,D,F0.50, F0.50 – 
0.26, E0.45, G0.36 – 0.26, H0.36 – 0.16 
S. enterica 4C (P. rettgeri) 
A0.96, A0.91, B,D0.55, C,D0.52, D,E0.50, F0.48 – 
0.36, E0.47, E0.45,  G,HN/I 
S. aureus 1 (Enterobacteriaceae) 
A0.96, A,B,E,F0.91, A,B,C,D,E,F,G0.84, A,B0.72, A0.58, 
A,B0.57, C0.55, D0.52,  C,D,E,F0.50, E0.50 – 0.40, 
F0.50 – 0.28, C,D0.45, D0.40, G0.38 – 0.20, 
D0.28, E0.16, HN/I 
S. aureus 5 (Enterobcateriaceae) 
A,B0.96 – A,H0.94, E,F0.91, E,F0.84, D0.58 – 0.40, 
B,E0.52, E0.52 – 0.50, F0.50 – 0.32, C0.42 – 
0.46, G0.40 – 0.16 
Key: (Table 5.3)  Experiment: A – Fraction A; B – Fraction B; C – Fraction C, D – Fraction D; E – Fraction E; F – Fraction F; G – 
Fraction G; H – Fraction H.  
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A number of compounds with similar Rf values were found to be active after pH purification of 
the extracellularly produced compounds. 
5.3.3. Salt purification of proteins produced extracellularly by strain CZA14T in an airlift 
reactor  
Extracellularly (SNF) produced proteins were subjected to salt purification using A/S 
precipitation and dialysis. Figure 5.6 shows the colour change of the crude solvent extract from 
a brick-red colour to pink colour after A/S precipitation and dialysis. 
 
Figure 5.6: Colour changes of EtOAc extraction during purification. A – Crude extracellular (Supernatant 
filtrate - SNF) EtOAc extract (brick red colour), B – EtOAc extract from SNF after ammonium sulphate 
precipitation (clear colour), C – EtOAc extract from pellet resuspended in 20 mM Tris-HCl after 
ammonium sulphate precipitation and dialysis (pink colour). 
 
Figure 5.6 shows the effectiveness of the precipitation purification technique. Results 
pertaining to determining the molecular weight of the purified compound/s and bio-activity 
testing follow below.  
5.3.3.1. Bradford’s assay to quantify the total protein content in salt purified samples 
The crude SNF was subjected to protein precipitation using an 80 % A/S saturation required to 
precipitate the total proteins produced by CZA14T. After A/S precipitation, dialysis was 
performed on the resuspended 80 % saturated pellet sample using 20 mM Tris-HCl buffer 
overnight. Table 5.4 shows the protein concentration of extracellularly produced proteins by 
CZA14T after A/S precipitation, dialysis and solvent extraction. 
Stellenbosch University  https://scholar.sun.ac.za
124 
 
Table 5.4: Protein concentration of extracellularly produced proteins by S. pharetrae CZA14T 
Sample Starting volume (ml) Protein concentration (mg/ml) 
1 300 0.621 
2 80 0.786 
3 30 0.925 
4 260 0.376 
5 2 0.426 
6 - 0.889 
7 0.1 0 
8 - -0 
Key: 1: Crude supernatant filtrate (SNF); 2: Pellet in 20 mM Tris-HCl after ammonium sulphate (A/S) precipitation (80 % 
saturation); 3: Dialysate; 4: Crude supernatant filtrate (SNF) after A/S precipitation; 5: Pellet in 20 mM Tris-HCl after A/S 
precipitation, dialysis, extraction with 2:3 v/v ethyl acetate (EtOAc) and reconstituted with 20 mM Tris-HCl to 50 x concentrate; 
6: 50 x concentrated EtOAc extract extracted from pellet in 20 mM Tris-HCl after A/S precipitation, dialysis and extraction with 
2:3 v/v EtOAc; 7: 50 x concentrated EtOAc extract extracted from crude supernatant after A/S precipitation, dialysis and 
extraction with 2:3 v/v EtOAc; 8: 20 mM Tris-HCl control. 
5.3.3.2. Determining the molecular weight of salt precipitated proteins using sodium 
dodecyl sulphate–polyacrylamide gel electrophoresis assay 
The molecular weight of the unknown protein of interest was determined using sodium dodecyl 
sulphate–polyacrylamide gel electrophoresis (SDS-PAGE) assay and the standards from the 
PAGE-ruler molecular weight marker. Results are presented in Table 5.5; Appendix M, Figures 
M1 and M2. 
Table 5.5: Determination of the size of the unknown protein partially purified after A/S precipitation, 
dialysis and organic solvent extraction 
 
Length (mm) Rf Mw (kDa) Log10 Mw 
Gel length 50 
   
Standard 49 0.98 170 2.23 
 
47 0.94 130 2.11 
 
44.5 0.91 100 2.00 
 
42 0.89 70 1.85 
 
38.5 0.87 55 1.74 
 
35 0.83 40 1.60 
 
31.5 0.82 35 1.54 




27 0.77 25 1.40 
 
18 0.57 15 1.18 
 
13.5 0.50 10 1.00 
*Unknown 9 0.67 6.7 0.83 
*Unknown: Pellet in 20 mM Tris-HCl after A/S precipitation, dialysis, and extraction with 2:3 v/v ethyl acetate (EtOAc) and 
reconstituted with 20 mM Tris-HCl to 50 x concentrate  
The size of the unknown protein/s of interest which was partially purified using A/S 
precipitation, dialysis and EtOAc extraction were determined using SDS-PAGE. The standards 
were used to plot a graph (Appendix M, Figure M2) and the size of the unknown protein/s were 
determined by extrapolating the data from the graph. The protein/s of interest was determined 
to be 6.7 kDa in size. Because the product is such a small size; this experiment needs to be 
repeased in future using a higher percentage separating gel. 
5.3.4. Bioassays 
Bioassays in terms of filter disk diffusion assays and bioautography assays were performed in 
duplicate against a number of DRWH system isolates. Results were averaged and are presented 
in Tables 5.6 and 5.7 (see Appendix M, Figure M3 for an example of a filter disk diffusion assay 
related to Table 5.6 and zones of inhibitions determinied during this study (section 5.7.4.1) and 
Appendix M, Figures M4–M8 (section 5.7.4.2) for bioautography assays related to Table 5.7). 
Table 5.6: Filter disk diffusion assay against environmental DRWH isolates 
Test strain Controls 
Zone of inhibition (mm) – 
experiment (Average from 
duplicate samples) 
Zone of inhibition 
(mm) - controls 
B. cereus (Ochrobactrum 
spp.) 




16; 0 and 0 
E. coli K4 CCA 
(Enterobacteriaceae) 






15; 0 and 0 
E. cloacae 22 1; 2; 3; 4; and 5 
*
9 0; 0; 
*
13; 0 and 0 








0; 0 and 0 




15 and 0 
P. aeruginosa 1; 2; 3; 4; and 5 0 0; 0; 0; 0 and 0 
S. enterica 4C  
(P. rettgeri) 






14 and 0 
S. aureus 1 
(Enterobacteriaceae) 








9; 0 and 0 
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9; 0 and 0 
Key: Control – 1 = ampicillin; 2 = vancomycin; 3 = chloramphenicol; 4 = sterile filter disk; and 5 = EtOAc control filter dis. 
#
Filter 






Table 5.7: Bio-activity of partially purified extract against environmental DRWH isolates 
Test strain Bio-activity 
B. cereus (Ochrobactrum spp.) N/I 
E. faecalis C513 A 
K. pneumoniae 3 A 
P. aeruginosa A 
S. aureus 1 (Enterobacteriaceae) A 
S. aureus 4 A 
S. aureus 5 (Enterobacteriaceae) A 
Key: *N/I – No Inhibition. A – Inhibition/active 
Salt precipitated partially purified extracellularly produced crude extracts from the ALR 
exhibited bactericidal activity against all of the DRWH isolates tested against (Table 5.6) using 
the filter disk-diffusion assay except for B. cereus (Ochrobactrum spp.), K. pneumoniae 3 and P. 
aeruginosa. However, during the bioautography assay the compounds were active against all of 
the DRWH strains tested against (Table 5.7) except for B. cereus. 
5.3.5. Staining of developed TLC plates containing EtOAc extracts partially purified during 
silica gel 60 column chromatography 
After developing TLC plates it is necessary to visualise the compounds and determine their 
functional groups in order to characterise the compounds of interest. Results pertaining to the 
visualisation and staining of compounds of interest are presented in Table 5.8. The sample 
labelled as “PP” in the table is the 50x concentrated EtOAc extract from the pellet resuspended 
in 20 mM Tris-HCl after A/S precipitation, dialysis and extraction with 2:3 v/v EtOAc. Fractions 
A–H are solvent fractions from the silica gel column chromatography technique. 
Twelve compounds were visualised under short-wave UV light (254 nm), while seven 
compounds were visualised under long-wave UV light (365 nm) with three out of the seven 
compounds being of similar Rf value to those visualised under short-wave UV light. A number of 
Stellenbosch University  https://scholar.sun.ac.za
127 
 
compounds from fractions A-D showed compounds present after staining with iodine that were 
similar in Rf values to compounds visible under UV light. A number of different compounds in 
fractions E-H were detected using the iodine stain that was not visible under UV light. A number 
of compounds not visible under UV light in the ‘PP’ extract were visualised after the application 
of the universal iodine stain. Ten compounds were detected with Rf values ranging from 0.52-
0.30. All silica purified fractions and ‘PP’ extract produced a positive result with the p–
anisaldehyde – sulphuric acid stain. Fractions A-H rendered white/cream, brown and red 
coloured compounds with Rf values ranging from 0.98-0.16. Only one compound in fraction A 
from the silica gel 60 purified extracts were positive for the presence of free amino groups. This 
compound had an Rf value of 0.94. The vanillin/sulphuric acid stain produced a positive result 
for the presence of unsaturation by compounds detected in Fractions A, B, C and H of silica gel 
60 purified samples. 
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0.98, 0.87, 0.74, 
0.60, 0.58 
0.94* 0.94, 0.87 0.94 Red 0.94 0.84 Green/brown 
Fraction B 
0.87, 0.74, 0.60, 
0.58 
0.94*, 0.78*, 0.74**, 
0.61**, 0.58** 

















0.54 0.56 Brown No bands 0.53 Red 
Fraction D 0.87, 0.31, 0.18 No bands 0.54, 0.50,  0.47 0.50 Grey/white No bands No bands 
Fraction E 0.87, 0.18 No bands 0.47, 0.45, 0.44 0.49 Grey/white No bands No bands 
Fraction F 0.88 No bands 
0.47, 0.45, 0.44, 0.41, 
0.40 
0.98 
0.50 – 0.26 
Brown 
Grey/white 
No bands No bands 
Fraction G 0.90 No bands 0.90 
0.98 
0.87 




No bands No bands 
Fraction H 0.91 No bands 0.91 
0.87 
0.33 – 0.16 
Brown 
Grey/white 
No bands 0.87 Green 
#
PP No bands No bands 
0.52, 0.50, 0.47, 0.45, 
0.42, 0.40, 0.37, 0.35, 
0.32, 0.30 
0.52 – 0.30 Grey/white No bands No bands 
*Orange fluorescent colour, **blue fluorescent colour 
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570 nm 540 nm 
400 nm 
5.3.6. Spectroscopic measurement 
The spectrometric measurement of antimicrobial compounds produced by CZA14T was 
performed by UV/Visible spectrometry (Figure 5.7). The extra- and intra-cellularly produced 
compounds extracted as crude compounds from fermentation broth from the ALR, as well as 
the partially purified extracellularly produced compounds (#PP)  were analysed (Table 5.9).  
 
Figure 5.7: UV absorption spectrum of partially purified extracellularly produced compounds. Main 
peaks detected are indicated by red arrows. 
 
UV scans of crude extracts from the ALR fermentation broth dissolved in EtOAc were 
performed. The absorbance maxima were obtained at 290 nm, 410 nm, 540 nm and 570 nm for 
extracellularly produced compounds and at 290 nm for intracellularly produced compounds 
(Table 5.9; Appendix N, Figures N1 and N2). UV scans of partially purified extracellularly 
produced compounds (#PP) showed absorbance maxima at 280 nm, 320 nm, 400 nm, 540 nm 
and 570 nm. 
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Table 5.9: UV maxima of compounds produced by S. pharetrae CZA14T in an ALR 
Sample UV max (nm) 
Extracellularly produced crude compounds 290, 410, 540, and 570 
Intracellularly produced crude compounds 290 
Partially purified extracellularly produced 
compounds (A/S precipitation and dialysis) (#PP) 
280, 320, 400, 540, and 570 
 
5.4. DISCUSSION 
Partial purification of compounds by changing the pH of extracellular fluid and extracting 
compounds using various solvents 
Extracellularly produced antimicrobial compounds were extracted using different solvents, 
including benzene, chloroform, dichloromethane, EtOAc, n-butanol and petroleum ether. The 
partially purified extracellularly produced compounds were slightly soluble to soluble in all of 
the aforementioned solvents. The results with the crude EtOAc extracts presented in Chapter 4 
saw compounds with Rf values in a range of 0.10 – 0.94, most of which were active against the 
test strains used in this study. In comparison to those results, similar compounds were 
extracted using different solvents from SNF adjusted to various pH values (Tables 5.2). These 
compounds were active against the methicillin-resistant ATCC S. aureus strain and the DRWH 
isolated S. aureus. The best extraction solvents for full extraction of antimicrobial compounds 
were EtOAc and petroleum ether. EtOAc was chosen over the other solvents for extraction 
purposes for current and future downstream processes due to it being inexpensive and due to 
its polarity and miscibility.  
Preliminary small-scale purification of crude EtOAc extracts from airlift reactor fermentation 
broth using gradient elution column chromatography 
Pooled extra- and intra-cellularly produced compounds extracted from ALR fermentation broth 
and mycelial mass was partially purified using silica gel 60 column chromatography. Partially 
purified compounds were bioassayed to ascertain the antimicrobial bio-active profile of these 
compounds against the DRWH system isolates used in this study and to compare activities to 
bio-active results obtained during bioassays with the crude extracts.  
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No inhibition was detected against B. cereus, E. coli K4 CCA, P. aeruginosa and S. enterica 4C 
when the filter disk diffusion assay (Figure 5.5) was used. Various factors such as the poor 
diffusibility of the compounds into the agar medium, could contribute to the lack of inhibition 
observed. Fractions E and F collected during the pdurification process were active against E. 
cloacae 22. Fraction A was active against E. faecalis C513, while fractions F and G were active 
against K. pneumoniae 3. Fractions A, E, F and G were active against S. aureus 2, and fractions 
A, E, F, G and H were active against S. aureus 4. The commercial antibiotics were active against 
the DRWH system isolates except for P. aeruginosa. No inhibition was detected in the EtOAc 
control and sterile filter disk control.  
The bioautography assay showed that compounds present in all fractions were active against 
the DRWH system isolates with an exception to fractions G and H, which exhibited no bio-
activity against S. enterica 4C and no bio-activity with fraction H against S. aureus 1  (Table 5.3).  
All compounds in the crude extract active against the DRWH system isolates remained active 
after partial purification using silica gel column chromatography. Interestingly, the expected 
band with an Rf value of 0.81 active against E. coli K4 CCA, E. cloacae 11 and E. faecalis C513 
during tests with the crude extracts showed no activity during the bioautography assays with 
the partially purified extracts. The functionality of the compound may have been lost during the 
purification process, it may not have eluted from the column or the concentration of the 
compound may be too low to exhibit an inhibitory effect. Another interesting observation was 
the inhibitory effect of a new active compound with an Rf value of 0.96, not previously observed 
during the bioautography assay with the crude extracts. This compound was active against B. 
cereus, E. cloacae 11, S. enterica 4C, S. aureus 1 and S. aureus 5. Concentrations of this 
compound may have increased after purification enabling it to have an inhibitory effect. 
Another theory could be due to a synergistic effect whereby compounds in the crude extract 
together causes bactericidal activity and separated exhibits no bio-activity. A number of growth 
promoters were observed throughout bioautography assays with partially purified extracts and 
(as well as crude extracts, Chapter 5) where purple bands were visualised on a developed TLC 
plate containing areas of enhanced growth of pathogenic bacteria stained with MTT (Appendix 
H and L). 
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Partial purification of antimicrobials produced extracellularly by strain CZA14T in an airlift 
reactor 
It was determined with the Bradford’s assay that after ammonium sulphate precipitation of the 
crude extract, the protein concentration of the 80% saturated pellet increased from 
0.621 mg/mL to 0.786 mg/mL. After further purification methods using dialysis techniques, the 
protein concentration increased from 0.786 mg/mL to 0.925 mg/mL. The protein concentration 
decreased after extraction with EtOAc of salt purified pellet from 0.925 mg/mL to 0.426 mg/mL, 
indicating that some of the compounds reacting with the Bradford’s reagent were extracted 
into the EtOAc. No protein was detected in the buffer used to constitute the EtOAc extracts 
after drying and no protein was detected in the crude supernatant extract after A/S 
precipitation, dialysis and solvent extraction with EtOAc. 
Determining the molecular weight of partially purified proteins: sodium dodecyl sulphate–
polyacrylamide gel electrophoresis 
EtOAc extracted partially purified salt precipitated compounds were resolved on a denaturing 
SDS-PAGE to determine the molecular weight of the protein of interest. This was performed to 
ascertain whether an antimicrobial peptide was isolated during purification and extraction 
processes. Typically, antimicrobial peptides are low molecular weight compounds with a small 
size of < 10 kDa (Yount and Yeaman, 2004). A 6.7 kDa protein was isolated from the 
supernatant filtrate by salt precipitation, dialysis and EtOAc solvent extraction. The 
compound/s was labelled as “PP” and were further analysed to determine their bio-active 
profile and other characteristics using UV light, staining and spectrometric analysis.   
Bioassays 
Filter disk diffusion and bioautography assays on salt purified EtOAc extracts 
After determining that the active compound/s were isolated by EtOAc extraction, the partially 
purified extract was subjected to filter disk diffusion assays and bioautography assays against a 
limited number of DRWH isolates due to the limited volume of extract available for testing 
purposes. During the filter disk diffusion assay, the partially purified compounds exhibited no 
inhibition against B. cereus (Ochrobactrum spp.), K. pneumoniae 3 and P. aeruginosa. 
Bactericidal activity was exhibited against E. coli K4 CCA, E. cloacae 22, E. faecalis C513, S. 
aureus 1 and 4 with an average zone of clearing of 8 mm, 9 mm, 9 mm, 10 mm and 10 mm, 
Stellenbosch University  https://scholar.sun.ac.za
133 
 
respectively. Bacteriostatic activity was exhibited against S. enterica 4C with a large zone of 
inhibition of 31.5 mm (Table 5.6). No zone of inhibition was detected against B. cereus during 
bioautography assays. The partially purified extract was active against E. faecalis C513, K. 
pneumoniae 3, P. aeruginosa, S. aureus 1 and 4 and S. aureus 5 during the bioautography 
assays.   
Visualisation of compounds separated on TLC plates (Appendix O, Figures O1 – O7) 
After developing the TLC it is important to visualize the components within a reaction mixture. 
The main reason for doing so is because most organic compounds are colourless. Most 
chromophore-containing compounds can be visualised under short- and long-wave ultraviolet 
(UV) light (254 nm and 365 nm, respectively). Typical functional groups found in chromophore-
containing compounds which may be visualised under UV light, are α, β- unsaturated carbonyls, 
aromatic groups, and any other compounds which contain extensively π-conjugated systems. 
For those compounds which do not absorb under UV light, permanent or semi-permanent TLC 
staining can be performed for visualisation of these compounds and determination of their 
functional groups (Kasal et al., 2010). 
Fraction A contained compounds with Rf values of 0.98, 0.87, 0.74, 0.60 and 0.58 which 
absorbed under short-wave UV light (254 nm) and a compound with an Rf value of 0.94 was 
absorbed under long-wave UV light (365 nm) and fluoresced as an orange colour. Compounds 
0.94 and 0.87 were detected with the universal iodine stain and compound 0.94 was detected 
using the anisaldehyde stain and ninhydrin stain. Compound 0.84 was not visible under UV but 
was detected using the vanillin/sulphuric acid stain. Compound 0.94 displayed broad range bio-
activity against DRW isolates – E. cloacae 11, E. faecalis C513, E. coli K4 CCA, K. pneumonia, K. 
pneumonia 3, S. aureus 5 and P. aeruginosa (Table 5.5). A positive ninhydrin result (detection of 
amino acids, amines or amino-sugars) combined with the positive anisaldehyde result 
(detection of phenols, terpenes, steroids and sugars) could indicate the presence of an 
aminoglycoside antibiotic. CZA14T contain genes for the expression of an aminoglycoside which 
are situated on contig 54, cluster 9 of the CZA14T genome (Appendix P, Table P1). Compound 
0.84 was active against S. aureus 1; this compound displayed a green/brown colour spot when 
stained with vanillin/sulphuric acid reagent. A green spot is indicative of phenols or higher 
alcohols. Typically, polyether antibiotics such as lysocellin give a bright yellow-green to green 
colour when stained with vanillin/sulphuric acid.   
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Fraction B contained compounds with Rf values of 0.87, 0.74, 0.60 and 0.58 that was absorbed 
under 254 nm UV light. Compounds 0.94 and 0.78 fluoresced as orange compounds under 365 
nm UV light and compounds 0.74, 0.61 and 0.58 fluoresced as blue compounds under 365 nm 
UV light. Compounds 0.87, 0.60 and 0.58 were iodine positive. Compounds 0.94, 0.64 and 0.58 
were anisaldehyde positive and displayed red to brown colour spots and compounds 0.60 and 
0.53 were vanillin positive and displayed as red spots.  An anisaldehyde positive result and a 
vanillin/sulphuric acid positive result may indicate the presence of terpenes. Typically terpenes 
appear as red and blue colours with the vanillin/sulphuric acid stain. CZA14T have six 
biosynthetic gene clusters (BGC) which code for the expression of terpenes (Appendix P, Table 
P1). According to antiSMASH predictions, One of the BGCs coded for the terpene, 
albaflavenone (100 % similarity). This terpene is situated on contig 32, cluster 4 of the CZA14T 
genome. The compound with the same Rf value was also detected in Fraction C. Compound 
0.60 was active against B. cereus and compound 0.53 may be active against E. coli K4 CCA and 
E. cloacae 11.  
Fraction C contained compounds with Rf values of 0.87, 0.58, 0.54, 0.50 and 0.31 that absorbed 
under 254 nm UV light and; compound 0.94 which fluoresced as an orange compound and 
compounds 0.58, 0.54 and 0.50 which fluoresced as blue compounds under 365 nm UV light. 
Compound 0.54 was visible during the iodine stain. Compound 0.56 was active against E. 
cloacae 11 and K. pneumoniae 3, this compound appeared as a brown spot with the 
anisaldehyde stain – glucosamine compounds give brownish–red chromatographic spots. 
Compound 0.53 which was also detected in fraction B appeared as a red spot with the 
vanillin/sulphuric acid stain. As previously suggested, this compound may be a terpene.  
Fraction D contains compounds with Rf values of 0.87, 0.31 and 0.18 which absorbs under 254 
nm UV light. Compounds 0.54, 0.50 and 0.47 were detected using the iodine stain. Compound 
0.50 was also detected with the anisaldehyde stain and appeared as a grey/white spot. This 
compound was active against E. cloacae, P. aeruginosa, P. rettgeri and S. aureus 1. 
Fraction E contains compounds with Rf values of 0.87 and 0.18 which absorbs under 254 nm UV 
light. Compounds 0.47, 0.45 and 0.44 were detected using the iodine stain. Compound 0.49 
appeared as a grey/white spot when stained with anisaldehyde. Compounds in fraction E were 
active against Ochrobactrum spp., E. coli K4 CCA, E. cloacae 11, K. pneumoniae 1, K. 
pneumoniae 3, P. aeruginosa, S. aureus 1 and 5. 
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Fraction F contains a compound 0.88 which absorbs at 254 nm. Compounds 0.47, 0.45, 0.44, 
0.41 and 0.40 were detected with iodine. Compound 0.98 appeared as a brown spot on the 
developed TLC and compounds 0.50 – 0.26 appeared as grey/white spots after staining with 
anisaldehyde. Compounds in fraction F were active against B. cereus, E. coli K4 CCA, E. cloacae 
11, K. pneumoniae 1, K. pneumoniae 3, P. aeruginosa, P. rettgeri and S. aureus 1 and 5. 
Fraction G contained a compound with an Rf value of 0.90 which absorbed under 254 nm UV 
light. This compound was also detected using the iodine stain. Compound 0.98 appeared as a 
brown spot, compound 0.87 appeared as a red spot and compounds 0.36 – 0.24 appeared as a 
grey/white spot with the anisaldehyde stain. Compounds 0.36 – 0.24 were active against B. 
cereus, E. coli K4 CCA, E. cloacae 11, E. faecalis C513, K. pneumoniae 1, K. pneumoniae 3, P. 
aeruginosa, S. aureus 1 and 5. 
Fraction H contained a compound with an Rf value of 0.91 which absorbed under 254 nm UV 
light. This compound was also detected using the iodine stain. Compound 0.87 appeared as a 
brown spot when stained with anisaldehyde and as a green spot when stained with 
vanillin/sulphuric acid. Compounds 0.33 – 0.16 were detected as a grey-white spot with 
anisaldehyde stain. These compounds were active against B. cereus, E. coli K4 CCA, E. faecalis 
C513, K. pneumoniae 1, K. pneumoniae 3 and P. aeruginosa. 
A number of compounds were detected in the sample labelled “PP” when using the iodine stain 
and anisaldehyde stain which stained as grey/white spots. All these compounds were active 
against the DRWH isolates tested against in this study except for B. cereus (Ochrobactrum spp.). 
These compounds had Rf values of 0.52, 0.50, 0.47, 0.45, 0.42, 0.40, 0.37, 0.35, 0.32 and 0.30. 
These Rf values are very close to each other – it was suggested that these compounds could be 
isomers of each other. Isomers are two or more compounds that have the same molecular 
formula. However, these molecules possess a different arrangement causing a different 
chemical structure which in turn exhibits different properties when separated on a TLC plate.  
Compounds in Fractions C–H and sample “PP” tested positive with anisaldehyde: spots 
coloured violet/brown, blue, red, grey or green may indicate the presence of terpenes, sugars 
and steroids. This could indicate a number of classes of antimicrobial compounds such as 
compounds produced by the polyketide synthase (PKS) and non-ribosomal peptide synthetase 
(NRPS) pathways. CZA14T contain a number of genes encoding for the production of 
antimicrobials from the aforementioned pathways (Appendix P, Table P1).  




Characteristics of antimicrobial compounds produced by CZA14T with UV spectroscopy analyses 
showed that SM compounds produced extracellularly and extracted as crude compounds 
exhibited a maximum UV absorption at 290, 410, 540 and 570 nm in EtOAc. Crude 
intracellularly produced active compounds exhibited a maximum UV absorption of 290 nm. 
These compounds exhibited broad-spectrum antibacterial and antifungal activity against the 
ATCC clinical test strains and DRWH isolates. Extracellularly produced crude compounds were 
purified using salt precipitation, dialysis and EtAOc solvent extraction. Active compounds 
exhibited a maximum UV absorption at 280, 320, 400, 540 and 570 nm. These compounds 
exhibited bio-activity against the DRWH isolates used in the current study.  
5.5. CONCLUSION 
A summary of the various physicochemical properties of the compounds produced by CZA14T in 
an airlift reactor is presented in Table 5.10 







Appearance Deep red Yellow Pink 
Solubility 
Slightly soluble in 
benzene, chloroform, 
dichloromethane, n-
butanol and petroleum 
ether. Soluble in EtOAc, 
water, methanol and 
DMSO 
Soluble in EtOAc 













Anisaldehyde + + 
UV λmax 
(nm) 
290, 410, 540 and 570 nm 290 nm 





Ranging between 0.96 – 0.13 
0.52, 0.50, 0.47, 0.45, 
0.42, 0.40, 0.37, 0.35, 
0.32, 0.30 
Active B. cereus (Ochrobactrum spp.), E. coli K4 CCA E, faecalis C513, K. 






(Enterobacteriaceae), E. cloacae 11, E. faecalis C513, 
K. pneumoniae 1 (Enterobacteriaceae), K. 
pneumoniae 3, P. aeruginosa, S. enterica 4C (P. 




aeruginosa, S .aureus 1 
(Enterobacteriaceae) 
and 4, S. aureus 5 
(Enterobacteriaceae) 
 
Evaluation of the crude and partially purified organic extracts identified a number of biologically 
active compounds with various physicochemical properties as presented in Table 5.10. After pH 
adjusted and partial purification of extracellularly produced compounds, a number of 
compounds with similar Rf values were detected. These compounds were active against 
methicillin-resistant S. aureus ATCC 33591 as well as the S. aureus 4 DRWH system isolate. 
Broad-range bio-activity was exhibited against all 14 of the DRWH system isolates tested 
against in this study by the organic extract which was preliminarily purified using small-scale 
silica gel 60 column chromatography.  Extracellularly produced proteins were subjected to salt 
precipitation and these proteins were also active against the DRWH system isolates tested in 
this study. During the purification with ammonium sulphate salt, a 6.7 kDa protein was isolated. 
It was suggested that this protein could be a peptide antibiotic due to its small size and may be 
one of the compounds exhibiting activity against the DRWH system isolates (a way to detect if 
this protein is active is by direct bioassay, but this result was not clear and should be repeated – 
see Appendix Q, Figures Q1 and Q2).  In Chapter 5, we see that the number of SM compounds 
produced (Chapter 3) were seriously underestimated as a number of these compounds were 
not visualised under UV light and could only be visualised using various stains and during 
bioautography assays. 
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Molecular techniques to determine the 
biosynthetic potential of Streptomyces 
pharetrae CZA14T 
  




Microbial genome sequence analyses for access to the diversity of microbial biosynthetic 
pathways by the use of bioinformatics tools and molecular detection technologies have 
revealed a number of “cryptic” secondary metabolite biosynthetic gene clusters (smBGCs). This 
is valuable for the production of new natural products: ‘genome mining’ can be used to predict 
certain classes of antimicrobial agents and experiments for their expression can be designed. 
The CZA14T genome was ‘mined’ for the detection of its biosynthetic pathways using the online 
bioinformatics programme, antiSMASH, and molecular techniques were used in the discovery 
of smBGCs. AntiSMASH revealed eight out of the 55 smBGCs to be polyketide synthase based 
compounds (PKS). Using polymerase chain reaction (PCR) and fermentation (Chapter 4), one of 
the eight PKSs detected belonged to a Type-II PKS family containing ketosynthase (KSα) genes. 
AntiSMASH determined that CZA14T contained genes showing 100 % homology to curamycin A. 
This prediction was confirmed through the isolation of total RNA, its conversion to cDNA, and 
the use of the cDNA as a template for the PCR amplification of the KSα gene. Furthermore, a 
mass peak with the exact molecular weight as curamycin A was detected when partially 









Key words: AntiSMASH, smBGCs, PCR, Type-II PKSs 




Full microbial genome sequencing is beneficial as it can be used to identify the genes which 
govern the biosynthesis of a natural product. These genes are often clustered together in so-
called ‘silent’ or ‘cryptic’ pathways and more often than not, organisms contain more potential 
biosynthetic gene clusters for secondary metabolite (SM) production than the number of 
metabolites reported (Corre and Challis, 2009; Walsh and Fischbach, 2010; Wenzel and Muller, 
2007). These ‘silent’ pathways hold much potential for researchers as it provides new 
opportunities for novel drug discovery, as putative natural products are often overlooked under 
standard detection and fermentation conditions (Walsh and Fischbach, 2010). Cryptic pathways 
are appealing not only because of their potential for novel natural product discovery, but also 
because most of the pathways contain genes coding for multi-modular and multi-domain PKS 
and NRPS – these enzymes are highly sought after as they are involved in the biosynthesis of 
many known therapeutic products (Walsh and Fischbach, 2010). 
SM biosynthesis is regulated via specific sets of structural genes. These genes are typically 
clustered on the chromosome and organised in the order the biosynthetic reaction will occur. 
Genes regulating the expression of SMs are adjacent to the biosynthetic genes which control 
pathways specific for SM biosynthesis. The expression of genes of interest is dependent on 
environmental conditions which will either activate or suppress the secondary metabolite 
biosynthetic genes (SMBG) (van Wezel et al., 1997; Narberhaus, 1999; Vincente et al., 1999). In 
order to make the genomic screening more effective, molecular techniques in combination with 
a bioinformatics approach should be followed. Molecular detection methodology has become 
increasingly valuable in determining the biosynthetic potential of microorganisms and to 
determine the taxonomic diversity of microorganisms producing antibiotics (August et al., 1999; 
Dalboge and Lange, 1998). The molecular based technique, the polymerase chain reaction 
(PCR), may be used to amplify selected biosynthetic genes with the use of degenerate primers. 
This method, independent of culturing conditions, has proven to be reliable at indicating the 
potential of actinobacteria to produce certain classes of antimicrobial compounds or novel 
compounds (Seow et al., 1997; Morris et al., 1999).    
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In this part of the study, the genome sequence of Streptomyces pharetrae CZA14T was re-
evaluated for the smBGCs present, through the use of the online bioinformatics tool 
antiSMASH. Degenerate primers for the amplification of Type I and Type II ketosynthases were 
used to detect the predicted polyketide gene clusters. The production of a polyketide was 
confirmed through the isolation of total RNA, conversion to cDNA, and the cDNA used as a 
template in PCR with the degenerate primers. The sequence information obtained was linked 
to the predicted gene cluster in the genome sequence. Figure 6.1 outline the methodology 














Figure 6.1: Flow-chart of methods used for the determination of the biosynthetic potential of 
Streptomyces pharetrae CZA14T. 
 
Determining the biosynthetic potential of  Streptomyces pharetrae CZA14T 




PCR screening for 






Solvent extraction after 
ammonium sulphate 
precipitation and 
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Materials and Methods 
6.1. Materials 
Most of the chemicals used in this study were purchased from Merck Millipore or Sigma-Aldrich 
unless otherwise stated. 
6.2. Methods 
6.2.1. Genome mining: bioinformatic analysis of S. pharetrae CZA14T genome 
Prior to this study, DNA was isolated from S. pharetrae CZA14T by Dr M. Le Roes-Hill and the 
genome was sequenced by Dr B. Kirby at the University of the Western Cape, Next Generation 
Sequencing Facility. The genome was annotated by Dr M. Le Roes-Hill, Dr B. Kirby, Dr N. Khan, 
Dr P. Meyers, Dr J. Rohland and Dr G. Everest. For the prediction of biosynthetic gene clusters 
and final products, the bioinformatics tool antiSMASH (Antibiotics and Secondary Metabolite 
Anaylsis SHell) (Blin et al., 2013) (http://antismash.secondarymetabolites.org) was used. The 
genome sequence was submitted to the online server and the predicted biosynthetic gene 
clusters were evaluated: 
(http://antismash.secondarymetabolites.org/upload/abef86c8-1752-4e11-8b3f-
c29ac0e37aaf/index.html).  
6.2.2. Molecular biology methodology  
Le Roes-Hill (2015; unpublished data), performed PCR on genomic DNA isolated from CZA14T 
and amplified Type-II polyketide synthases (PKS-II) genes to determine whether it contains the 
genes for the expression of a Type-II polyketide compound (Appendix R, Figure R1). 
Molecular screening was performed to determine whether CZA14T was expressing genes for a 
Type-II PKS in the optimal media, fermentation vessel and conditions (153 + glycerol, ALR, 30°C 
over 7 – 15 days). Details concerning the expression of those biosynthetic genes are detailed 
below. 
Total RNA isolation involved the growth of the CZA14T culture in an airlift reactor, followed by 
Gram stain to determine purity of cultures. Total RNA isolation was performed using the 
method described by the manufacturers of the Bioline kit used in this study. The RNA 
concentration was determined using a nanodrop, genomic DNA contaminants were determined 
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by PCR with DNA controls and RNA samples using 16S rRNA primers. Pure RNA was converted 
to cDNA using reverse transcriptase (RT) polymerase chain reaction (PCR) and PKS products 
were amplified using PKS primers and the cDNA as template. The products were visualised 
under UV after separation on a 1% agarose gel. 
6.2.2.1. Polymerase chain reaction (PCR) screening for the biosynthetic genes involved in 
the production of aromatic Type-II polyketide synthases (PKS-II) 
Genomic DNA was used in a PCR amplification of a Type-II PKS (Wood et al., 2006). The 
expression of the biosynthetic gene clusters were determined by collecting 2 mL samples 
throughout the fermentation with the airlift reactor (ALR) used in this study (see Chapter 4, 
section 4.2.1) from day 0 – 12. Cells were harvested from 2 mL of the cell suspension by 
centrifuging at 12 000 rpm for 10 minutes and the supernatant discarded. RNA was isolated and 
purified according to the manufacturer’s instructions using the Bioline isolate II RNA mini kit 
(catalogue no. BIO-52071).  
To determine whether the RNA was free from contaminating genomic DNA (gDNA), universal 
16S rRNA primers (16S-F: 5’ – AGAGTTTGATCITGGCTCAG - 3’, 16S-R: 5’ – 
ACGGITACCTTGTTACGACTT – 3’) were used to amplify any gDNA in the total RNA samples;  
gDNA from another actinomycete strain was used as a positive control. Conditions for 
amplification of the 16S rRNA gene were: 96°C for 2 minutes (initial denaturation), 30 cycles of 
96°C for 30 seconds (denaturation), 56°C for 30 seconds (annealing), 72°C for 2 minutes 
(extension) and a final extension of 72°C for 5 minutes. Samples were separated on a 1% (w/v) 
1 x tris-acetate-EDTA (TAE) agarose gel [100 volts (V) for 1 hour (hr) and viewed under UV 
(Appendix R, Figure R2)]. Upon determining whether the RNA isolated was pure, RNA was 
converted to cDNA by reverse transcription (RT) using RT-PCR according to the manufacturer’s 
instructions using the Ambion RETROscript kit (catalogue no. AM1710); the conditions for cDNA 
synthesis were as follows: 44°C for 1 hour and 92°C for 10 minutes. 2 µg of total RNA was used 
as a template (experiments were performed in duplicate) and 2 controls (in duplicate) were 
used during the procedure (RT control 1: contained a positive RNA control with the addition of 
reverse transcriptase, and RT control 2: contained nuclease free dH2O with the addition of 
reverse transcriptase).  
Once RNA was successfully converted to cDNA. Samples were electrophoresed on a 1% (w/v) 1 
x tris-borate-EDTA (TBE) agarose gel (100 V for 1 hr) and viewed under UV; Appendix R, Figure 
R3. 4 μL cDNA was used as the template with Thermo Fisher ScientificTM 2X dreamtaq PCR 
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master mix and aromatic type-II PKS primers (ARO-PKS-F: 5’ – GGCAGCGGITTCGGCGGITTCCAG 
– 3’, ARO-PKS-R: 5’ – CGITGTTIACIGCGTAGAACCAGGCG – 3’) in the amplification of the Type-II 
PKS biosynthetic gene in a 50 μL reaction. Gradient PCR was performed and the conditions for 
the amplification of the PKS-II gene were as follows: 96°C for 2 minutes (initial denaturation); 
30 cycles of 96°C for 45 seconds (denaturation); 56°C ∆ 9°C (annealing): gradient – 52.1°C, 
53.3°C, 54.9°C, 56.2°C, 57.9°C, 59.4°C, 52.6°C, 54.1°C, 55.6°C, 57.1°C, 58.7°C, 59.7°C; 72°C for 2 
minutes (extension); and 72°C for 5 minutes (final extension). Samples were separated on a 1% 
(w/v) 1 x tris-borate-EDTA (TBE) agarose gel (100 V for 1 hr) and viewed under UV. The PCR 
product was sequenced by Inqaba Biotec (http://www.inqababiotec.co.za/).  
6.2.2.2. Analysis of sequenced amplified PCR products 
Chromatograms received from Inqaba Biotec after sequencing were edited in Chromas (the 
Chromas Lite program (Technelysium) can be downloaded from: 
http://www.technelysium.com.au/chromas.html), exported as a FASTA format file and 
submitted to the basic local alignment search tool (BLAST) (using the BLASTn function) located 
on the NCBI database (http://blast.ncbi.nlm.nih.gov/Blast.cgi). A continuous sequence from the 
top hit (one with the highest identity) out of the sequences which produced a significant 
alignment during the BLASTn search was chosen and used to search for a similar/exact 
sequence(s) in the annotated CZA14T genome. The contig information found in the annotated 
CZA14T genome was then linked back to the antiSMASH information to determine the 
biosynthetic gene cluster responsible for the expression of the PKS-II.  
6.2.3. Tentative identification of compounds via Liquid Chromatography/Mass Spectrometry 
(LC/MS)  
A Dionex outlet 3000 high performance liquid chromatography (HPLC) coupled to an amazon SL 
ion trap mass spectrometer (MS) supplied by Bruker (http://www.bruker.com) was used to 
identify the exact mass of compounds present in the extracellularly (SNF) produced 
antimicrobials of strain CZA14T that were subjected to partial purification using A/S 
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6.3. RESULTS  
6.3.1. Genome mining using antiSMASH 
AntiSMASH was used to mine the genome of Streptomyces pharetrae CZA14T to determine its 
biosynthetic potential for SM production. Fifty-five biosynthetic gene clusters (Appendix P, 
Table P1) were detected using antiSMASH with eight being polyketide synthases (PKSs) which 
are of relevance to this study (Table 6.2). 
Table 6.2: Polyketide synthase biosynthetic potential of S. pharetrae CZA14T determined by AntiSMASH 
No. Biosynthetic gene cluster Contig/Cluster 
1 Butyrolactone-PKS-II 96/14 
2 PKS-I 116/16 
3 PKS-II 149/18 
4 PKS-II 196/24 
5 PKS-III 221/27 
6 PKS-I 336/35 
7 Other KS (type IV) PKS 344/36 
8 Other KS (type IV)-PKS-I 421/45 
 
6.3.2. Polymerase chain reaction (PCR) screening for the biosynthetic genes involved in the 
production of aromatic Type-II polyketides (PKS-II) 
Genes governing the expression of Type-II polyketide synthases (PKSs) were determined using 
aromatic PKS forward and reverse primers for PCR. The result is presented in Figure 6.2. 
Amplified PCR product obtained when cDNA was used (Figure 6.2) was submitted to Inqaba 
HPLC: MS: 
Gradient profile 
The gradient elution profile were as follow: 
0 min: 2 % B; 0 – 70 min: 100 % B; 70 – 71 
min: 2 % B; 71 – 80 min: 2 % B. 
 
*solvent A is 0.1 % formic acid and B is 
acetonitrile. 
Polarity 
Negative and positive mode, respectively 
Nebulizer Pressure 
2.4 Bar 
Dry gas flow 
9 L/min 
Dry gas temperature 
300 °C 
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Biotec for sequencing and similarities of nucleic acid sequences of SM biosynthetic genes within 
















Figure 6.2: 1 % TBE agarose gel electrophoretogram of PCR amplification of type-II PKS gene of cDNA 
products isolated from airlift fermentation broth a various time periods for the genes involved in the 
synthesis of PKS-II. Lanes 1 and 16: 1kb Kapa Biosystems universal molecular weight marker, Lanes 3 and 
4: cDNA of samples taken at day 0, Lanes 5 and 6: cDNA of samples taken at day 3; Lanes 7 and 8: cDNA 
of samples taken at day 6; Lanes 9 and 10: cDNA of samples taken at day 9; Lanes 11 and 12: cDNA of 
samples taken at day 12; Lane 13: RNA control; Lane 14: Control containing water (controls provided by 
manufacturer) 
 
During PCR screening of the Type-II PKS gene, an approximate 630 bp fragment was amplified 
for samples taken on day 0 and day 12 of the fermentation with the airlift bioreactor. No 
amplification of the Type-II PKS gene took place at days 3, 6, and 9. 
  
~ 630 bp 
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Table 6.3: Continuous sequence from strain with highest identity during BLASTn search (Streptomyces 
glaucescens strain GLA) of ARO-PKS sequences found to be similar in annotated genome of CZA14T 
Contig Start Stop Strand Function Evidence code 
196 4101 5342 + 
Polyketide chain 
length factor WhiE 
– CLF 




Figure 6.3: Percentage similarity of homologous known gene clusters compared to the query sequence 
(CZA14T) determined by antiSMASH. 
 
6.3.3. Analysis of sequenced amplified PCR products 
The PCR screening for the biosynthetic genes involved in the biosynthesis of a type-II PKS 
antimicrobial agent was established on the basis of the amplification with specific primers. 
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Sequencing data was analysed using the BLASTn function and the results were linked back to 
information found in the annotated CZA14T genome (Table 6.2) and antiSMASH results (Figure 
6.3). 
6.3.4. Tentative Identification via Liquid Chromatography/Mass Spectrometry (LC/MS)  
The fragmentation profile of the partially purified compounds produced extracellularly by 
CZA14T (#PP) were elucidated using the ion trap in both positive and negative mode. The MS 
product-ion mass spectra of #PP is presented in Figure 6.4 along with the structural elucidation 
of the Type-II PKS, curamycin produced by CZA14T under optimal fermentation conditions with 
the ALR. 
 
Figure 6.4: Chromatogram from LC/MS analysis of partially purified extract for the elucidation of 
antimicrobial agent curamycin A. 
 
The compound, curamycin A, was tentatively identified through LC/MS analysis of the salt 
precipitated partially purified extracellularly produced compounds extracted as crude 
compounds from the ALR (named “PP”). The exact mass of the compound determine by the 
LC/MS used in this study was 1374.8 m/z (minus 1 from the mass determined in positive mode); 
curamycin A has an exact mass of 1374.4 g/mol.  




Genome mining using antiSMASH 
Identification of novel antibiotics has become a major issue even though the number of 
antibiotics ubiquitous in nature may truly be large. A number of these antibiotics have already 
been well researched and may not be entirely useable due to either lacking desired 
pharmalogical properties or displaying low, weak or selective toxicity towards bacteria (Peleaz, 
2006). A number of microbiological approaches with the incorporation of genetic, structural 
and bioinformatics methods have been developed to deal with this issue and molecular 
screening has become invaluable to determine the chemical diversity of a microorganism via 
the detection of secondary metabolite biosynthetic genes.  
Strain CZA14T was chosen as an antimicrobial producer in this study as it showed weak 
antibiosis against Mycobacterium aurum A+, Bacillus coagulans ATCC 7050T and Acinetobacter 
calcoaceticus strain C91 (le Roes and Meyers, 2005). It is a Gram-positive, aerobic actinomycete 
capable of producing spores, green aerial mycelium and yellow-blue substrate mycelium when 
cultured on ISP 4 (inorganic salts- starch agar) as well as ISP #2, and melanin which is associated 
with secondary metabolite activity (le Roes and Meyers, 2005). Le Roes and Meyers (2005) 
reported that the substrate mycelium colour is dependent on the medium CZA14T is cultured 
in/on, but the colour of the aerial mycelial remains constant.  
Actinomycetes have relatively large genomes compared to other bacteria and are the most 
prolific antibiotic producers with about 10% of all genes used during the production of 
secondary metabolites, such as polyketides and non-ribosomal peptides (Donadio et al., 2007; 
Baltz, 2008).  
Based on genome sequencing, certain microorganisms, especially actinomycetes, have been 
shown to contain 20 or more biosynthetic gene clusters (Davies, 2011). In this study antiSMASH 
was used to mine the genome of strain CZA14T for biosynthetic gene clusters to determine its 
potential to produce antimicrobials. Fifty five biosynthetic gene clusters were detected 
(Appendix P, Table P1) with eight being PKSs (Table 6.1). This was accomplished by comparing 
individual genes in the CZA14T genome against a collection of profile Hidden Markov Models 
(pHMMs) that was manually curated. Key biosynthetic enzymes of the NRPS and PKS classes 
detectable by antiSMASH are described by these pHMMs with the use of HMMer3 software 
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(Eddy, 2011). Furthermore, individual gene clusters encoding key enzymes are assigned to 
secondary metabolite-specific Clusters of Orthologous Groups 32 (smCOGs) and a core 
chemical structure of the putative biosynthetic compound based on the data within antiSMASH 
was generated and displayed as an output file (Blin et al., 2013). AntiSMASH was chosen over 
other bioinformatics tools such as Clust Scanner (ClustScan), sequence analysis of polyketide 
synthases (SBSPKS) toolbox and NP.searcher, as the aforementioned bioinformatics tools are 
unfortunately largely limited to the analyses of NRPS and type I PKS clusters. Whereas, 
AntiSMASH identifies core genes as well as accessory genes for many other secondary 
metabolite platforms. AntiSMASH provides rapid and accurate detection of all known classes of 
secondary metabolite biosynthetic gene clusters (smBGCs), as well as predict PKS and NRPS 
product chemical structures and provide PKS and NRPS functional annotation with higher 
accuracy compared to existing techniques (Blin et al., 2013).   
Polyketides are generated by the assembly of large synthetases in a modular form. These 
modules consist of multiple domains each of which are able to catalyse a sequential reaction 
step (e.g. condensation, tailoring or building block activation) or recognizing a particular 
substrate (Walsh and Fischbach, 2010). Based on the fact that polyketides are templated, 
genomic loci that encode for biosynthetic pathways are easily identified by bioinformatics tools. 
This may provide clues to the properties and structure of natural products essential in the 
development of methods for their detection as well as their isolation.  
Whilst there are a large number of NRPSs predicted by antiSMASH only eight PKSs were 
predicted (Table 6.1). γ-butyrolactones are produced by a large number of streptomycetes 
(Horinouchi and Beppu, 1992) and are involved in the initiation of secondary metabolism in 
several species. Type I, II, III and hybrid PKSs has been described in Chapter 2 and little is known 
about type IV/other KS (some parts of this paragraph was adapted from Durrell, 2013, honours 
thesis).  
Using a combination of bioinformatics tools, antiSMASH and molecular techniques such as PCR; 
the genes governing the expression of curamycin A, a type-II PKS or a spore pigment was 
detected. Multi-enzyme type-II PKS, catalyzes the biosynthesis of an array of aromatic 
polyketide therapeutic agents (Shapiro, 1989). In this study, the primer pair ARO-PKS-F/ARO-
PKS-R for detection of type-II PKS genes was used and amplified a fragment of approximately 
630 bp for the ALR samples collected at days 0 and 12. The detection of amplified product at 
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day 0 could be a result of sporulation occurring in the ISP #2 pre-culture prior to inoculation of 
the ALR. According to Wood et al. (2007), depending on the bacterium tested, a fragment of 
492 – 630 bp is expected. Furthermore, the amplification of an α-ketoacyl synthase (KSα) – β 
ketoacyl synthase (KSβ) fragment which is involved in genes for the synthesis of a spore-
pigment is dependent on the primers used. Mono-functional proteins are involved in the 
synthesis of aromatic polyketides, these proteins contain catalytic activities. This is evident in 
Table 6.2, whereby the functional gene – polyketide chain length factor WhiE-CLF is involved in 
the biosynthesis of the type-II PKS by CZA14T. This gene is found on the spore pigment cluster in 
actinomycetes. In CZA14T, this gene is located on contig 196 (14 308 nucleotides (nt) in length), 
starting at 4101 nt and stops at 5342 nt on the positive strand of the CZA14T dsDNA.  
According to the antiSMASH data, 100% of CZA14T genes show homology to a curamycin 
biosynthetic gene cluster as well as the spore pigment biosynthetic gene cluster from 
Streptomyces glaucescens strain GLA (Figure 6.3).  
The antiSMASH and PCR screening of the Type-II PKS is indicative of CZA14T’s potential to 
possess genes which are necessary for the biosynthesis of that type of antimicrobial. It is only 
after purification and elucidation of the antimicrobials molecular structure which determines 
the identity of that antimicrobial. The optimal medium for maximum antimicrobial production 
by CZA14T used in this study supported the production of curamycin A and is discussed in 
greater detail below.  
Tentative Identification of curamycin A via Liquid Chromatography/Mass Spectrometry 
(LC/MS)  
AntiSMASH analysis of the CZA14T genome and PCR screening for Type-II PKS biosynthetic gene 
clusters from fermentation broth from the ALR in which CZA14T was cultured,  showed that 
CZA14T possess the biosynthetic genes for the production of Type-II PKS and produces 
curamycin A when cultured in optimal production medium 153 + glycerol, pH 6.0 at 30°C. 
Extracellularly produced compounds partially purified using A/S precipitation, dialysis and 
EtOAc solvent extraction were subjected to LC/MS analysis to determine the production of 
curamycin A by CZA14T. Curamycin A has a molecular formula of C59H84Cl2O32 and a molecular 
weight of 1376.18506 g/mol 
(http://pubchem.ncbi.nlm.nih.gov/compound/71587265#section=Top). This compound has an 
exact mass of 1374.432276 g/mol. The compound produced by CZA14T was derived in the 
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positive mode only. A compound with an exact mass of 1375. 8 m/z was detected from the 
mass spectra presented in Figure 6.7. Positive ion mode data was adjusted accordingly by 
adding a Na atom and subtracting an electron producing a compound with an m/z of 1374. 8.  
The differences in exact mass by 0.4 m/z could be as a result of minor differences in the 
chemical and physicochemical properties of the compound or due to calibration inefficiencies 
of the LC/MS. Curamycin A is highly active against a number of Gram positive microorganisms. 
This PK antibiotic can inhibit the growth of S. aureus, B. subtilis, Streptococcus pyogenes, 
Streptococcus faecalis, Neissera gonorrheae, Lactobacillus acidophilus, Streptococcus 
agalactiae, Streptococcus haemolyticus and Bacillus polymyxa at concentrations as low as 0.5 
mcg/mL. Curamycin does not inhibit the growth of Gram-negative bacteria Escherichia coli, 
Aerobacter aerogenes, Proteus vulgaris, Salmonella schottmulleri, P. aeruginosa and K. 
pneumoniae even at concentrations as high as 50 mcg/mL. In this study, the sample labelled as 
“PP” containing the isolated compound, curamycin, was active against K. pneumoniae and P. 
aeruginosa DRWH system isolates during the bioautography assay. This suggests that more 
than one compound (including curamycin A) was isolated during solvent extraction and 
purification processes (Cataldi et al., 1962).    
6.5. CONCLUSION 
AntiSMASH prediction software predicted a total of fifty-five biosynthetic gene clusters of 
which eight were PKSs. Predicting genes which govern the expression of compounds produced 
by S. pharetrae CZA14T prior to fermentation studies showed to be advantageous as it aided in 
the design of media for the expression and identification of a Type-II PKS biosynthetic gene 
cluster. Along with molecular techniques, CZA14T showed 100% homology to curamycin A via 
antiSMASH; this was confirmed by PCR.  Although curamycin A was rediscovered and produced 
by CZA14T in this study, CZA14T possess a number of biosynthetic genes and the genetic 
information of strain CZA14T has shown that these natural resources with regards to their 
metabolite production capabilities, have been seriously underestimated: the number of 
compounds produced under laboratory conditions (Chapter 3) are lower than the amount of 
biosynthetic gene clusters predicted by antiSMASH (Appendix A, Table 8.1). Salt purified 
compounds were tentatively identified using LC/MS analysis and a compound with an exact 
mass of 1376.18506 g/mol was detected. This compound was identified by mass as Curamycin 
A, a type II PK antimicrobial.  
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Concluding remarks and 
recommendations 
  




Pre-screening actinomycete genomes using bioinformatics tools such as antiSMASH and 
molecular techniques such as PCR prior to the commencement of fermentation studies provide 
a reliable indicator of the biosynthetic potential of the producing strain. CZA14T contains a 
number of secondary metabolite biosynthetic gene clusters (smBGCs), some of which were 
expressed during this study. One of these were a Type-II polyketide (PK) named curamycin A as 
determined using PCR and LC/MS. The production of these compounds were favoured due to 
constituents in the liquid media. Antimicrobial bioassays used in this study successfully 
detected highly active products containing antibacterial and antifungal activity. Partially 
purified extracts were active against most of the domestic rainwater harvesting (DRWH) system 
isolates used in this study. Further antimicrobial assays such as minimal inhibitory 
concentrations (MICs) will be tested in future. This was not performed during this study due to 
low volume of extracts and time constraints. UV/Vis spectroscopic studies and various TLC 
staining methods were used in characterising crude and partially purified extracts. Further 
purification and characterisation will be performed on these compounds as they exhibit broad-
spectrum activities against both American Type Culture Collection (ATCC) test strains and 
DRWH system isolates. Toxicity tests (e.g. in mouse or rat models) may be performed to 
ascertain whether these antimicrobials are safe to use in the treatment of infectious diseases 
caused by pathogenic bacteria found in DRWH systems and hospital settings where the clinical 
ATCC test strains were isolated.  
In conclusion, linking back my results with objectives of this study:  
Objective 1 
Optimize medium-scale (2L – 5L) production of antimicrobials produced by Streptomyces 
pharetrae CZA14T 
Conclusion 
The production of compounds of interest was favoured due to constituents in the liquid media 
as well as due to increased aeration in the airlift reactor (3 L). 
 
 




Test the inhibitory efficacy of crude extracts against ATCC test strains and DRWH system 
isolates 
Conclusion 
Results obtained during bioassay screening of compounds produced by CZA14T against 
rainwater harvesting system isolates were comparable to bio-activities detected against clinical 
ATCC isolates. However, more active compounds were produced during the culturing of CZA14T 
in the airlift reactor compared to the number of active compounds produced during culturing of 
CZA14T in the 2 L baffled flasks and continuous stirred tank reactor; this was confirmed by 
bioautography assays. 
Objective 3 
The partial purification of selected compounds and the determination of their antimicrobial 
profiles 
Conclusion 
Extracts partially purified by ammonium salt precipitation were active against all of the 
rainwater harvesting system isolates used in this study. Furthermore, exceeding the 
expectation of this study - it was found that predicting genes which govern the expression of 
compounds produced by CZA14T prior to fermentation studies showed to be advantageous as it 
aided in the design of media for the expression and tentative identification by LC/MS of a Type-
II PKS biosynthetic gene cluster and its product. Along with molecular techniques, CZA14T 
showed 100% homology of its genes to curamycin A via antiSMASH; this was confirmed by PCR.  
The bio-activities detected in this study may be a result of curamycin A along with other 
compounds extracted resulting in a synergistic effect. Although curamycin A was rediscovered 
and produced by CZA14T in this study, CZA14T possess a number of novel biosynthetic genes 
which may be explored in future. 
What makes this project unique? 
This project is unique as it is the first time CZA14T, a novel Streptomyces species, is explored for 
its biosynthetic potential related to its ability to produce antimicrobials. There is also no other 
Stellenbosch University  https://scholar.sun.ac.za
159 
 
research study that have focused on the determination of the bio-activity of antimicrobials 
produced by a Streptomyces species against pathogens isolated from rainwater harvesting 
systems. 
Future work and Recommendations 
 Genome mining has become increasingly inexpensive over the past decade – further 
analysis of the genome by other bioinformatics tools and molecular techniques (i.e. DNA 
probes for detection of ‘silent’ biosynthetic gene clusters) to aid in the discovery of 
novel natural products may be performed in future 
 Other fermentation vessels, optimisation of currently used fermentation vessels in this 
study, and solid state fermentation may be explored to produce chemically different 
natural products 
 Further purification of selected compounds using column chromatography methods (i.e. 
high performance liquid chromatography (HPLC) – preparative HPLC), precipitation and 
extraction methods may be performed 
 The use of heterologous/homologous hosts to express gene clusters of interest 
containing silent phenotypes 
 High-throughput techniques such as mass-spectroscopy and near-infrared spectroscopy 
to discover novel secondary metabolites 
 Co-culturing of antibiotic-producing microorganisms with a target pathogen to 
accelerate evolution of the producer’s ability to biosynthesize a chemical product that 
completely inhibits the growth of the target pathogen  
  












Flat-bottom flask vs baffled flask optimisation in 0.5 L flask volume 
 
Figure A1: Developed TLC visualised under short wave 254 nm ultraviolet light. Ethyl acetate extracts 
separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). 500 ml Flat-bottom flask vs baffled flask optimisation tests with S. pharetrae sp. 
strain CZA14T cultured in 153 + glycerol, pH 6.0, 30 °C at 160 rpm for 3 – 10 days. Lane 1 and 2: EtOAc 
extracts – from supernatant filtrate (SNF), day 3, flat-bottom flask. Lane 3 and 4: EtOAc extracts – from 
SNF, day 3, baffled flask. Lane 5 and 6: EtOAc extracts – from SNF, day 5, flat-bottom flask. Lane 7 and 8: 
EtOAc extracts – from SNF, day 10, baffled flask. Lane 9 and 10: EtOAc extracts – from SNF, day 7, flat-
bottom flask. Lane 11 and 12: EtOAc extracts – from SNF, day 7, baffled flask. Lane 13 and 14: EtOAc 
extracts – from SNF, day 10, flat-bottom flask. Lane 15: EtOAc control. Lane 16 and 17: EtOAc extracts – 
from SNF, day 3, baffled flask. Lane 18: 153 + glycerol media control. 
  




Figure A2: Developed TLC visualised under long wave 365 nm ultraviolet light. Ethyl acetate extracts 
separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). 500 ml Flat-bottom flask vs baffled flask optimisation tests with S. pharetrae sp. 
strain CZA14T cultured in 153 + glycerol, pH 6.0, 30 °C at 160 rpm for 3 – 10 days. Lane 1 and 2: EtOAc 
extracts – from supernatant filtrate (SNF), day 3, flat-bottom flask. Lane 3 and 4: EtOAc extracts – from 
SNF, day 3, baffled flask. Lane 5 and 6: EtOAc extracts – from SNF,day 5, flat-bottom flask. Lane 7 and 8: 
EtOAc extracts – from SNF, day 10, baffled flask. Lane 9 and 10: EtOAc extracts – from SNF, day 7, flat-
bottom flask. Lane 11 and 12: EtOAc extracts – from SNF, day 7, baffled flask. Lane 13 and 14: EtOAc 
extracts – from SNF, day 10, flat-bottom flask. Lane 15: EtOAc control. Lane 16 and 17: EtOAc extracts – 
from SNF, day 3, baffled flask. Lane 18: 153 + glycerol media control.  
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Figure A3: Developed TLC visualised under short wave 254 nm ultraviolet light. Ethyl acetate extracts 
separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Flat-bottom flask vs baffled flask optimisation tests with S. pharetrae sp. strain 
CZA14T cultured in 153 + glycerol, pH 6.0, 30 °C at 160 rpm for 3 – 10 days. Lane 1 and 2: EtOAc extracts 
– from cell mass (cell), day 3, flat-bottom flask. Lane 3 and 4: EtOAc extracts – from cell, day 3, baffled 
flask. Lane 5 and 6: EtOAc extracts – from cell, day 5, flat-bottom flask. Lane 7 and 8: EtOAc extracts – 
from cell day 5, baffled flask. Lane 9 and 10: EtOAc extracts – from cell, day 7, flat-bottom flask. Lane 11 
and 12: EtOAc extracts – from cell, day 7, baffled flask. Lane 13 and 14: EtOAc extracts – from cell, day 
10, flat-bottom flask. Lane 15 and 16: EtOAc extracts – from cell, day 10, baffled flask. Lane 17: EtOAc 




Figure A4: Developed TLC visualised under short wave 254 nm ultraviolet light. Ethyl acetate extracts 
separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Flat-bottom flask vs baffled flask optimisation tests with S. pharetrae sp. strain 
CZA14T cultured in 153 + glycerol, pH 6.0, 30 °C at 160 rpm for 3 – 10 days. Lane 1 and 2: EtOAc extracts 
– from cell mass (cell), day 3, flat-bottom flask. Lane 3 and 4: EtOAc extracts – from cell, day 3, baffled 
flask. Lane 5 and 6: EtOAc extracts – from cell, day 5, flat-bottom flask. Lane 7 and 8: EtOAc extracts – 
from cell day 5, baffled flask. Lane 9 and 10: EtOAc extracts – from cell, day 7, flat-bottom flask. Lane 11 
and 12: EtOAc extracts – from cell, day 7, baffled flask. Lane 13 and 14: EtOAc extracts – from cell, day 
10, flat-bottom flask. Lane 15 and 16: EtOAc extracts – from cell, day 10, baffled flask. Lane 17: EtOAc 
control. Lane 18: 153 + glycerol control. 
 






Figure B1: An example to demonstrate the way in which Rf values are calculated. 
 
  




Optimisation of inoculum volume in 500 ml baffled flasks 
 
 
Figure C1: Developed TLC visualised under short wave 254 nm ultraviolet light. Ethyl acetate extracts 
separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Inoculum optimisation tests in 500 ml baffled flask with S. pharetrae sp. strain 
CZA14T cultured in 153 + glycerol, pH 6.0, 30 °C at 160 rpm for 3 – 10 days. Lane 1 and 2: EtOAc extracts 
– from supernatant filtrate (SNF), day 3, 5 % v/v inoculum vol. Lane 3: 153 + glycerol media control, day 
3, 95 ml media vol; Lane 4 and 5: EtOAc extracts – from supernatant filtrate (SNF), day 3, 10 % v/v 
inoculum vol. Lane 6: 153 + glycerol media control, day 3, 90 ml media vol; Lane 7 and 8: EtOAc extracts 
– from supernatant filtrate (SNF), day 3, 15 % v/v inoculum vol. Lane 9: 153 + glycerol media control, day 
3, 85 ml media vol; Lane 10 and 11: EtOAc extracts – from supernatant filtrate (SNF), day 3, 20 % v/v 
inoculum vol. Lane 12: 153 + glycerol media control, day 3, 80 ml media vol; Lane 13 and 14: EtOAc 
extracts – from supernatant filtrate (SNF), day 5, 5 % v/v inoculum vol. Lane 15: 153 + glycerol media 
control, day 5, 95 ml media vol; Lane 16 and 17: EtOAc extracts – from supernatant filtrate (SNF), day 5, 












Figure C2: Developed TLC visualised under long wave 365 nm ultraviolet light. Ethyl acetate extracts 
separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Inoculum optimisation tests in 500 ml baffled flask with S. pharetrae sp. strain 
CZA14T cultured in 153 + glycerol, pH 6.0, 30 °C at 160 rpm for 3 – 10 days. Lane 1 and 2: EtOAc extracts 
– from supernatant filtrate (SNF), day 3, 5 % v/v inoculum vol. Lane 3: 153 + glycerol media control, day 
3, 95 ml media vol; Lane 4 and 5: EtOAc extracts – from supernatant filtrate (SNF), day 3, 10 % v/v 
inoculum vol. Lane 6: 153 + glycerol media control, day 3, 90 ml media vol; Lane 7 and 8: EtOAc extracts 
– from supernatant filtrate (SNF), day 3, 15 % v/v inoculum vol. Lane 9: 153 + glycerol media control, day 
3, 85 ml media vol; Lane 10 and 11: EtOAc extracts – from supernatant filtrate (SNF), day 3, 20 % v/v 
inoculum vol. Lane 12: 153 + glycerol media control, day 3, 80 ml media vol; Lane 13 and 14: EtOAc 
extracts – from supernatant filtrate (SNF), day 5, 5 % v/v inoculum vol. Lane 15: 153 + glycerol media 
control, day 5, 95 ml media vol; Lane 16 and 17: EtOAc extracts – from supernatant filtrate (SNF), day 5, 
10 % v/v inoculum vol. Lane 18: 153 + glycerol media control, day 5, 90 ml media vol; Lane 19: EtOAc 
control. 
  




Figure C3: Developed TLC visualised under short wave 254 nm ultraviolet light. Ethyl acetate extracts 
separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Inoculum optimisation tests in 500 ml baffled flask with S. pharetrae sp. strain 
CZA14T cultured in 153 + glycerol, pH 6.0, 30 °C at 160 rpm for 3 – 10 days. Lane 1 and 2: EtOAc extracts 
– from supernatant filtrate (SNF), day 5, 15 % v/v inoculum vol. Lane 3: 153 + glycerol media control, day 
5, 85 ml media vol; Lane 4 and 5: EtOAc extracts – from supernatant filtrate (SNF), day 5, 20 % v/v 
inoculum vol. Lane 6: 153 + glycerol media control, day 5, 80 ml media vol; Lane 7 and 8: EtOAc extracts 
– from supernatant filtrate (SNF), day 7, 5 % v/v inoculum vol. Lane 9: 153 + glycerol media control, day 
7, 95 ml media vol; Lane 10 and 11: EtOAc extracts – from supernatant filtrate (SNF), day 7, 10 % v/v 
inoculum vol. Lane 12: 153 + glycerol media control, day 7, 90 ml media vol; Lane 13 and 14: EtOAc 
extracts – from supernatant filtrate (SNF), day 7, 15 % v/v inoculum vol. Lane 15: 153 + glycerol media 
control, day 7, 85 ml media vol; Lane 16 and 17: EtOAc extracts – from supernatant filtrate (SNF), day 7, 
20 % v/v inoculum vol. Lane 18: 153 + glycerol media control, day 7, 80 ml media vol; Lane 19: EtOAc 
control; Lane 21 and 22: EtOAc extracts – from supernatant filtrate (SNF), day 10, 5 % v/v inoculum vol. 
Lane 23: 153 + glycerol media control, day 10, 95 ml media vol; Lane 24 and 55: EtOAc extracts – from 
supernatant filtrate (SNF), day 10, 10 % v/v inoculum vol. Lane 26: 153 + glycerol media control, day 10, 
90 ml media vol; Lane 27 and 28: EtOAc extracts – from supernatant filtrate (SNF), day 10, 15 % v/v 
inoculum vol. Lane 29: 153 + glycerol media control, day 10, 85 ml media vol; Lane 30 and 31: EtOAc 
extracts – from supernatant filtrate (SNF), day 10, 20 % v/v inoculum vol. Lane 32: 153 + glycerol media 
control, day 10. 
 





Figure C4: Developed TLC visualised under long wave 365 nm ultraviolet light. Ethyl acetate extracts 
separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Inoculum optimisation tests in 500 ml baffled flask with S. pharetrae sp. strain 
CZA14T cultured in 153 + glycerol, pH 6.0, 30 °C at 160 rpm for 3 – 10 days. Lane 1 and 2: EtOAc extracts 
– from supernatant filtrate (SNF), day 5, 15 % v/v inoculum vol. Lane 3: 153 + glycerol media control, day 
5, 85 ml media vol; Lane 4 and 5: EtOAc extracts – from supernatant filtrate (SNF), day 5, 20 % v/v 
inoculum vol. Lane 6: 153 + glycerol media control, day 5, 80 ml media vol; Lane 7 and 8: EtOAc extracts 
– from supernatant filtrate (SNF), day 7, 5 % v/v inoculum vol. Lane 9: 153 + glycerol media control, day 
7, 95 ml media vol; Lane 10 and 11: EtOAc extracts – from supernatant filtrate (SNF), day 7, 10 % v/v 
inoculum vol. Lane 12: 153 + glycerol media control, day 7, 90 ml media vol; Lane 13 and 14: EtOAc 
extracts – from supernatant filtrate (SNF), day 7, 15 % v/v inoculum vol. Lane 15: 153 + glycerol media 
control, day 7, 85 ml media vol; Lane 16 and 17: EtOAc extracts – from supernatant filtrate (SNF), day 7, 
20 % v/v inoculum vol. Lane 18: 153 + glycerol media control, day 7, 80 ml media vol; Lane 19: EtOAc 
control; Lane 21 and 22: EtOAc extracts – from supernatant filtrate (SNF), day 10, 5 % v/v inoculum vol. 
Lane 23: 153 + glycerol media control, day 10, 95 ml media vol; Lane 24 and 25: EtOAc extracts – from 
supernatant filtrate (SNF), day 10, 10 % v/v inoculum vol. Lane 26: 153 + glycerol media control, day 10, 
90 ml media vol; Lane 27 and 28: EtOAc extracts – from supernatant filtrate (SNF), day 10, 15 % v/v 
inoculum vol. Lane 29: 153 + glycerol media control, day 10, 85 ml media vol; Lane 30 and 31: EtOAc 
extracts – from supernatant filtrate (SNF), day 10, 20 % v/v inoculum vol. Lane 32: 153 + glycerol media 
control, day 10. 
 




Figure C5: Developed TLC visualised under short wave 254 nm ultraviolet light. Ethyl acetate extracts 
separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Inoculum optimisation tests in 500 ml baffled flask with S. pharetrae sp. strain 
CZA14T cultured in 153 + glycerol, pH 6.0, 30 °C at 160 rpm for 3 – 10 days. Lane 1: 153 + glycerol media 
control, day 3, 95 ml media vol; Lane 2 and 3: EtOAc extracts – from cell mass (cell), day 3, 5 % v/v 
inoculum vol; Lane 4: 153 + glycerol media control, day 3, 90 ml media vol; Lane 5 and 6: EtOAc extracts 
– from cell mass (cell), day 3, 10 % v/v inoculum vol; Lane 7: EtOAc control; Lane 8: 153 + glycerol media 
control, day 3, 85 ml media vol; Lane 9 and 10: EtOAc extracts – from cell mass (cell), day 3, 15 % v/v 
inoculum vol; Lane 11: 153 + glycerol media control, day 3, 80 ml media vol; Lane 12 and 13: EtOAc 
extracts – from cell mass (cell), day 3, 20 % v/v inoculum vol. Lane 14: 153 + glycerol media control, day 
5, 95 ml media vol; Lane 15 and 16: EtOAc extracts – from cell mass (cell), day 5, 5 % v/v inoculum vol. 
Lane 17: 153 + glycerol media control, day 5, 90 ml media vol; Lane 18 and 19: EtOAc extracts – from cell 
mass (cell), day 5, 10 % v/v inoculum vol; Lane 20: 153 + glycerol media control, day 5, 85 ml media vol; 
Lane 21 and 22: EtOAc extracts – from cell mass (cell), day 5, 15 % v/v inoculum vol; Lane 23: 153 + 
glycerol media control, day 5, 80 ml media vol; Lane 24 and 25: EtOAc extracts – from cell mass (cell), 














Figure C6: Developed TLC visualised under long wave 365 nm ultraviolet light. Ethyl acetate extracts 
separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Inoculum optimisation tests in 500 ml baffled flask with S. pharetrae sp. strain 
CZA14T cultured in 153 + glycerol, pH 6.0, 30 °C at 160 rpm for 3 – 10 days. Lane 1: 153 + glycerol media 
control, day 3, 95 ml media vol; Lane 2 and 3: EtOAc extracts – from cell mass (cell), day 3, 5 % v/v 
inoculum vol; Lane 4: 153 + glycerol media control, day 3, 90 ml media vol; Lane 5 and 6: EtOAc extracts 
– from cell mass (cell), day 3, 10 % v/v inoculum vol; Lane 7: EtOAc control; Lane 8: 153 + glycerol media 
control, day 3, 85 ml media vol; Lane 9 and 10: EtOAc extracts – from cell mass (cell), day 3, 15 % v/v 
inoculum vol; Lane 11: 153 + glycerol media control, day 3, 80 ml media vol; Lane 12 and 13: EtOAc 
extracts – from cell mass (cell), day 3, 20 % v/v inoculum vol. Lane 14: 153 + glycerol media control, day 
5, 95 ml media vol; Lane 15 and 16: EtOAc extracts – from cell mass (cell), day 5, 5 % v/v inoculum vol. 
Lane 17: 153 + glycerol media control, day 5, 90 ml media vol; Lane 18 and 19: EtOAc extracts – from cell 
mass (cell), day 5, 10 % v/v inoculum vol; Lane 20: 153 + glycerol media control, day 5, 85 ml media vol; 
Lane 21 and 22: EtOAc extracts – from cell mass (cell), day 5,15 % v/v inoculum vol; Lane 23: 153 + 
glycerol media control, day 5, 80 ml media vol; Lane 24 and 25: EtOAc extracts – from cell mass (cell), 
day 5, 20 % v/v inoculum vol; Lane 26: EtOAc control. 
 
  




Figure C7: Developed TLC visualised under short wave 254 nm ultraviolet light. Ethyl acetate extracts 
separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Inoculum optimisation tests in 500 ml baffled flask with S. pharetrae sp. strain 
CZA14T cultured in 153 + glycerol, pH 6.0, 30 °C at 160 rpm for 3 – 10 days. Lane 1: 153 + glycerol media 
control, day 7, 95 ml media vol; Lane 2 and 3: EtOAc extracts – from cell mass (cell), day 7, 5 % v/v 
inoculum vol; Lane 4: 153 + glycerol media control, day 7, 90 ml media vol; Lane 5 and 6: EtOAc extracts 
– from cell mass (cell), day 7, 10 % v/v inoculum vol; Lane 7: EtOAc control; Lane 8: 153 + glycerol media 
control, day 7, 85 ml media vol; Lane 9 and 10: EtOAc extracts – from cell mass (cell), day 7, 15 % v/v 
inoculum vol; Lane 11: 153 + glycerol media control, day 7, 80 ml media vol; Lane 12 and 13: EtOAc 
extracts – from cell mass (cell), day 7, 20 % v/v inoculum vol. Lane 14: 153 + glycerol media control, day 
10, 95 ml media vol; Lane 15 and 16: EtOAc extracts – from cell mass (cell), day 10, 5 % v/v inoculum vol. 
Lane 17: 153 + glycerol media control, day 10, 90 ml media vol; Lane 18 and 19: EtOAc extracts – from 
cell mass (cell), day 10, 10 % v/v inoculum vol; Lane 20: 153 + glycerol media control, day 10, 85 ml 
media vol; Lane 21 and 22: EtOAc extracts – from cell mass (cell), day 10, 15 % v/v inoculum vol; Lane 
23: 153 + glycerol media control, day 10, 80 ml media vol; Lane 24 and 25: EtOAc extracts – from cell 








Figure C8: Developed TLC visualised under long wave 365 nm ultraviolet light. Ethyl acetate extracts 
separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Inoculum optimisation tests in 500 ml baffled flask with S. pharetrae sp. strain 
CZA14T cultured in 153 + glycerol, pH 6.0, 30 °C at 160 rpm for 3 – 10 days. Lane 1: 153 + glycerol media 
control, day 7, 95 ml media vol; Lane 2 and 3: EtOAc extracts – from cell mass (cell), day 7, 5 % v/v 
inoculum vol; Lane 4: 153 + glycerol media control, day 7, 90 ml media vol; Lane 5 and 6: EtOAc extracts 
– from cell mass (cell), day 7, 10 % v/v inoculum vol; Lane 7: EtOAc control; Lane 8: 153 + glycerol media 
control, day 7, 85 ml media vol; Lane 9 and 10: EtOAc extracts – from cell mass (cell), day 7, 15 % v/v 
inoculum vol; Lane 11: 153 + glycerol media control, day 7, 80 ml media vol; Lane 12 and 13: EtOAc 
extracts – from cell mass (cell), day 7, 20 % v/v inoculum vol. Lane 14: 153 + glycerol media control, day 
10, 95 ml media vol; Lane 15 and 16: EtOAc extracts – from cell mass (cell), day 10, 5 % v/v inoculum vol. 
Lane 17: 153 + glycerol media control, day 10, 90 ml media vol; Lane 18 and 19: EtOAc extracts – from 
cell mass (cell), day 10, 10 % v/v inoculum vol; Lane 20: 153 + glycerol media control, day 10, 85 ml 
media vol; Lane 21 and 22: EtOAc extracts – from cell mass (cell), day 10, 15 % v/v inoculum vol; Lane 
23: 153 + glycerol media control, day 10, 80 ml media vol; Lane 24 and 25: EtOAc extracts – from cell 
mass (cell), day 10, 20 % v/v inoculum vol; Lane 26: EtOAc control. 
 
  




1 litre and 2 litre baffled flask optimisation 
 
 
Figure D1: Developed TLC visualised under short wave 254 nm ultraviolet light. Ethyl acetate extracts 
separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Testing the effects of scale-up from 500 ml to 1 litre baffled flasks on antimicrobial 
production by S. pharetrae sp. strain CZA14T cultured in 153 + glycerol, pH 6.0, 30 °C at 160 rpm for 3 – 
10 days. Lane 1 and 2: EtOAc extracts – from supernatant filtrate (SNF), day 3 in duplicate. Lanes 3 and 
4: EtOAc extracts – from SNF, day 5 in duplicate. Lanes 5 and 6: EtOAc extracts – from SNF, day 7 in 
duplicate. Lanes 7 and 8: EtOAc extracts – from SNF, day 10 in duplicate. Lane 9: 153 + glycerol, pH 6.0 
media control. Lanes 10 and 11: EtOAc extracts – from cell mass (cell), day 3 in duplicate. Lanes 12 and 
13: EtOAc extracts – from cell, day 5 in duplicate. Lanes 14 and 15:  EtOAc extracts – from cell, day 7 in 
duplicate. Lanes 16 and 17: EtOAc extracts – from cell, day 10 in duplicate. Lane 18: 153 + glycerol, pH 
6.0 media control. Lane 19: EtOAc control. 




Figure D2: Developed TLC visualised under long wave 365 nm ultraviolet light. Ethyl acetate extracts 
separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Testing the effects of scale-up from 500 ml to 1 litre baffled flasks on antimicrobial 
production by S. pharetrae sp. strain CZA14T cultured in 153 + glycerol, pH 6.0, 30 °C at 160 rpm for 3 – 
10 days. Lane 1 and 2: EtOAc extracts – from supernatant filtrate (SNF), day 3 in duplicate. Lanes 3 and 
4: EtOAc extracts – from SNF, day 5 in duplicate. Lanes 5 and 6: EtOAc extracts – from SNF, day 7 in 
duplicate. Lanes 7 and 8: EtOAc extracts – from SNF, day 10 in duplicate. Lane 9: 153 + glycerol, pH 6.0 
media control. Lanes 10 and 11: EtOAc extracts – from cell mass (cell), day 3 in duplicate. Lanes 12 and 
13: EtOAc extracts – from cell, day 5 in duplicate. Lanes 14 and 15:  EtOAc extracts – from cell, day 7 in 
duplicate. Lanes 16 and 17: EtOAc extracts – from cell, day 10 in duplicate. Lane 18: 153 + glycerol, pH 
6.0 media control. Lane 19: EtOAc control. 
  




Figure D3: Developed TLC visualised under short wave 254 nm ultraviolet light. Ethyl acetate extracts 
separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Testing the effects of scale-up from 1 litre to 2 litre baffled flasks on antimicrobial 
production by S. pharetrae sp. strain CZA14T cultured in 153 + glycerol, pH 6.0, 30 °C at 160 rpm for 3 – 
10 days.. Lane 1 and 2: EtOAc extracts – from supernatant filtrate (SNF), day 3 in duplicate. Lanes 3 and 
4: EtOAc extracts – from SNF, day 5 in duplicate. Lanes 5 and 6: EtOAc extracts – from SNF, day 7 in 
duplicate. Lanes 7 and 8: EtOAc extracts – from SNF, day 10 in duplicate. Lane 9: 153 + glycerol, pH 6.0 
media control. Lanes 10 and 11: EtOAc extracts – from cell mass (cell), day 3 in duplicate. Lanes 12 and 
13: EtOAc extracts – from cell, day 5 in duplicate. Lanes 14 and 15:  EtOAc extracts – from cell, day 7 in 
duplicate. Lanes 16 and 17: EtOAc extracts – from cell, day 10 in duplicate. Lane 18: 153 + glycerol, pH 
















Figure D4: Developed TLC visualised under long wave 365 nm ultraviolet light. Ethyl acetate extracts 
separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Testing the effects of scale-up from 1 litre to 2 litre baffled flasks on antimicrobial 
production by S. pharetrae sp. strain CZA14T cultured in 153 + glycerol, pH 6.0, 30 °C at 160 rpm for 3 – 
10 days.. Lane 1 and 2: EtOAc extracts – from supernatant filtrate (SNF), day 3 in duplicate. Lanes 3 and 
4: EtOAc extracts – from SNF, day 5 in duplicate. Lanes 5 and 6: EtOAc extracts – from SNF, day 7 in 
duplicate. Lanes 7 and 8: EtOAc extracts – from SNF, day 10 in duplicate. Lane 9: 153 + glycerol, pH 6.0 
media control. Lanes 10 and 11: EtOAc extracts – from cell mass (cell), day 3 in duplicate. Lanes 12 and 
13: EtOAc extracts – from cell, day 5 in duplicate. Lanes 14 and 15:  EtOAc extracts – from cell, day 7 in 
duplicate. Lanes 16 and 17: EtOAc extracts – from cell, day 10 in duplicate. Lane 18: 153 + glycerol, pH 
















Airlift reactor (ALR) fermentation optimisation 
 
Figure E1: Developed TLC visualised under short wave 254 nm ultraviolet light. Ethyl acetate extracts 
separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Antimicrobial production by S. pharetrae sp. strain CZA14T in an airlift bioreactor 
cultured in 153 + glycerol, pH 6.0, 30 °C at 160 rpm for 0 – 20 days. Lane 1: EtOAc extracts – from 
supernatant filtrate (SNF), day 3. Lanes 2: EtOAc extracts – from cell mass (cell), day 3. Lane 1: EtOAc 
extracts – from supernatant filtrate (SNF), day 3. Lanes 2: EtOAc extracts – from cell mass (cell), day 3. 
Lane 3: EtOAc extracts – from supernatant filtrate (SNF), day 5. Lanes 4: EtOAc extracts – from cell mass 
(cell), day 5. Lane 5: EtOAc extracts – from supernatant filtrate (SNF), day 7. Lanes 6: EtOAc extracts – 
from cell mass (cell), day 7. Lane 7: EtOAc extracts – from supernatant filtrate (SNF), day 10. Lanes 8: 
EtOAc extracts – from cell mass (cell), day 10. Lane 9: EtOAc extracts – from supernatant filtrate (SNF), 
day 13. Lanes 10: EtOAc extracts – from cell mass (cell), day 13. Lane 11: EtOAc extracts – from 
supernatant filtrate (SNF), day 15. Lanes 12: EtOAc extracts – from cell mass (cell), day 15. Lane 13: 
EtOAc extracts – from supernatant filtrate (SNF), day 17. Lanes 14: EtOAc extracts – from cell mass (cell), 
day 17. Lane 15: EtOAc extracts – from supernatant filtrate (SNF), day 20. Lanes 16: EtOAc extracts – 









Continuous stirred tank reactor (CSTR) fermentation optimisation 
 
Figure F1: Developed TLC visualised under short wave 254 nm ultraviolet light. Ethyl acetate extracts 
separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Antimicrobial production by S. pharetrae sp. strain CZA14T in a continuous stirred 
tank reactor (CSTR) cultured in 153 + glycerol, pH 6.0, 30 °C at 160 rpm for 0 – 20 days. Lane 1: EtOAc 
extracts – from supernatant filtrate (SNF), day 3. Lanes 2: EtOAc extracts – from cell mass (cell), day 3. 
Lane 1: EtOAc extracts – from supernatant filtrate (SNF), day 3. Lanes 2: EtOAc extracts – from cell mass 
(cell), day 3. Lane 3: EtOAc extracts – from supernatant filtrate (SNF), day 5. Lanes 4: EtOAc extracts – 
from cell mass (cell), day 5. Lane 5: EtOAc extracts – from supernatant filtrate (SNF), day 7. Lanes 6: 
EtOAc extracts – from cell mass (cell), day 7. Lane 7: EtOAc extracts – from supernatant filtrate (SNF), 
day 10. Lanes 8: EtOAc extracts – from cell mass (cell), day 10. Lane 9: EtOAc extracts – from 
supernatant filtrate (SNF), day 13. Lanes 10: EtOAc extracts – from cell mass (cell), day 13. Lane 11: 
EtOAc extracts – from supernatant filtrate (SNF), day 15. Lanes 12: EtOAc extracts – from cell mass (cell), 
day 15. Lane 13: EtOAc extracts – from supernatant filtrate (SNF), day 17. Lanes 14: EtOAc extracts – 
from cell mass (cell), day 17. Lane 15: EtOAc extracts – from supernatant filtrate (SNF), day 20. Lanes 16: 








DNA isolation of Domestic Rainwater Harvesting (DRWH) test strains for the identification of 
these strains to genus level using phylogenetic analysis 
 
Figure G1: 1 % TAE agarose gel electrophoretogram of DNA extracted from DRWH isolates – Lanes 1 and 
25: 1kb Kapa Biosystems universal molecular weight marker; Lanes 2-3: DNA isolated from B. cereus; 
Lanes 4-5: DNA isolated from S. aureus 1; Lanes 6-7: DNA isolated from S. aureus 2; Lanes 8-9: DNA 
isolated from  S. aureus 4; Lanes 10-11: DNA isolated from S. aureus 5; Lanes 12-13: DNA isolated from 
E. cloacae 11; Lanes 14-15: DNA isolated from E. cloacae 20; Lanes 16-17: DNA isolated from E. cloacae 
22; Lanes 18-19: DNA isolated from  E. faecalis C513; Lanes 20-21: DNA isolated from  K. pneumonia 1; 











Figure G2: 1 % TAE agarose gel electrophoretogram of DNA extracted from DRWH isolates – Lanes 1 and 
10: 1kb Kapa Biosystems universal molecular weight marker; Lanes 3-4: DNA isolated from S. enterica 
















Bioautography assay of crude extract from the SNF and cell mass extracted from 
fermentation broth from 2 L baffled flasks, CSTR and ALR 
ATCC clinical control strains 
 
Figure H1: Bacillus cereus ATCC 10876 - Lanes 1-2: EtOAc extract from ALR fermentation, SNF; Lanes 3-4: 
EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR fermentation, SNF; 
Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc extract from 2 L baffled 
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Figure H2: Salmonella enterica subsp. arizonae ATCC 13314 - Lanes 1-2: EtOAc extract from ALR 
fermentation, SNF; Lanes 3-4: EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract 
from CSTR fermentation, SNF; Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: 
EtOAc extract from 2 L baffled flask fermentation, SNF; and Lanes 11-12: EtOAc extract from 2 L baffled 
flask fermentation, cell mass. 
 
 
Figure H3: Eschericia coli ATCC 25922 - Lanes 1-2: EtOAc extract from ALR fermentation, SNF; Lanes 3-4: 
EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR fermentation, SNF; 
Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc extract from 2 L baffled 
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Figure H4: Pseudomonas aeruginosa ATCC 27853 - Lanes 1-2: EtOAc extract from ALR fermentation, 
SNF; Lanes 3-4: EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR 
fermentation, SNF; Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc 
extract from 2 L baffled flask fermentation, SNF; and Lanes 11-12: EtOAc extract from 2 L baffled flask 




Figure H5: Klebsiella pneumonia subsp. pneumonia ATCC 700603 - Lanes 1-2: EtOAc extract from ALR 
fermentation, SNF; Lanes 3-4: EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract 
from CSTR fermentation, SNF; Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: 
EtOAc extract from 2 L baffled flask fermentation, SNF; and Lanes 11-12: EtOAc extract from 2 L baffled 
flask fermentation, cell mass. 
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Figure H6: Staphylococcus aureus subsp. aureus ATCC 29213 - Lanes 1-2: EtOAc extract from ALR 
fermentation, SNF; Lanes 3-4: EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract 
from CSTR fermentation, SNF; Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: 
EtOAc extract from 2 L baffled flask fermentation, SNF; and Lanes 11-12: EtOAc extract from 2 L baffled 
flask fermentation, cell mass. 
 
 
Figure H7: Staphylococcus aureus subsp. aureus ATCC 33591 - Lanes 1-2: EtOAc extract from ALR 
fermentation, SNF; Lanes 3-4: EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract 
from CSTR fermentation, SNF; Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: 
EtOAc extract from 2 L baffled flask fermentation, SNF; and Lanes 11-12: EtOAc extract from 2 L baffled 
flask fermentation, cell mass. 
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Figure H8: Enterococcus faecalis ATCC 29212 - Lanes 1-2: EtOAc extract from ALR fermentation, SNF; 
Lanes 3-4: EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR 
fermentation, SNF; Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc 
extract from 2 L baffled flask fermentation, SNF; and Lanes 11-12: EtOAc extract from 2 L baffled flask 




Figure H9: Enterococcus faecalis ATCC 51299 - Lanes 1-2: EtOAc extract from ALR fermentation, SNF; 
Lanes 3-4: EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR 
fermentation, SNF; Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc 
extract from 2 L baffled flask fermentation, SNF; and Lanes 11-12: EtOAc extract from 2 L baffled flask 
fermentation, cell mass.  
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Figure H10: Enterobacter cloacae subsp. cloacae ATCC BAA-1143 - Lanes 1-2: EtOAc extract from ALR 
fermentation, SNF; Lanes 3-4: EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract 
from CSTR fermentation, SNF; Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: 
EtOAc extract from 2 L baffled flask fermentation, SNF; and Lanes 11-12: EtOAc extract from 2 L baffled 




Figure H11: Candida krusei ATCC 34135 - Lanes 1-2: EtOAc extract from ALR fermentation, SNF; Lanes 3-
4: EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR fermentation, 
SNF; Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc extract from 2 L 
baffled flask fermentation, SNF; and Lanes 11-12: EtOAc extract from 2 L baffled flask fermentation, cell 
mass. 
 
Environmental DRWH isolates 
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Figure H12: Bacillus cereus - Lanes 1-2: EtOAc extract from ALR fermentation, SNF; Lanes 3-4: EtOAc 
extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR fermentation, SNF; Lanes 
7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc extract from 2 L baffled flask 
fermentation, SNF; and Lanes 11-12: EtOAc extract from 2 L baffled flask fermentation, cell mass. 
 
 
Figure H13: Salmonella enterica 4C - Lanes 1-2: EtOAc extract from ALR fermentation, SNF; Lanes 3-4: 
EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR fermentation, SNF; 
Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc extract from 2 L baffled 
flask fermentation, SNF; and Lanes 11-12: EtOAc extract from 2 L baffled flask fermentation, cell mass. 
 
 
Figure H14: Escherichia coli K4 CCA - Lanes 1-2: EtOAc extract from ALR fermentation, SNF; Lanes 3-4: 
EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR fermentation, SNF; 
Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc extract from 2 L baffled 
flask fermentation, SNF; and Lanes 11-12: EtOAc extract from 2 L baffled flask fermentation, cell mass. 
 




Figure H15: Pseudomonas aeruginosa - Lanes 1-2: EtOAc extract from ALR fermentation, SNF; Lanes 3-4: 
EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR fermentation, SNF; 
Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc extract from 2 L baffled 




Figure H16: Klebsiella pneumonia 1 - Lanes 1-2: EtOAc extract from ALR fermentation, SNF; Lanes 3-4: 
EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR fermentation, SNF; 
Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc extract from 2 L baffled 








Figure H17: Klebsiella pneumonia 3 - Lanes 1-2: EtOAc extract from ALR fermentation, SNF; Lanes 3-4: 
EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR fermentation, SNF; 
Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc extract from 2 L baffled 




Figure H18: Staphylococcus aureus 1 - Lanes 1-2: EtOAc extract from ALR fermentation, SNF; Lanes 3-4: 
EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR fermentation, SNF; 
Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc extract from 2 L baffled 








Figure H19: Staphylococcus aureus 2 - Lanes 1-2: EtOAc extract from ALR fermentation, SNF; Lanes 3-4: 
EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR fermentation, SNF; 
Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc extract from 2 L baffled 
flask fermentation, SNF; and Lanes 11-12: EtOAc extract from 2 L baffled flask fermentation, cell mass. 
 
 
Figure H20: Staphylococcus aureus 4 - Lanes 1-2: EtOAc extract from ALR fermentation, SNF; Lanes 3-4: 
EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR fermentation, SNF; 
Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc extract from 2 L baffled 
flask fermentation, SNF; and Lanes 11-12: EtOAc extract from 2L baffled flask fermentation, cell mass.  
  




Figure H21: Staphylococcus aureus 5 - Lanes 1-2: EtOAc extract from ALR fermentation, SNF; Lanes 3-4: 
EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR fermentation, SNF; 
Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc extract from 2 L baffled 
flask fermentation, SNF; and Lanes 11-12: EtOAc extract from 2 L baffled flask fermentation, cell mass. 
 
 
Figure H22: Enterococcus faecalis C513 - Lanes 1-2: EtOAc extract from ALR fermentation, SNF; Lanes 3-
4: EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR fermentation, 
SNF; Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc extract from 2 L 









Figure H23: Enterobacter cloacae 11 - Lanes 1-2: EtOAc extract from ALR fermentation, SNF; Lanes 3-4: 
EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR fermentation, SNF; 
Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc extract from 2 L baffled 
flask fermentation, SNF; and Lanes 11-12: EtOAc extract from 2 L baffled flask fermentation, cell mass. 
 
 
Figure H24: Enterobacter cloacae 20 - Lanes 1-2: EtOAc extract from ALR fermentation, SNF; Lanes 3-4: 
EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR fermentation, SNF; 
Lanes 7-8:  EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc extract from 2 L baffled 








Figure H25: Enterobacter cloacae 22 - Lanes 1-2: EtOAc extract from ALR fermentation, SNF; Lanes 3-4: 
EtOAc extract from ALR fermentation, cell mass; Lanes 5-6: EtOAc extract from CSTR fermentation, SNF; 
Lanes 7-8: EtOAc extract from CSTR fermentation, cell mass; Lanes 9-10: EtOAc extract from 2L baffled 
















Partial purification of antimicrobials produced extracellularly by Streptomyces pharetrae sp. 
strain CZA14T in an airlift reactor  
Bradford’s assay to quantify the total protein content in partially purified samples 
 
 
Figure I1: Standard curve of Abs620nm vs protein concentration of standards constructed and used to 














SDS – PAGE:  
*prepared 10 % w/v SDS, 10 % w/v ammonium persulphate (AMPS) 
Gel: 
16 % resolving gel (10 mL volume):  
2.1 mL dH2O; 5.3 mL 30 % acrylamide/bis-acrylamide (29.2g acrylamide and 0.8 g bis-
acrylamide in 100 ml dH2O); 2.5 mL 1.5 M Tris-HCl, pH 8.8; 0.1 mL 10 % w/v SDS; 0.05 mL 10 % 
AMPS; and 0.005 mL TEMED 
4 % stacking gel (10 mL volume): 
6.1 mL dH2O; 1.3 mL 30 % acrylamide/ bis-acrylamide; 2.5 mL 0.5 M Tris-HCl, pH 6.8; 0.1 mL 10 
% SDS; 0.05 mL 10 % AMPS; and 0.010 mL TEMED  
Sample loading buffer: 
3.55 mL dH2O; 1.25 mL 0.5 M Tris-HCl, pH 6.8; 2.5 mL glycerol; 2.0 mL 0.5 % w/v SDS and 0.5 % 
w/v bromophenol blue. 0.05 mL dithriothreitol (DTT) was added to a 9.5 mL loading buffer prior 
to use. 
10 x Electrode/running buffer: 
(g/L): 30.3 g Tris; 144.0 g glycine; 10.0 g SDS. Dissolve and bring to volume using dH2O. 10 x 
electrode buffer was diluted to 1 X concentration for the use during electrophoresis. 
Native – PAGE: 
10 % resolving gel (10 mL volume):   
4.2 mL dH2O; 3.3 mL 30 % acrylamide/ bis-acrylamide; 2.5 ml 1.5 M Tris-HCl, pH 8.8, 0.05 mL 10 
% AMPS; and 0.005 mL TEMED 
4 % stacking gel (10 mL volume): 
6.1 mL dH2O; 1.3 mL 30 % acrylamide/ bis-acrylamide; 2.5 mL 0.5 M Tris-HCl, pH 6.8; 0.05 mL 
10 % AMPS; and 0.010 mL TEMED  




Partial purification of supernatant filtrate (SNF) from airlift reactor fermentation broth using 
various solvents 




Figure K1: Developed TLC visualised under short 
wave 254 nm ultraviolet light. Benzene extracts 
separated using a solvent system consisting of 
chloroform: formic acid: ethyl acetate: n-
hexane (5:4:1:0.02 v/v/v/v). Lane 1: pH 3, Lane 
2: pH 4, Lane 3: pH 5, Lane 4: pH 6, Lane 5: pH 
7, Lane 6: pH 8, Lane 7: pH 9, Lane 8: Benzene 
solvent control. 
Figure K2: Developed TLC visualised under short 
wave 254 nm ultraviolet light. Chloroform 
extracts separated using a solvent system 
consisting of chloroform: formic acid: ethyl 
acetate: n-hexane (5:4:1:0.02 v/v/v/v). Lane 1: 
pH 3, Lane 2: pH 4, Lane 3: pH 5, Lane 4: pH 6, 












   
  
Figure K3: Developed TLC visualised under short 
wave 254 nm ultraviolet light. Dichloromethane 
extracts separated using a solvent system 
consisting of chloroform: formic acid: ethyl 
acetate: n-hexane (5:4:1:0.02 v/v/v/v). Lane 1: 
pH 3, Lane 2: pH 4, Lane 3: pH 5, Lane 4: pH 6, 
Lane 5: pH 7, Lane 6: pH 8, Lane 7: pH 9, Lane 8: 
dichloromethane solvent control. 
Figure K4: Developed TLC visualised under short 
wave 254 nm ultraviolet light. Ethyl acetate 
extracts separated using a solvent system 
consisting of chloroform: formic acid: ethyl 
acetate: n-hexane (5:4:1:0.02 v/v/v/v). Lane 1: 
pH 3, Lane 2: pH 4, Lane 3: pH 5, Lane 4: pH 6, 
Lane 5: pH 7, Lane 6: pH 8, Lane 7: pH 9, Lane 8: 
ethyl acetate solvent control. 
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Figure K5: Developed TLC visualised under short 
wave 254 nm ultraviolet light. N-butanol 
extracts separated using a solvent system 
consisting of chloroform: formic acid: ethyl 
acetate: n-hexane (5:4:1:0.02 v/v/v/v). Lane 1: 
pH 3, Lane 2: pH 4, Lane 3: pH 5, Lane 4: pH 6, 
Lane 5: pH 7, Lane 6: pH 8, Lane 7: pH 9, Lane 8: 
n-butanol solvent control. 
Figure K6: Developed TLC visualised under short 
wave 254 nm ultraviolet light. Petroleum ether 
extracts separated using a solvent system 
consisting of chloroform: formic acid: ethyl 
acetate: n-hexane (5:4:1:0.02 v/v/v/v). Lane 1: 
pH 3, Lane 2: pH 4, Lane 3: pH 5, Lane 4: pH 6, 
Lane 5: pH 7, Lane 6: pH 8, Lane 7: pH 9, Lane 8: 
petroleum ether solvent control. 
 
Bioautography assay on partially purified solvent extracts: 
 
 
Figure K7: S. aureus ATCC 33591 – Benzene 
solvent extracts: Lane 1: pH 3, Lane 2: pH 4, 
Lane 3: pH 5, Lane 4: pH 6, Lane 5: pH 7, Lane 6: 
pH 8, Lane 7: pH 9. 
Figure K8: S. aureus 4 (DRW isolate) – Benzene 
solvent extracts: Lane 1: pH 3, Lane 2: pH 4, 
Lane 3: pH 5, Lane 4: pH 6, Lane 5: pH 7, Lane 6: 
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Figure K9: S. aureus ATCC 33591 – Chloroform 
solvent extracts: Lane 1: pH 3, Lane 2: pH 4, 
Lane 3: pH 5, Lane 4: pH 6, Lane 5: pH 7, Lane 6: 
pH 8, Lane 7: pH 9. 
Figure K10: S. aureus 4 (DRW isolate) – 
Chloroform solvent extracts: Lane 1: pH 3, Lane 
2: pH 4, Lane 3: pH 5, Lane 4: pH 6, Lane 5: pH 
7, Lane 6: pH 8, Lane 7: pH 9. 
 
  
Figure K11: S. aureus ATCC 33591 – 
Dichloromethane solvent extracts: Lane 1: pH 3, 
Lane 2: pH 4, Lane 3: pH 5, Lane 4: pH 6, Lane 5: 
pH 7, Lane 6: pH 8, Lane 7: pH 9. 
Figure K12: S. aureus 4 (DRW isolate) – 
Dichloromethane solvent extracts: Lane 1: pH 3, 
Lane 2: pH 4, Lane 3: pH 5, Lane 4: pH 6, Lane 5: 
pH 7, Lane 6: pH 8, Lane 7: pH 9.




Figure K13: S. aureus ATCC 33591 – Ethyl 
acetate solvent extracts: Lane 1: pH 3, Lane 2: 
pH 4, Lane 3: pH 5, Lane 4: pH 6, Lane 5: pH 7, 
Lane 6: pH 8, Lane 7: pH 9, Lane 8: solvent 
control. 
 
Figure K14: S. aureus 4 (DRW isolate) – Ethyl 
acetate solvent extracts: Lane 1: pH 3, Lane 2: 
pH 4, Lane 3: pH 5, Lane 4: pH 6, Lane 5: pH 7, 
Lane 6: pH 8, Lane 7: pH 9. 
 
Figure K15: S. aureus ATCC 33591 – n-butanol 
solvent extracts: Lane 1: pH 3, Lane 2: pH 4, 
Lane 3: pH 5, Lane 4: pH 6, Lane 5: pH 7, Lane 6: 
pH 8, Lane 7: pH 9. 
Figure K16: S. aureus 4 (DRW isolate) – n-
butanol solvent extracts: Lane 1: pH 3, Lane 2: 
pH 4, Lane 3: pH 5, Lane 4: pH 6, Lane 5: pH 7, 
Lane 6: pH 8, Lane 7: pH 9. 





      
Figure K17: S. aureus ATCC 33591 – petroleum 
ether solvent extracts: Lane 1: pH 3, Lane 2: pH 
4, Lane 3: pH 5, Lane 4: pH 6, Lane 5: pH 7, Lane 
6: pH 8, Lane 7: pH 9. 
Figure K18: S. aureus 4 (DRW isolate) – 
petroleum ether solvent extracts: Lane 1: pH 3, 
Lane 2: pH 4, Lane 3: pH 5, Lane 4: pH 6, Lane 5: 








Small - scale purification of crude EtOAc extracts from airlift reactor fermentation broth using 
gradient elution column chromatography method 
 
Figure L1: Bioautography assay of silica gel purified crude EtOAc extracts from airlift reactor 
fermentation broth against DRW isolate S. aureus 4. Lane 1 – 17: Fractions 1 – 17. 
 
Figure L2: Bioautography assay of silica gel purified crude EtOAc extracts from airlift reactor 
fermentation broth against DRW isolate S. aureus 4. Lane 18 – 34: Fractions 18 – 34. 
 




Figure L3: Bioautography assay against B. cereus 
(DRW isolate) – Lane A: Fraction A; Lane B: 
Fraction B; Lane C: Fraction C; Lane D: Fraction 
D; Lane E: Fraction E; Lane F: Fraction F; Lane G: 
Fraction G; Lane H: Fraction H. 
Figure L4: Bioautography assay against E. 
cloacae 11 (DRW isolate) – Lane A: Fraction A; 
Lane B: Fraction B; Lane C: Fraction C; Lane D: 
Fraction D; Lane E: Fraction E; Lane F: Fraction 
F; Lane G: Fraction G; Lane H: Fraction H.
  
Figure L5: Bioautography assay against E. coli K4 
CCA (DRW isolate) – Lane A: Fraction A; Lane B: 
Fraction B; Lane C: Fraction C; Lane D: Fraction 
D; Lane E: Fraction E; Lane F: Fraction F; Lane G: 
Fraction G; Lane H: Fraction H. 
Figure L6: Bioautography assay against E. 
faecalis (DRW isolate) – Lane A: Fraction A; Lane 
B: Fraction B; Lane C: Fraction C; Lane D: 
Fraction D; Lane E: Fraction E; Lane F: Fraction 
F; Lane G: Fraction G; Lane H: Fraction H. 




Figure L7: Bioautography assay against K. 
pneumonia 1 (DRW isolate) – Lane A: Fraction 
A; Lane B: Fraction B; Lane C: Fraction C; Lane D: 
Fraction D; Lane E: Fraction E; Lane F: Fraction 
F; Lane G: Fraction G; Lane H: Fraction H. 
Figure L8: Bioautography assay against K. 
pneumonia 3 (DRW isolate) – Lane A: Fraction 
A; Lane B: Fraction B; Lane C: Fraction C; Lane D: 
Fraction D; Lane E: Fraction E; Lane F: Fraction 
F; Lane G: Fraction G; Lane H: Fraction H. 
  
Figure L9: Bioautography assay against P. 
aeruginosa (DRW isolate) – Lane A: Fraction A; 
Lane B: Fraction B; Lane C: Fraction C; Lane D: 
Fraction D; Lane E: Fraction E; Lane F: Fraction 
F; Lane G: Fraction G; Lane H: Fraction H. 
Figure L10: Bioautography assay against S. 
aureus 1 (DRW isolate) – Lane A: Fraction A; 
Lane B: Fraction B; Lane C: Fraction C; Lane D: 
Fraction D; Lane E: Fraction E; Lane F: Fraction 
F; Lane G: Fraction G; Lane H: Fraction H. 




      
 
  
Figure L11: Bioautography assay against S. 
aureus 5 (DRW isolate) – Lane A: Fraction A; 
Lane B: Fraction B; Lane C: Fraction C; Lane D: 
Fraction D; Lane E: Fraction E; Lane F: Fraction 
F; Lane G: Fraction G; Lane H: Fraction H. 
Figure L12: Bioautography assay against S. 
enterica 4C (DRW isolate) – Lane A: Fraction A; 
Lane B: Fraction B; Lane C: Fraction C; Lane D: 
Fraction D; Lane E: Fraction E; Lane F: Fraction 
F; Lane G: Fraction G; Lane H: Fraction H. 
  




Determining the molecular weight of proteins partially purified using sodium dodecyl 
sulphate – polyacrylamide gel electrophoresis (SDS-PAGE) assay 
 
 
Figure M1: SDS-PAGE on partially purified extracellularly produced compounds by CZA14T. Lane 1: 
Unknown compound of interest - Pellet in 20 mM Tris-HCl after A/S precipitation, dialysis, and 
extraction with 2:3 v/v ethyl acetate (EtOAc) and reconstituted with 20 mM Tris-HCl to 50 x concentrate; 
Lane 4: Crude SNF after A/S precipitation; Lane 7: Dialysate. 





Figure M2: Line graph of standard curve of log Mw (kDa) of standards vs Rf values measured of 
standards. Extrapolation of graph to determine Mw of unknown compound of interest (red dot). 
 
Bioassays 
Filter disk diffusion assay on purified EtOAc extracts 
 
Figure M3 Filter disk diffusion assay of 50 x concentrated EtOAc extract extracted from pellet in 20 
mM Tris-HCl after A/S precipitation, dialysis and extraction with 2:3 v/v EtOAc  against DRWH 
isolate S. enterica 4C. 
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Bioautography assay to determine bio-active metabolites on purified EtOAc extracts 
 








































Figure N1: UV absorption spectrum of extracellularly produced crude compounds 
 
 
Figure N2: UV absorption spectrum of intracellularly produced crude compounds 




Ultra Violet (UV) light 
 
 
Figure O1: Developed TLC visualised under short wave 254 nm ultraviolet light. Ethyl acetate extracts 
were separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Partial purification of pooled crude extra- and intra- cellularly (SNF and cell mass, 
respectively) produced compounds using silica gel column chromatography. Lane 1: fraction A; Lane 2: 
fraction B; Lane 3: fraction C; Lane 4: fraction D; Lane 5: fraction E; Lane 6: fraction F; Lane 7: fraction G; 
Lane 8: fraction H; Lane 9:  50 x concentrated EtOAc extract extracted from pellet in 20 mM Tris-HCl 













Figure O2: Developed TLC visualised under long wave 365 nm ultraviolet light. Ethyl acetate extracts 
were separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Partial purification of pooled crude extra- and intra- cellularly (SNF and cell mass, 
respectively) produced compounds using silica gel column chromatography. Lane 1: fraction A; Lane 2: 
fraction B; Lane 3: fraction C; Lane 4: fraction D; Lane 5: fraction E; Lane 6: fraction F; Lane 7: fraction G; 
Lane 8: fraction H; Lane 9:  50 x concentrated EtOAc extract extracted from pellet in 20 mM Tris-HCl 
after A/S precipitation, dialysis and extraction with 2:3 v/v EtOAc  













Figure O3: Developed TLC visualised after staining with iodine. Ethyl acetate extracts were separated 
using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane (5:4:1:0.02 
v/v/v/v). Partial purification of pooled crude extra- and intra- cellularly (SNF and cell mass, respectively) 
produced compounds using silica gel column chromatography. Lane A: fraction A; Lane B: fraction B; 
Lane C: fraction C; Lane D: fraction D; Lane E: fraction E; Lane F: fraction F; Lane G: fraction G; Lane H: 
fraction H; Lane PP:  50 x concentrated EtOAc extract extracted from pellet in 20 mM Tris-HCl after 
A/S precipitation, dialysis and extraction with 2:3 v/v EtOAc.   
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ρ – anisaldehyde – sulphuric acid stain 
 
Figure O4: Developed TLC visualised after staining with ρ – anisaldehyde. Ethyl acetate extracts were 
separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Partial purification of pooled crude extra- and intra- cellularly (SNF and cell mass, 
respectively) produced compounds using silica gel column chromatography. Lane A: fraction A; Lane B: 
fraction B; Lane C: fraction C; Lane D: fraction D; Lane E: fraction E; Lane F: fraction F; Lane G: fraction G; 
Lane H: fraction H; Lane PP:  50 x concentrated EtOAc extract extracted from pellet in 20 mM Tris-
HCl after A/S precipitation, dialysis and extraction with 2:3 v/v EtOAc.   
 
  





Figure O5: Developed TLC visualised after staining with ninhydrin. Ethyl acetate extracts were separated 
using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane (5:4:1:0.02 
v/v/v/v). Partial purification of pooled crude extra- and intra- cellularly (SNF and cell mass, respectively) 
produced compounds using silica gel column chromatography. Lane A: fraction A; Lane B: fraction B; 
Lane C: fraction C; Lane D: fraction D; Lane E: fraction E; Lane F: fraction F; Lane G: fraction G; Lane H: 
fraction H; Lane PP:  50 x concentrated EtOAc extract extracted from pellet in 20 mM Tris-HCl after 
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Vanillin-sulphuric acid stain 
 
Figure O6: Developed TLC visualised after staining with vanillin-sulphuric acid. Ethyl acetate extracts 
were separated using a solvent system consisting of chloroform: formic acid: ethyl acetate: n-hexane 
(5:4:1:0.02 v/v/v/v). Partial purification of pooled crude extra- and intra- cellularly (SNF and cell mass, 
respectively) produced compounds using silica gel column chromatography. Lane A: fraction A; Lane B: 
fraction B; Lane C: fraction C; Lane D: fraction D; Lane E: fraction E; Lane F: fraction F; Lane G: fraction G; 
Lane H: fraction H; Lane PP:  50 x concentrated EtOAc extract extracted from pellet in 20 mM Tris-














Figure O7: Developed TLC visualised after staining with vanillin-sulphuric acid under 365nm long-
wave UV light. Ethyl acetate extracts were separated using a solvent system consisting of chloroform: 
formic acid: ethyl acetate: n-hexane (5:4:1:0.02 v/v/v/v). Partial purification of pooled crude extra- and 
intra- cellularly (SNF and cell mass, respectively) produced compounds using silica gel column 
chromatography. Lane A: fraction A; Lane B: fraction B; Lane C: fraction C; Lane D: fraction D; Lane E: 
fraction E; Lane F: fraction F; Lane G: fraction G; Lane H: fraction H; Lane PP:  50 x concentrated EtOAc 
extract extracted from pellet in 20 mM Tris-HCl after A/S precipitation, dialysis and extraction with 















































1 Siderophore 5/1 
Desferrioxamine 
B 
83 21 Terpene 180/21 Unknown - 41 NRPS 400/41 Unknown - 
2 NRPS 11/2 Friulimicin 54 22 Terpene 184/22 Hopene 53 42 NRPS 408/42 Unknown - 
3 Lassopeptide 20/3 Borrelidin 4 23 NRPS 195/23 Zorbamycin 8 43 NRPS 413/43 Unknown - 
4 Terpene 32/4 Albaflavenone 100 24 PKS-II 196/24 Curamycin 100 44 NRPS 419/44 Unknown - 
5 NRPS 33/5 SF2575 4 25 Siderophore 201/25 Unknown - 45 OtherKS-PKS-I 421/45 Unknown - 
6 Siderophore 36/6 Unknown - 26 Terpene 211/26 Isorenieratene 42 46 Bacteriocin 435/46 Unknown - 
7 Bacteriocin 48/7 Unknown - 27 PKS-III 221/27 Azinomycin B 6 47 NRPS 438/47 Unknown - 
8 Other 53/8 Unknown - 28 Ectoine 222/28 Kosinostatin 18 48 NRPS 462/48 Unknown - 
9 Amglyccycl-NRPS 54/9 Unknown - 29 NRPS 232/29 Quinomycin 11 49 NRPS 465/49 Unknown - 
10 Terpene 59/10 Unknown - 30 Other 236/30 Unknown - 50 Terpene 518/50 Carotenoid 27 




12 Bacteriocin 65/12 Unknown - 32 Bacteriocin 302/32 Unknown - 52 NRPS 530/52 Unknown - 
13 Butyrolactone 88/13 
Neocarzinostati
n 




96/14 Kosinostatin 14 34 NRPS 328/34 Unknown - 54 NRPS 542/54 Unknown - 
15 Ectoine 104/15 Ectoine 100 35 PKS-I 336/35 Antimycin 13 55 NRPS 556/55 Unknown - 
16 PKS-I 116/16 Divergolide 13 36 OtherKS 344/36 Unknown - 
   
  
17 Melanin 138/17 Melanin 80 37 Lantipeptide 372/37 Unknown - 
   
  
18 PKS-II 149/18 Xantholipin 12 38 NRPS 376/38 Althiomycin 33 
   
  
19 NRPS 159/19 SW-163 14 39 NRPS 389/39 Unknown  
   
  
20 Lassopeptide 172/20 Laspartomycin 20 40 NRPS 399/40   
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Direct bioassay of native-PAGE gels against DRWH isolate - Staphylococcus aureus 4  
10 % resolving gel (see Appendix 5A) with a 4 % stacking gel was used during native-PAGE. 
Native-PAGE is a non-denaturing gel electrophoresis which involves the absence of SDS in the 
gel and dithriothreitol (DTT) in the loading buffer, no boiling of the sample is performed and no 
SDS is added to the electrode/running buffer as the aim of a native-PAGE assay is to retain the 
secondary structures of the proteins of interest. SDS-PAGE gels were also not included as SDS 
could have inhibitory effects against test strain which will render inconclusive results. The 
native-PAGE gel was directly assayed against DRWH isolate - Staphylococcus aureus 4 by placing 
the stained gel onto a petri dish containing Mueller Hinton agar (MHA) medium (g/L: 2 
beef/meat extract, 17.5 casein hydrolysate, 1.5 starch and 17 bacteriological agar, pH 7.3) and 
overlaid with sterile 0.7 % nutrient broth sloppy agar inoculated with S. aureus 4. The number 
of μLs of test bacteria used per 6 ml sloppy agar overlay was such that when multiplying the 
number of μLs of bacterial culture used per sloppy agar by the OD600 of the broth culture 
approximate values of: 4 OD600 – μL for S. aureus 4 was achieved. The sloppy agar was allowed to 
set, inverted, incubated overnight at optimal temperature (37 °C) and the zones of inhibition 
were recorded.  
Bioassay was performed against DRWH isolate S. aureus 4 on the native-PAGE containing 
partially purified EtOAc and 20 mM Tris-HCl extracts, respectively. Lanes 1 and 2 contains the 
EtOAc extracted 20 mM Tris-HCl resuspended pellet after A/S precipitation and dialysis. The A/S 
(80 %) pellet resuspended in 20 mM Tris-HCl and dialysate was loaded into lanes 3 and 4, 
respectively (Figure 8.98). These samples were included in the assay to determine whether the 
active compound was in the EtOAc extract or in the partially purified 20 mM Tris-HCl samples. 
Results of the compound of interest and the inhibitory effects of the compound against S. 








Figure Q1: Coomassie stained native-PAGE on CZA14T partially purified samples. Lane 1 and 2 - Pellet in 
20 mM Tris-HCl after A/S precipitation, dialysis, and extraction with 2:3 v/v ethyl acetate (EtOAc) and 
reconstituted with 20 mM Tris-HCl to 50 x concentrate. Lane 3 - A/S (80 %) pellet resuspended in 20 mM 
Tris-HCl. Lane 4 – dialysate.  
 
Figure Q2: Direct assay of Coomassie stained native-PAGE on CZA14T partially purified samples against 
DRWH isolate S. aureus 4. . Lane 1 and 2 - Pellet in 20 mM Tris-HCl after A/S precipitation, dialysis, and 
extraction with 2:3 v/v ethyl acetate (EtOAc) and reconstituted with 20 mM Tris-HCl to 50 x concentrate. 
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The 6.7 kDa protein/s of interest were subjected to direct bioassay by overlaying the native-
PAGE gel that contained the unknown protein with sloppy agar containing DRWH isolate S. 
aureus 4 to determine whether the compound of interest was active. A large zone of inhibition 
was detected for the first replicate around the entire area from the wells to where the 
compounds migrated within the gel during resolving via electrophoresis. However, a zone of 
inhibition only occurred around the wells of the gel for the duplicate sample. The sample may 
not have migrated sufficiently. No activity occurred against the 20 mM Tris-HCl control samples. 
The active compounds were thus only in the EtOAc solvent extracted compounds after salt 
precipitation and dialysis, reconstituted in 20 mM Tris-HCl. The test should be repeated as clear 
activity was only detected in one of the replicates. 
  




Polymerase chain reaction (PCR) screening for the biosynthetic genes involved in the 
production of aromatic Type-II polyketide synthases (PKS-II) 
  
Figure R1: 1 % TBE agarose gel electrophoretogram of PCR amplification of type-II PKS gene of gDNA 
products isolated from S. pharetrae sp. strain CZA14T. Lane 1: 1kb Kapa Biosystems universal molecular 
weight marker, Lanes 2 - 13: Gradient PCR amplification of gDNA for the genes involved in the synthesis 
of type-II PKS. 
 
Figure R2: 1 % TAE agarose gel electrophoretogram of PCR amplification of RNA and DNA samples with 
universal 16S rRNA primers. Lane 1 and 2: RNA extracted from samples taken at day 0; Lane 3 and 4: 
RNA extracted from samples taken at day 3; Lane 5 and 6: RNA extracted from samples taken at day 6; 
Lane 7 and 8: RNA extracted from samples taken at day 9; Lane 9 and 10: RNA extracted from samples 
taken at day 12; Lane 12: Control containing RNA control; Lane 13: Control containing water; Lane 15 
and 16: DNA positive control isolated from Streptomyces polyantibioticus sp. nov., Lane 18: 1kb Kapa 
Biosystems universal molecular weight marker. 




Figure R3: 1 % TBE agarose gel electrophoretogram of cDNA converted from RNA extracted from 
fermentation samples taken at different time periods from an airlift bioreactor. Lanes 1 and 16: 1kb 
Kapa Biosystems universal molecular weight marker, Lanes 3 and 4: cDNA of samples taken at day 0, 
Lanes 5 and 6: cDNA of samples taken at day 3; Lanes 7 and 8: cDNA of samples taken at day 6; Lanes 9 
and 10: cDNA of samples taken at day 9; Lanes 11 and 12: cDNA of samples taken at day 12; Lane 13: 
Control containing RNA control; Lane 14: Control containing water. 
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